Dynamic Regulation of Aryl Hydrocarbon Receptor Function and Activity by Different Stimuli by Lücke, Sandra
 From the Institute of Environmental Medicine  
Karolinska Institutet, Stockholm, Sweden 
 
Dynamic Regulation of                              
Aryl Hydrocarbon Receptor 
Function and Activity                              
by Different Stimuli 
Sandra Lücke 
 
 
Stockholm 2010 
 
 
 
  
 
2010
Gårdsvägen 4, 169 70 Solna
Printed by
All previously published papers were reproduced with permission from the publisher. 
 
Published by Karolinska Institutet. Printed by Reproprint. 
 
© Sandra Lücke, 2010 
ISBN 978-91-7409-851-8 
 “What we know is a drop,  
what we don´t know an 
ocean.” 
Isaac Newton 

  
ABSTRACT 
Cells have to sense and adapt to changes in their surrounding environment. Most of the 
cellular responses to environmental and developmental stimuli are mediated by PAS 
(Per-ARNT-Sim) proteins. A member of this family of proteins is the aryl hydrocarbon 
receptor (AhR), a ligand-activated bHLH transcription factor and E3 ubiquitin ligase. 
Many xenobiotics, in particular the highly toxic 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD), bind to and activate the AhR giving this receptor a critical role in mediating 
xenobiotic-induced toxicity and carcinogenesis. Developmental defects in AhR-/- mice, 
the strong evolutionary conservation of the AhR and its ubiquitous expression imply a 
role of this receptor beyond xenobiotic-induced toxicity and xenobiotic metabolism. 
The physiological function of the AhR has long remained nebulous, but more and more 
experimental evidence emerges for a role of the AhR in proliferation and differentiation 
processes and in the maintenance of cellular homeostasis.   
AhR signaling has mainly been studied upon activation by TCDD, an experimental 
condition that certainly does not mimic the physiological situation. The photoproduct 6-
formylindolo[3,2-b]carbazole which is formed upon irradiation of tryptophan with 
UVB or visible light, has been suggested as a physiological AhR ligand. As shown in 
paper I, FICZ is both a high affinity ligand for the AhR and a good substrate for the 
cytochromes P450 (CYP) family of enzymes and induces its own metabolism 
suggesting a regulatory circuit between the AhR and CYP enzymes. The identification 
of FICZ metabolites in human urine indicates the presence of this ligand or its 
metabolites in biological systems and underlines its physiological relevance.  
The regulation of AhR function and activity in a normal, xenobiotic-free context 
was analyzed in paper II using indolocarbazoles as physiological ligands. Due to their 
rapid metabolism, these ligands evoke a very transient activation of the transcription 
factor and ubiquitin ligase function of the AhR. On the contrary, AhR stimulation by 
TCDD results in a sustained transcriptional activation and a persistent down-regulation 
of AhR and estrogen receptor levels, thereby impairing the receptors responsiveness to 
new stimulation. This mode of action of TCDD and presumably other non-
metabolizable xenobiotics may contribute to their toxicity, whereas dynamic AhR 
regulation seems to be a prerequisite for normal physiological cell signaling. 
The regulation of the AhR when activated by UVB was studied in paper III. Upon 
UVB irradiation, AhR activity and CYP1A1 gene expression were found to be 
modulated by nuclear factor κB, probably as part of the cellular stress response to UV.   
Exposure to UVB and xenobiotics stimulate the formation of protective melanin 
polymers in melanocytes. As shown in paper IV, these cells enhance both their activity 
of tyrosinase, the key enzyme for melanin biosynthesis, and their intracellular melanin 
content upon AhR activation. Melanogenesis was shown to be induced by the AhR 
through the transcriptional up-regulation of melanogenic genes, without effecting 
melanocyte proliferation.   
The results of this study contribute to our knowledge of dioxin toxicity, but first and 
foremost extend our mechanistic understanding of the regulation and functioning of 
AhR signaling under physiological conditions. Moreover, a novel function of the AhR 
in the skin was identified. 
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1 INTRODUCTION 
 
1.1 GENERAL INTRODUCTION 
Cells have to cope and adapt themselves to a variety of environmental conditions. In 
order to respond to stimuli of the changing environment, cells possess extracellular and 
intracellular receptors which sense and transduce the received signals into changes in 
gene expression.  
One of these receptors is the aryl hydrocarbon receptor (AhR), a ligand-activated 
transcription factor and ubiquitin ligase of the Per-ARNT-Sim family of proteins that is 
ubiquitously expressed in all cells. The AhR was originally discovered as a binding site 
for planar, non-halogenated and halogenated xenobiotics, in particular the highly toxic 
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Nearly all toxic and carcinogenic effects 
of these anthropogenically produced compounds are mediated by the AhR. With the 
identification of naturally-occurring compounds as AhR ligands, the sole role of this 
receptor as a sensor for xenobiotics and a mediator of toxicity and carcinogenesis were 
questioned. AhR function and activity have mainly been studied upon activation by 
xenobiotics, an experimental condition that certainly does not mimic the physiological 
situation. Studies on AhR-deficient mice, however, revealed that AhR signaling is 
essential for normal physiological cell signaling. In a number of different tissues, 
including the immune system, the gastrointestinal tract, the reproductive organs, the 
liver and the skin, the AhR regulates proliferation and differentiation processes thereby 
maintaining homeostasis. As a transcription factor and ubiquitin ligase, the AhR is able 
to modulate the expression levels of proteins involved in mediating important normal 
cellular functions. Being such an important modulator of intracellular protein levels, the 
activity of the AhR itself has to be tightly regulated. Numerous molecular mechanisms 
exist to induce and restrict AhR signaling in response to changing environmental 
conditions. Now, it becomes more and more evident that the disturbance and dys-
regulation of normal AhR activity and responsiveness account for the pleiotropic toxic 
effects observed after exposure to xenobiotics. It therefore seems that the AhR can 
rather be considered as a “sensor” of developmental and environmental stimuli than 
exogenous signals in the form of xenobiotics.   
 
 
1.2 PER-ARNT-SIM (PAS) PROTEINS 
Many transcription factors that are involved in the modulation of gene expression in 
response to developmental and environmental stimuli belong to the superfamily of Per-
ARNT-Sim (PAS) proteins. The name PAS originates from the first letters of the 
proteins Per, ARNT and Sim. Per, the Period protein, regulates circadian rhythmicity in 
Drosophila. The aryl hydrocarbon receptor nuclear translocator, abbreviated ARNT, 
was identified as a dimerization partner for both the AhR and the hypoxia-inducible 
factor (HIF-1α), a PAS protein regulating cellular responses to low oxygen. The single-
minded protein (Sim) fulfills important functions in the control of midline cell 
development in Drosophila. In general, PAS proteins can be divided into (i) sensor 
proteins such as AhR and HIF and (ii) partner proteins such as ARNT and Bmal 
(reviewed in Crews and Fan, 1999; Gu et al., 2000).   
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Figure 1. Members of the PAS superfamily of proteins. The basic helix-loop-helix (bHLH) domain is 
depicted in green, the PAS domain with its two repeats, PAS A and B, in blue. The C-terminal region of 
these proteins is variable containing often domains for transactivation (light red) or transrepression (dark 
red).  
 
PAS proteins share a common structural organization (Figure 1) (for review see 
Kewley et al., 2004). The PAS domain, the hallmark of these proteins, consists of a 
region of 230-300 amino acids with two adjacent, highly degenerated repeats, called 
PAS A and PAS B. The PAS domain allows interactions with PAS partner proteins and 
molecular chaperones. In spite of its relative low amino acid sequence homology, this 
region is structurally highly conserved. PAS-like proteins, involved in light sensing and 
oxygen regulation, have also been identified in prokaryotes (Taylor and Zhulin, 1999). 
At their N-terminal end most PAS proteins possess a basic helix-loop-helix (bHLH) 
motif which mediates binding to cognate response elements in the major groove of the 
DNA and interactions with other bHLH proteins. The C-terminal region of these 
proteins often contains a transactivation or transrepression domain and is rather variable 
in its amino acid sequence composition.  
 
 
1.3 THE ARYL HYDROCARBON RECEPTOR (AhR) 
1.3.1 Structure of the AhR 
Based on its structure, the AhR is classified as a bHLH-PAS protein (Figure 2). Among 
all bHLH-PAS proteins that have been characterized with regard to their ability to bind 
ligands, so far only the vertebrate AhR has been shown to bind ligands (reviewed in 
Furness et al., 2007). 
 
 
 
 
 
bHLH PAS 
Per 
ARNT 
SIM 
AhRR 
AhR 
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Figure 2. Schematic representation of the structural and functional organization of the AhR. 
bHLH, basic helix-loop-helix motif; NLS, nuclear localization signal; NES, nuclear export signal; PAS, 
Per-ARNT-Sim domain; TAD: transactivation domain with subdomains. 
 
1.3.1.1 The bHLH motif and the nuclear localization and nuclear export 
signals of the N-terminus 
The basic region of the N-terminal bHLH motif of the AhR mediates sequence-specific 
binding to gene regulatory elements, called xenobiotic response elements (XREs), 
whereas the two α-helices of this region, together with the PAS domain, promote 
dimerization with the partner bHLH-PAS-protein ARNT (Fukunaga and Hankinson, 
1996). Heterodimer formation with ARNT is a prerequisite for DNA-binding. 
Activated AhR fails to bind to DNA in the absence of ARNT, indicating that the AhR 
is not able to interact as a homodimer with its response elements (Probst et al., 1993; 
Whitelaw et al., 1993a). Even though the bHLH motif clearly functions as the DNA-
binding domain of the AhR (Dong et al., 1996; Swanson and Jun-hua, 1996), other 
amino acids outsides this region may as well contribute to interactions with the DNA 
(Sun et al., 1997). 
In addition to the bHLH motif, the N-terminus also harbors a nuclear localization 
signal (NLS) and nuclear export signal (NES), two sequences commonly found in 
proteins shuttling between the cytoplasm and the nucleus. Both sequences, the 
minimum bipartite NLS and the leucine-rich NES, lie in the region of the bHLH motif 
partly overlapping with the basic region respectively the second helix of this motif 
(Ikuta et al., 1998). A second NES, which seems to promote mainly nuclear export of 
unliganded receptor, has been identified in the PAS A repeat (Berg and Pongratz, 
2001). The AhR undergoes dynamic nucleocytoplasmic shuttling, but is mostly 
cytoplasmic in the absence of ligand (Ikuta et al., 2000; Richter et al., 2001). The 
inactive receptor seems to be retained in the cytoplasm due to masking of its NLS by 
chaperone binding and rapid active nuclear export (Antonsson et al., 1995; Ikuta et al., 
1998; Whitelaw et al., 1993b). Translocation of the AhR into the nucleus is essential 
for functional AhR signaling, because mice bearing a receptor variant with a mutated 
NLS show no signs of toxicity after treatment with TCDD (Bunger et al., 2003). AhR 
translocation is mediated by the nuclear pore complex proteins importin α and β, which 
TAD 
Transactivation 
Ligand binding 
HSP90 binding
AhR/ARNT dimerization 
NLS NES 
PAS bHLH 
NES 
HSP90 binding 
DNA-binding
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recognize the dephosphorylated NLS and allow nuclear import (Ikuta et al., 2004b). 
Nuclear export of the receptor occurs through interactions between the chromosome 
region maintenance 1 (CRM1) export receptors and the leucine residues of the NES 
(Ikuta et al., 2000). Nuclear export is required for the restriction of AhR activity by 
degradation via the 26S proteasomal pathway (Davarinos and Pollenz, 1999; Pollenz 
and Barbour, 2000).  
Thus, it seems that the balance between nuclear import and export determines the 
intracellular localization of inactive and activated AhR. As the molecular mechanisms 
underlying this regulation, masking and unmasking as well as phosphorylation and de-
phosphorylation of the two signal sequences have been identified (Ikuta et al., 1998; 
Ikuta et al., 2004a, b; Ikuta et al., 2000).  
 
1.3.1.2 The PAS domain – heterodimer formation, chaperone and ligand 
binding   
Deletion analyses revealed that the PAS domain is involved in (i) AhR/ARNT 
heterodimer formation, (ii) chaperone binding and (iii) ligand recognition (Dolwick et 
al., 1993b; Fukunaga and Hankinson, 1996). By providing a secondary dimerization 
surface in addition to the bHLH region, the PAS domain mediates dimerization with 
ARNT. Within this domain, the PAS A and PAS B repeats fulfill different functions. In 
particular, the PAS A repeat seems to stabilize the dimer formation (Chapman-Smith et 
al., 2004; Lindebro et al., 1995), whereas the PAS B repeat mediates binding of the 
molecular chaperone heat shock protein 90 (HSP90) to the AhR. An additional HSP90 
binding site in the region of the bHLH motif suggests that HSP90 spans over the N-
terminal part of the AhR from the PAS B repeat to the bHLH motif (Fukunaga and 
Hankinson, 1996; Perdew and Bradfield, 1996). Both PAS repeats play an important 
role in mediating the transformation of activated AhR into its DNA-binding form by 
promoting heterodimerization and replacement of HSP90 (Soshilov and Denison, 
2008). 
In addition to the HSP90 binding site, the PAS B repeat covers also the ligand-
binding domain (LBD) of the AhR. Even though the structural and functional domains 
of the AhR have been well characterized, an NMR or X-ray structure of the receptor 
has not yet been solved. By using crystal structures of other PAS proteins (FixL, 
ARNT, HIF) as templates for homology modeling, the LBD of the mouse AhR was 
predicted as a 5-stranded antiparallel β-sheet with a central helix coupled to three small 
helices (Pandini et al., 2007; Procopio et al., 2002). Based on the 3D-structure, a model 
proposes that ligand molecules like TCDD may enter the cavity by displacing the 
central helix. Detailed site-directed mutagenesis, using TCDD as a model ligand, 
identified numerous amino acid residues within the ligand-binding pocket that 
essentially facilitate the entrance and optimal binding of ligand molecules (Pandini et 
al., 2009). For example, alanine 375 has been defined as a key residue for ligand 
recognition in the LBD of the mouse AhR (mAhR) (Murray et al., 2005). Replacement 
of this residue by amino acids with bulky side chains e.g. valine sterically hinders 
ligand binding and leads to profound inter- and intraspecies-specific differences in 
ligand binding affinities (Ema et al., 1994; Moriguchi et al., 2003). The human AhR 
(hAhR), which contains a valine at position 381 (equal to position 375 in mAhR), 
shows a 10-fold lower affinity to TCDD than its murine counterpart. Similar to 
humans, DBA/2J mice possess a receptor variant with a valine residue (at position 
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375). These mice are nearly resistant to the toxic effects of TCDD, whereas C57BL6 
mice, containing a receptor with an alanine residue, are very sensitive (Pohjanvirta and 
Tuomisto, 1994). Binding of molecules other than TCDD, low affinity agonists or 
antagonists, however, seems to be mediated by other amino acids in the ligand-binding 
pocket, suggesting that binding of structurally different molecules is promoted by 
specific subsets of residues (Backlund and Ingelman-Sundberg, 2004; Goryo et al., 
2007; Henry and Gasiewicz, 2008). Partial removal of the LBD renders the receptor 
into a state in which it has lost its capacity to bind both ligands and HSP90 and 
becomes constitutively active with regard to its transcriptional activation properties and 
ubiquitin ligase function (AhR-CA) (Andersson et al., 2002; McGuire et al., 2001; 
Ohtake et al., 2008).  
 
1.3.1.3 The C-terminal transactivation domain (TAD) 
Both the AhR and its partner protein ARNT contain a transactivation domain (TAD) in 
their C-terminal region (Jain et al., 1994). TADs mediate transcriptional initiation by 
recruiting general transcription factors and co-regulators to the transcriptional site. 
Detailed analysis revealed that the TAD of the AhR consists of three subdomains. Each 
of these subdomains shows a rather low transactivation potential itself, but is able to act 
in synergy with the others. The TAD of the hAhR, for instance, consists of an acidic-, 
glutamine (Q)-, and proline/serine/threonine (PST)-rich subdomain, of which the Q-
rich domain is absolutely essential for transactivation activity (Kumar et al., 2001; 
Rowlands et al., 1996) .  
Another possible function of the C-terminal region including the TAD was revealed 
by degradation studies using AhR mutant variants. Receptor variants truncated at the 
carboxyl-end and TAD were improperly degraded upon ligand activation, suggesting 
that the TAD may also serve as a degron, a structural motif important for proteasomal 
degradation of proteins (Ma and Baldwin, 2000).  
 
1.3.2 The dual function of the AhR   
The AhR has been shown to possess two intrinsic functions (Figure 3). On the one 
hand, the receptor serves as a ligand-activated transcription factor regulating the 
expression of genes containing XREs in their 5´-flanking regions (see a review in 
Beischlag et al., 2008). On the other hand, the AhR functions as a ligand-dependent 
ubiquitin E3 ligase targeting itself and other substrate proteins for proteasomal 
degradation (reviewed by Ohtake et al., 2009). So far, this ubiquitin ligase function 
seems to be unique for the AhR among all sequence-specific transcription factors. 
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Figure 3. The dual function of the AhR. The AhR is both a ligand-activated transcription factor and a 
ligand-dependent ubiquitin E3 ligase targeting itself and substrate proteins such as steroid receptors and 
β-catenin for proteasomal degradation (modified after Ohtake et al., 2009). 
 
1.3.2.1 The AhR as a transcriptional regulator - translocation, XRE-
binding and transcriptional activation of target genes 
The molecular events, following AhR activation by ligands that lead to the 
transcriptional up-regulation of AhR target genes, are fairly well understood (Figure 4). 
In its latent form, the AhR resides in the cytoplasm bound to a complex of molecular 
chaperones (reviewed in Petrulis and Perdew, 2002) consisting of two molecules of 
HSP90 (Chen and Perdew, 1994; Perdew, 1988), the immunophilin hepatitis B virus X-
associated protein 2 (XAP) (Carver and Bradfield, 1997; Ma and Whitlock, 1997; 
Meyer et al., 1998) and p23 (Kazlauskas et al., 1999). The two molecules of HSP90 
assist the proper folding of the receptor and stabilize it in the cytoplasm in a 
conformation capable to bind ligands. Disruption of the HSP90-AhR complex impairs 
the receptor to bind ligands (Pongratz et al., 1992) and targets it to proteasomal 
degradation (Chen et al., 1997; Pollenz and Buggy, 2006; Song and Pollenz, 2002). The 
removal of unliganded, improper folded receptor seems not to require DNA-binding 
prior to degradation and employs mechanisms different from the proteolysis of ligand-
activated receptor (Pollenz et al., 2005). Overall, it appears that HSP90 plays an 
essential role in holding the receptor in a functional, ligand-responsive state. The 
immunophilin XAP, also termed ARA9 (AhR associated protein 9) or AIP (Ah 
receptor-interacting protein), has also been implicated in the stabilization of the 
cytoplasmic AhR-HSP90 complex by interacting via its tetraticopeptide repeats with 
HSP90 and the AhR (Bell and Poland, 2000; Carver et al., 1998). However, its exact 
molecular role in AhR signaling remains unclear (Pollenz and Dougherty, 2005; 
Pollenz et al., 2006). While in mouse cells XAP modulates the localization of mAhR 
partly by disrupting nuclear translocation via importin β (Petrulis et al., 2003) and 
   7 
hindering degradation (Kazlauskas et al., 2000), the subcellular localization of the 
human receptor appears not to be significantly affected by XAP (Ramadoss et al., 
2004), indicating differences in XAP-AhR interactions. XAP mediates also interactions 
between the AhR and EBNA-3, an Epstein-Barr virus-encoded protein implied in the 
regulation of lymphocyte proliferation and transformation (Kashuba et al., 2006).  
Nevertheless, XAP seems to be important for the cytoplasmic stability and distribution 
of the unliganded, inactive receptor. Bound to the ATP-binding domain of HSP90, p23 
has been implicated in the stabilization of the liganded complex during translocation to 
the nucleus (Kazlauskas et al., 1999) and in the transformation of the complex to its 
AhR/ARNT-DNA-bound form (Shetty et al., 2003). However, the exact role of p23 in 
AhR signaling is questioned, since p23- heterozygous mice and p23-deficient embryos 
showed no direct signs of disrupted signaling (Flaveny et al., 2009). 
 
Figure 4.  The molecular mechanisms underlying the activation of the transcription factor function 
of the AhR by ligands. In its latent form, the AhR resides in the cytoplasm bound to a complex of 
molecular chaperones (HSP90, XAP and p23). Upon ligand binding, the AhR translocates into the 
nucleus and heterodimerizes with its partner protein ARNT. The AhR-ARNT dimer binds to xenobiotic 
response elements (XREs) in the promoter region of target genes and regulates their transcription. BTE, 
basal transcription element; TF, transcription factors; TBP, TATA-binding protein.  
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Upon ligand binding, the complex translocates to the nucleus. Concomitantly with 
the release of the HSP90 molecules, the AhR can undergo dimerization with ARNT 
(Heid et al., 2000). Studies on ARNT-deficient cells (murine hepatoma cells Hepa-1 
c4) revealed that ARNT is absolutely required for the formation of the DNA-bound, 
transcriptional active dimer (Probst et al., 1993; Whitelaw et al., 1993a). Once the 
AhR-ARNT heterodimer has been formed (Reyes et al., 1992), it binds to its cognate 
response elements (XREs) (core nucleotide sequence  5´-TNGCGTG-3´) in the 5´-
flanking region of target genes (reviewed in Swanson, 2002). The AhR binds to the 
TNGC half-site of the core sequence, whereas ARNT interacts with the typical GTG 
site, to which many bHLH transcription factors bind (Bacsi et al., 1995). The 
identification of extended XREs suggests that additional nucleotides outside the core 
sequence contribute to dimer-XRE interactions.  
Following binding of the AhR-ARNT dimer, one model proposes the bending of the 
DNA into a configuration that allows contact between the dimer at the enhancer and the 
basal transcriptional machinery at the promoter (Tian et al., 2003). Via the subdomains 
of its TAD, the AhR interacts with basal transcription factors (Rowlands et al., 1996) 
and concomitantly recruits co-factors (reviewed in Hankinson, 2005). As shown for the 
well-established AhR target gene CYP1A1, this gene is silenced by nucleosomes but 
becomes active after nucleosome repositioning following AhR activation by TCDD 
(Whitlock, 1999). Thus, interactions between the AhR-ARNT dimer and histone 
acetylases and components of the chromatin remodeling machinery may also take place 
at these sites and histone modifications and chromatin remodeling, including 
repositioning of nucleosomes, are prerequisites for the initiation and facilitation of 
transcription. 
Among the hundreds of AhR target genes identified are e.g. genes encoding phase I 
metabolizing enzymes e.g. CYP1A1, CYP1A1, CYP1B1 (see a review in Fujii-
Kuriyama and Mimura, 2005), phase II metabolizing enzymes e.g. UDP-glucuronosyl 
transferase, glutathione S-transferase Ya and NADP(H)oxidoreductase, the repressor of 
AhR function, AhRR, and genes involved in cell cycle regulation and cell 
differentiation. 
 
1.3.2.2 The ubiquitin ligase activity of the AhR  
Besides functioning as a transcriptional regulator, the AhR acts also as an ubiquitin E3 
ligase. In general, substrate-specific E3 ligases associate with their substrate proteins 
thereby enabling E2 ubiquitin conjugating enzymes to tag the substrate with ubiquitin 
for degradation via the ubiquitin 26S proteasomal pathway (Schwartz and Ciechanover, 
2009). Unlike typical CUL4BDCFA E3 ligases which contain DDB1- and CUL4-
associated factors (DCFA) as substrate-specific adaptors, the CUL4BAhR complex uses 
activated AhR for substrate recognition. The CUL4BAhR complex consists of the 
scaffold protein CUL4B, the β-transducin-like protein TBL3, the ring finger protein 
RBX1, subunits of the proteasomal 19S particle, DDB1, ARNT and activated AhR and 
is only assembled and functional in the context of activated AhR (Ohtake et al., 2007). 
So far, the only substrate proteins identified for this atypical ligase complex are β-
catenin (Kawajiri et al., 2009) and the steroid receptors, estrogen receptors (ERα, ERβ) 
and androgen receptor (AR) (Ohtake et al., 2007). Down-regulation of ERα protein 
levels was noted in cells treated with TCDD in the absence of estrogen (E2) (Wormke 
et al., 2000; Wormke et al., 2003). Similar to the ERα, AhR levels are also reduced 
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upon TCDD treatment (reviewed by Pollenz, 2002) indicating that ligand-induced 
degradation of the receptor is partly mediated by its own ubiquitin ligase function 
(Kawajiri et al., 2009; Ohtake et al., 2007). Self-ubiquitination has also been observed 
for other substrate adaptors of E3 ligase complexes.  
 
Taken together, the AhR functions both as a ligand-activated transcription factor and 
ubiquitin ligase. Equipped with these two functions, the AhR is able to modulate the 
expression, function and activity of other proteins in response to exogenous and 
endogenous stimuli.  
 
 
1.4 REGULATION OF AhR SIGNALING 
Due to its essential role in the modulation of intracellular protein levels, the AhR itself 
has to be tightly regulated. Several, complex mechanisms have been identified in the 
regulation of this signaling pathway (Figure 5) (reviewed in Fujii-Kuriyama and 
Kawajiri, 2010; Harper et al., 2006).  
Figure 5. Schematic overview over the mechanisms regulating AhR signaling. (I) AhR activation by 
ligands and modulation of the activity of  ligand-activated AhR by phosphorylation. (II) Ligand-induced 
expression of the CYP1 enzymes results in the metabolic clearance of activating ligands. (III) Activated 
AhR induces the expression of the AhR repressor (AhRR). The AhRR suppresses, among others, the 
receptors own expression by interactions with histone deacetylases (HDACs). (IV) The AhR can be 
positively or negatively regulated by crosstalk with other signaling pathways. (V) Regulation of AhR 
activity by modulation of receptor expression levels. AhR activity is restricted by ligand-induced 
degradation.  
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1.4.1 Binding of ligands 
The AhR can be activated by various, structurally diverse compounds. A typical AhR 
ligand is hydrophobic and planar in its structure and enters the cell by diffusion across 
the cell membrane. The dioxin molecule complies with all these features, making this 
compound a prototypical high affinity AhR ligand. Molecules of the size of TCDD 
easily fit in the ligand-binding pocket of the AhR, which was estimated to be 
approximately 14Å*12Å*5Å, whereas ligands with larger size may not be 
accommodated in the pocket. With the continuously identification of novel ligands, 
however, there is more and more evidence that the ligand-binding pocket of the AhR is 
more promiscuous with regard to ligand size and structure than previously predicted. A 
promiscuous ligand-binding pocket would allow the sensing of a broader spectrum of 
compounds making it thereby possible for the receptor to respond to a greater variety of 
different environmental stimuli (reviewed in Denison et al., 2002).  
Among the ligands that have been identified to bind to the AhR are both xenobiotic and 
naturally-occurring compounds (see Box 1) (reviewed by Denison and Nagy, 2003; 
Nguyen and Bradfield, 2007). Developmental defects in AhR-/- mice (Fernandez-
Salguero et al., 1995; Schmidt et al., 1996), the strong evolutionary conservation of the 
Xenobiotic compounds 
Halogenated aromatic hydrocarbons 
   2,3,7,8-tetrachlorodibenzo-p-dioxin 
   2,3,7,8-tetrachlorodibenzofuran 
   2,3,6,7-tetrachloronapthalene 
   3,3´,4,4´-tetrachloroazoxybenzene 
   3, 3´,4,4´,5-pentachlorobiphenyl 
Polycyclic aromatic hydrocarbons 
   benzo[a]pyrene 
   β-napthoflavone (β-NF) 
   3-methylcholantrene    
 
    
Naturally-occurring compounds 
Arachidonic acid metabolites 
   lipoxin 4A, prostaglandins B3,D3,F3a,G2, H1,H2 
Flavonoids: curcumin 
Carotenoids: canthaxanthin, astaxanthin,                  
quercetin 
Indoles 
   indigo, indirubin 
   6-formylindolo[3,2-b]carbazole (FICZ) 
   6,12-diformylindolo[3,2-b]carbazole (dFICZ) 
   indolo[3,2-b]carbazole (ICZ) 
   3,3´-diindolylmethane (DIM) 
tryptamine (TA), indole acetic acid (IAA),      
kynurenic acid 
2-(1´H-indole-3´-carbonyl)-thiazole-4-carboxylic    
acid methyl ester (ITE) 
Heme metabolites 
   bilirubin, biliverdin, hemin 
Malassezin 
Equilenin 
Box 1. AhR activators  
Other activators 
cAMP, oxLDL, omeprazole, primaquine, nicotine, pyridines, disruption of cell-cell contacts 
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receptor (reviewed in Hahn, 2002), the inability of ancestral AhR to bind xenobiotics 
and its activation in cells in the absence of ligand treatment (Chiaro et al., 2007; Ikuta et 
al., 2004a; Sadek and Allen-Hoffmann, 1994a) suggest the existence of endogenous 
ligands. Several of the naturally-occurring compounds have been proposed as 
endogenous ligands. However, for many of these compounds their formation and 
physiological role in vivo have to be confirmed. It is tempting to speculate that the 
promiscuity of the ligand-binding pocket of the AhR may be due to the existence of 
several endogenous ligands. 
 
Xenobiotic compounds. Among potent AhR activators are the halogenated aromatic 
hydrocarbons (HAHs) and polycyclic aromatic hydrocarbons (PAHs). These synthetic 
compounds are mainly anthropogenically produced during incomplete combustion, 
waste incineration, as flame retardants and insulators and as by-products in the 
manufacturing process of chemicals and pesticides. Many of these environmental 
contaminants are fairly resistant to microbiological and chemical degradation and have 
the ability to bio-accumulate in the food chain. They can activate the AhR in pM 
(HAHs) to µM (PAHs) concentrations and evoke multiple toxic responses in exposed 
organisms (reviewed in Poland and Knutson, 1982).     
 
Naturally-occurring compounds. This group of ligands contains structurally diverse 
compounds from all different kinds of sources. Numerous compounds are derived from 
plant products e.g. flavonoids, indigoids and derivates of the indole-3-carbinole (I3C). 
Flavonoids and carotenoids and related compounds, which are taken up through 
consumption of tea, fruits, and vegetables, show low AhR-activating capacity. On the 
other hand, indirubin and indigo, two indigoids produced by cytochromes P450s from 
indoles, are rather good AhR activators (Adachi et al., 2001; Guengerich et al., 2004). 
Even though they have been identified in serum and human urine (Adachi et al., 2001), 
their formation in vivo has not yet been shown. I3C is derived from glucobrassicin, a 
tryptophan-based second plant metabolite, and is found in vegetables from the Brassica 
genus. I3C can be converted to the potent AhR ligand indolo[3,2-b]carbazole (ICZ) by 
the intestinal flora and the acidic environment of the stomach (Bjeldanes et al., 1991). 
A second indolocarbazole and high affinity ligand, activating the AhR at pM-nM 
concentrations, is 6-formylindolo[3,2-b]carbazole (FICZ). FICZ is derived by 
photolysis of the amino acid tryptophan (Rannug et al., 1987; Rannug et al., 1995) and 
can be formed intracellular in UVB-irradiated cells (Fritsche et al., 2007). Other 
compounds derived from tryptophan are indole acetic acid (IAA) and tryptamine, both 
weak AhR activators (Heath-Pagliuso et al., 1998), and the more potent ligand 
kynurenic acid (DiNatale et al., 2010). Furthermore, bilirubin, biliverdin and hemin, 
degradation products of the heme pathway, have been identified to activate the AhR at 
µM concentrations. Of these three compounds, bilirubin, which is derived from hemin 
and biliverdin, is the most potent one. However, it remains unclear whether these 
compounds are present in relevant concentrations under non-pathological conditions 
(Phelan et al., 1998; Sinal and Bend, 1997). Also, arachidonic acid metabolites, 
including lipoxin A4 (Schaldach et al., 1999) and various prostaglandins (PGB3, PGD3, 
PGF3α, PGG2, PGH1, PGH2) (Seidel et al., 2001) have been described as AhR activators. 
Whereas lipoxin A4 is quite potent at higher nM concentrations, µM concentration of 
prostaglandins are required for AhR activation. Prostaglandins are produced with the 
help of cyclooxygenase (Cox) and degraded by cytochrome P450, two enzymes under 
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the transcriptional control of the AhR. Another potent AhR ligand, 2-(1´H-indole-3´-
carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE), has been isolated from the 
lung tissue of the pig (Henry et al., 2006; Song et al., 2002).  
 
Other AhR activators. In addition to the above described ligands, AhR activation has 
also been observed in cells in the absence of exogenous ligands in response to cyclic 
adenosine monophosphate (cAMP) treatment (Oesch-Bartlomowicz et al., 2005), 
oxidized LDL modified by fluid shear stress (McMillan and Bradfield, 2007) and 
disruption of cell-cell contacts (Cho et al., 2004; Sadek and Allen-Hoffmann, 1994a, b).  
 
1.4.2 Depletion of ligands through ligand-induced expression of 
metabolizing enzymes 
Ligand-activated AhR induces the expression of genes coding for the first family of 
cytochromes. High basal, non-inducible CYP1A1 mRNA levels have been observed in 
cells deficient in functional CYP1A1 (e.g. murine hepatoma cells Hepa-1 c37) (Chang 
and Puga, 1998; RayChaudhuri et al., 1990). This implies a regulatory circuit between 
CYP1A1 activity and the AhR pathway. The CYP1A1 enzyme metabolizes many of 
the naturally-occurring ligands and thereby clearly restricts their AhR-activating 
potential. The metabolic clearance of ligands through ligand-induced expression of 
metabolizing enzymes may therefore be an important autoregulatory feedback 
mechanism in the control of AhR signaling (Chiaro et al., 2007).    
 
1.4.3 Post-translational modification – phosphorylation 
The activity of many proteins is modulated by phosphorylation. Even the AhR has been 
identified as a phosphoprotein (Berghard et al., 1993; Carrier et al., 1992), yet the exact 
number and positions of its phosphoresidues remain controversial (Backlund and 
Ingelman-Sundberg, 2005; Mahon and Gasiewicz, 1995; Minsavage et al., 2004; Park 
et al., 2000). Mitogen-activated protein kinases (MAPK) (reviewed in Henklova et al., 
2008), tyrosine kinases (Backlund and Ingelman-Sundberg, 2005; Park et al., 2000) and 
protein kinase C (PKC) (Berghard et al., 1993; Carrier et al., 1992; Chen and Tukey, 
1996; Long et al., 1998; Machemer and Tukey, 2005) have been implicated in the 
phosphorylation of the AhR. Impaired AhR/ARNT dimer formation and reduced DNA 
binding has been observed in cell extracts from TCDD-stimulated cells when treated 
with phosphatase (Berghard et al., 1993; Pongratz et al., 1991). From these studies is 
seems that phosphorylation of the AhR promotes DNA-binding, whereas 
phosphorylation of ARNT is essential for AhR/ARNT interaction upon dimerization 
(Berghard et al., 1993). Phosphorylation and dephosphorylation have also partly been 
identified as the underlying mechanism controlling nucleocytoplasmic shuttling and the 
subcellular distribution of the AhR (Ikuta et al., 2004a, b). Moreover, it seems that 
phosphorylation at the C-terminus may contribute to proteasomal degradation of the 
receptor, because overexpression of MAPK reduces AhR protein levels (Chen et al., 
2005).  
As part of the cytoplasmic AhR-chaperone complex, the c-src kinase has been 
implicated in the phosphorylation of the AhR (Enan and Matsumura, 1996). Its release 
and the activation of the epidermal growth factor signaling pathway can been observed 
after receptor activation by UVB irradiation (Fritsche et al., 2007). Both c-src -/- mice 
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(Enan et al., 1998) and rat H4IIE cells treated with c-src inhibitors or transfected with 
dominant-negative c-src (Backlund and Ingelman-Sundberg, 2005) showed a reduced 
response to receptor activation by TCDD suggesting that c-src may also be involved in 
the regulation of AhR signaling.  
 
1.4.4 Crosstalk with other signal transduction pathways 
The AhR regulates and is regulated by many other signaling pathways (reviewed in 
Carlson and Perdew, 2002). Examples of crosstalk between the AhR and some 
signaling pathways are listed below.  
 
Growth factor and cytokine signaling. Several growth factors and cytokines interact 
with the AhR pathway (see a review in Haarmann-Stemmann et al., 2009). AhR and 
transforming growth factor (TGF)-β, for example, mutually modulate their expression 
(reviewed in Gomez-Duran et al., 2009). 
 
Steroid receptor signaling. Crosstalk between the AhR and steroid receptors has been 
shown. E2-activated ERα clearly modulates transcription of AhR target genes and can 
be associated with the AhR on XREs (Beischlag and Perdew, 2005). On the contrary, 
ER signaling can be modified by the AhR through (i) activation of ER in absence of E2 
on ER target genes (Ohtake et al., 2003), (ii) competition for ARNT and other 
coactivators, (iii) inhibitory XREs in the promoter region of ER target genes, (iv) 
modulation of the expression of estrogen synthesizing enzymes (CYP19, aromatase) 
and (v) targeting ER to proteasomal degradation (reviewed in Swedenborg and 
Pongratz, 2010). 
 
Nuclear factor κB signaling. TCDD-induced CYP1A1 expression can be suppressed 
by treatment with bacterial endotoxins (lipopolysaccharide) and proinflammatory 
cytokines (interleukin-1β; tumor necrosis factor (TNF)-α), well known NFκB activators 
(Ke et al., 2001; Tian et al., 1999). The NFκB subunit p65 (RelA) and AhR have been 
shown to directly interact with each other (Tian et al., 1999). In the case of CYP1A1, 
p65 suppresses AhR transcriptional activity through chromatin remodeling and 
competition for common coactivators (Ke et al., 2001). AhR and p65 interactions on an 
NFκB-site, however, can promote the expression of the c-myc gene (Kim et al., 2000) 
suggesting that the AhR and p65 mutually modulate their transactivation properties. In 
addition, the AhR and another member of the NFκB transcription factor family, RelB, 
can associate and promote the induction of both RelB- and XRE-controlled genes 
(chemokines, reporter genes) (Vogel et al., 2007) showing that intensive crosstalk 
between these two signaling pathways exists.  
 
Retinoblastoma protein. Similar to NFκB, the AhR seems also to interact with the 
hypophosphorylated active form of the retinoblastoma protein (Rb), which regulates 
cell cycle progression from G1 to S. The direct interaction between these two proteins, 
but not ARNT, is mediated by the Q-rich subdomain of the TAD and a LXCXE motif 
at the N-terminus of the AhR (Elferink et al., 2001; Ge and Elferink, 1998). Reduced 
CYP1A1 induction by LXCXE-mutated AhR after ligand activation (Elferink et al., 
2001) suggests Rb as a coactivator for the AhR.   
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1.4.5 Repression of AhR signaling by the AhR repressor (AhRR)  
Another bHLH-PAS protein, referred to as the AhR repressor (AhRR), is involved in 
the regulation of AhR signaling (for a review see Hahn et al., 2009). The AhRR 
resembles in its structural and functional organization the AhR, with the exception that 
it lacks the TAD and PAS B repeat (Kanno et al., 2007; Mimura et al., 1999). Thus, the 
AhRR is unable to bind ligands (Karchner et al., 2002). AhRR expression is 
transcriptionally controlled by the AhR through several XREs and an additional NFκB 
site (Baba et al., 2001) and AhR-/- mice have clearly reduced AhRR expression levels 
(Bernshausen et al., 2006).  
The AhRR itself is not transcriptionally active but represses the transcriptional 
activity of the AhR. Human dermal fibroblasts, which are non-responsive to TCDD 
treatment (Gradin et al., 1999), show constantly bound AhRR at their XREs in the 
CYP1A1 promoter (Haarmann-Stemmann et al., 2007). The exact molecular 
mechanisms underlying the repression of AhR signaling by the AhRR are not fully 
elucidated. Initially it was proposed that the AhRR competes for ARNT heterodimer 
formation (Mimura et al., 1999). Due to the nearly unlimited access of ARNT (Pollenz 
et al., 1999; Tomita et al., 2000) and temporally similar CYP1A1 and AhRR expression 
patterns (Tsuchiya et al., 2003), this mode of action is questionable. Studies using 
mutant AhR variants with impaired XRE-binding capacities as well as unlimited 
amounts of ARNT clearly showed that the observed inhibition is not due to competition 
for XRE-binding or for ARNT (Evans et al., 2008). The repressive action of the AhRR 
seems rather to be mediated by interactions between the SUMOylated repressor and 
histone deacetylases (Haarmann-Stemmann et al., 2007; Oshima et al., 2009; Oshima et 
al., 2007). This autoregulatory loop between AhR and AhRR signaling is evolutionary 
well conserved (Karchner et al., 2002) suggesting it as an important negative regulatory 
mechanism.  
 
1.4.6 Modulation of AhR levels 
AhR expression levels may also be reflected in the levels of receptor activity. AhR 
expression can be induced by growth factors (Vaziri et al., 1996) and is in parts under 
the transcriptional control of the transcription factor NF-E2 p45-related factor 2 
(NRF2), which acts via an antioxidant response element in the 5´flanking region of this 
gene (Shin et al., 2007).  
An important mechanism to control AhR function and activity is the down-
regulation of ligand-activated receptor. The inactive AhR is constantly distributed in 
the cytoplasm with a half-life of ~28 hours. However, upon activation, e.g. by ligands 
such as TCDD, the half-life of the receptor is shortened to ~ 3 hours (Ma and Baldwin, 
2000) and receptor protein levels are rapidly reduced both in vitro and in vivo in a dose 
and time-dependent manner, whereas ARNT levels remain unaffected (Pollenz, 1996; 
Pollenz et al., 1998; Roman et al., 1998). Because receptor levels decrease in both 
subcellular compartments (Pollenz, 1996; Reick M et al., 1994) without changes in 
AhR mRNA levels (Giannone et al., 1998) upon ligand treatment, repression of mRNA 
synthesis and shuttling of the receptor can be excluded as the underlying mechanisms 
for the observed decline in receptor levels. These results rather suggest the proteolytic 
degradation of the liganded AhR. Activated AhR undergoes partly self-ubiquitination 
through its own E3 ligase function (Kawajiri et al., 2009; Ohtake et al., 2007) and is 
then degraded in the cytoplasm via the 26S proteasomal pathway following DNA-
   15 
binding and nuclear export (Davarinos and Pollenz, 1999; Ma and Baldwin, 2000; 
Roberts and Whitelaw, 1999). As the degron, the structural motif at which 
ubiquitination occurs, the C-terminal region enclosing the TAD has been proposed (Ma 
and Baldwin, 2000). Down-regulation and cleavage of the receptor via the action of the 
Ca2+-dependent cysteine protease calpain, as suggested by Dale and colleagues (Dale 
and Eltom, 2006), could not be confirmed by other studies (Pollenz, 2007), excluding 
this pathway as the underlying proteolytic mechanism. Inhibition of TCDD-induced 
AhR degradation by protein synthesis inhibitors, e.g. cycloheximide, or proteasomal 
inhibitors, e.g. MG132, results in a so called superinduction of CYP1A1 gene 
expression, an induction higher than the one achieved by agonist treatment alone 
(Joiakim et al., 2004; Ma and Baldwin, 2000; Ma et al., 2000). It therefore seems that 
the control of AhR levels through degradation is an extremely important and universal 
mechanism for the restriction of receptor activity and the regulation of AhR signaling, 
occurring in all cells irrespectively of tissue and species origin.  
 
 
1.5 THE ROLE OF THE AhR IN PHYSIOLOGICAL PROCESSES  
The AhR has long been viewed as a receptor that mainly binds xenobiotics and 
mediates both their metabolism and toxicity. However, more and more evidence arises 
that the AhR plays pivotal roles in maintaining cellular homeostasis (Figure 6). 
Figure 6. Schematic overview over the role of the AhR in physiological processes.   
 
 
1.5.1 The role of the AhR in detoxification  
The AhR is part of the detection and detoxification system of organisms. By binding a 
broad range of structurally diverse compounds, the AhR serves, like other PAS 
proteins, as a sensor protein providing important information about the environment. At 
the same time, AhR activation induces the transcriptional up-regulation of phase I and 
II biotransformation enzymes of the detoxification system. In contrast to the 
invertebrate AhR orthologs (Butler et al., 2001; Powell-Coffman et al., 1998), only the 
vertebrate AhR seems to be able to bind ligands. It has been considered that this 
pathway may have originally evolved in higher organisms for the detoxification of 
plant material and was later further adapted to sense and eliminated harmful man-made 
contaminants. However, it remains strongly questionable whether the existence of these 
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artificial, synthetic compounds alone would apply enough evolutionary selection 
pressure to conserve this pathway.   
 
1.5.2 The AhR as a mediator of toxicity and carcinogenesis 
Despite its important function in detoxification, the AhR plays a critical role in 
mediating xenobiotic-induced toxicity and carcinogenesis (reviewed in Nebert et al., 
2004). Exposure to TCDD, for example, results in multiple toxic effects including 
thymus atrophy, liver enlargement, wasting, cardiovascular diseases, chloracne, 
tumorgenesis and immune suppression (reviewed in Pohjanvirta and Tuomisto, 1994; 
Schecter et al., 2006; White and Birnbaum, 2009). Studies on AhR-/- mice clearly 
showed that TCDD-induced toxicity (Fernandez-Salguero et al., 1996; Mimura et al., 
1997) and PAHs-induced carcinogenesis (Shimizu et al., 2000) are mainly mediated by 
the AhR. Metabolic activation of these compounds by AhR-induced CYP450 enzymes 
leads to the formation of damaging intermediates e.g. epoxides and reactive oxygen 
species that subsequently contribute to tumor development. Many of these adverse 
effects seems to be the consequence of prolonged AhR activation and dysregulation of 
physiological cell signaling, since similar signs of toxicity can be observed in AhR-CA 
mice (Andersson et al., 2002; Brunnberg et al., 2006; Tauchi et al., 2005).  
 
1.5.3 The role of the AhR in normal cellular functions  
The expression of the AhR during early embryonic development (Abbott et al., 1995), 
its ubiquitous expression later in adult organisms (Dolwick et al., 1993a), 
developmental defects in AhR-/- mice (Fernandez-Salguero et al., 1995; Fernandez-
Salguero et al., 1997; Schmidt et al., 1996) and its stong conservation throughout 
evolution (reviewed in Hahn, 2002) suggest a role of the receptor in physiological 
processes beyond the regulation of xenobiotic metabolism. Studies on the invertebrate 
AhR orthologs ahr-1 (Caenorhabditis elegans) and spineless (Drosophila 
melanogaster) revealed functions in the control of neuron differentiation in the 
nematode (Huang et al., 2004; Qin et al., 2006) as well as in dendrites, antenna, tarsus 
and ommatides development of flies (Duncan et al., 1998; Emmons et al., 1999; Kim et 
al., 2006; Wernet et al., 2006). It seems therefore that the ancestral AhR plays an 
important role in cell fate determination and differentiation.  
Studies on AhR-/- mice showing a reduced liver size, skin and gastrointestinal 
lesions as well as defects in the reproductive organs and the immune system, point 
towards the importance of this receptor in normal cellular functions (Baba et al., 2005; 
Fernandez-Salguero et al., 1995; Fernandez-Salguero et al., 1997; Kawajiri et al., 2009; 
Schmidt et al., 1996). 
Proliferation rates are decreased in AhR-deficient cells (Elizondo et al., 2000; Ma 
and Whitlock, 1996) suggesting a pivotal role of the AhR in the cell cycle regulation. 
The AhR appears to interact with various components of the cell cycle machinery to 
promote cell cycle progression. AhR-p65 interactions allow, for example, entry into the 
cycle by inducing c-myc gene expression (Kim et al., 2000). Receptor association with 
CDK4, CCND1 and Rb-E2F sequesters Rb to CDK4, thereby allowing its 
phosphorylation and the release of E2F which promotes the transcription of genes 
important for cell cycle progression to the S phase (Barhoover et al., 2010). 
Furthermore, interactions between the AhR and p300 promote also p300-mediated 
DNA-synthesis (Tohkin et al., 2000). Disruption of this signaling by xenobiotic 
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activation of the AhR clearly results in cell cycle arrest and growth inhibition 
(Gottlicher et al., 1990; Vaziri and Faller, 1997). Cell cycle progression is inhibited by 
TCDD-activated AhR through transcriptional up-regulation of the cell cycle inhibitor 
p27Kip (Kolluri et al., 1999) and repression of E2F-mediated transcription of S phase 
genes by interactions with hypophosphorylated Rb (Marlowe et al., 2004; Puga et al., 
2000).  
Besides its functional role in cell cycle regulation, the AhR seems also involved in 
the regulation of cell differentiation as shown for keratinocytes (Swanson, 2004), 
hematopoetic cells (Singh et al., 2009), adipocytes and immune cells (Esser et al., 
2009). Especially the role of the AhR in the differentiation of immune cells has been 
well characterized. By modulating Stat-1-mediated cytokine expression (Kimura et al., 
2008), the AhR modulates the functional differentiation of naïve T-cells into regulatory 
T cells (Treg) and T-helper 17 (TH17) cells (Quintana et al., 2008; Veldhoen et al., 
2008). It seems that AhR activation switches the development towards TH17 cells, a 
subset of effector T cells implicated in the development of autoimmunity and the 
defense against microbial infections. The AhR clearly transcriptionally controls the 
production and secretion of interleukin-17 and 22, two proinflammatory cytokines 
which mediate autoimmune and anti-microbial reactions. Furthermore, AhR signaling 
seems to contribute to Langerhans cell maturation, because AhR-/- mice show aberrant 
maturated cells (Jux et al., 2009).  
Even in other organs than the immune system the AhR seems to be involved in 
modulating differentiation, proliferation and cell fate decisions and thereby contribute 
to tissue homeostasis. AhR-/- mice show increased hepatocyte proliferation 
(Fernandez-Salguero et al., 1995; Schmidt et al., 1996) and are not able to close the 
ductus venosus in the liver after birth (Schmidt et al., 1996). In female AhR-/- mice 
folliculogenesis is impaired due to de-regulated CYP19 expression and E2 production 
(Baba et al., 2005). Recently, also a crucial role of the AhR in gastrointestinal 
homeostasis was revealed. AhR-/- mice show high incidences of intestinal cancer due 
to the accumulation of β-catenin (Kawajiri et al., 2009). β-catenin is a substrate for the 
E3 ligase function of the receptor and under normal physiological conditions its levels 
are downregulated following AhR activation by e.g. indolocarbazoles formed by the 
microbial intestinal flora.  
Thus, by controlling important cellular functions such as cell proliferation and 
differentiation the AhR seems to be essential for the maintenance of tissue homeostasis 
under physiological conditions.  
 
 
1.6 AhR SIGNALING IN THE SKIN 
1.6.1 The skin   
The skin, which is the outer protective barrier of the body, is composed of three layers, 
the hypodermis, dermis and epidermis. The epidermis, a 50-100µm thick terminally 
differentiated epithelium, defines the uppermost layer. Based on its morphological 
appearance, it can be further divided into (i) the stratum basale/stratum germanium, a 
single cell layer of keratinocytes with stem-cell like properties and melanocytes, (ii) the 
stratum spinosum, the prickle cell layer formed of irregular polyhedral-shaped 
keratinocytes, (iii) the stratum granulosum, a layer of flattened, non-dividing 
keratinocytes filled with granules of keratinohyalin and lipids important for the barrier 
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function and (iv) the stratum corneum, the uppermost layer consisting of terminally 
differentiated, metabolically inactive keratinocytes (corneocytes) building a network of 
cells and keratin (Figure 7). 
Figure 7. Cross section of the skin and the epidermal layers.  
 
Keratinocytes. Keratinocytes are the most abundant cells of the epidermis. Keratinocyte 
stem cells are located in the bulge region of hair follicles and the stratum basale 
supplying the renewing epidermis continuously with cells. When passing through the 
epidermis (epidermal turnover time: 50-75 days), these cells undergo a complex 
differentiation program under the influence of growth factors and controlled by 
surrounding calcium levels (for review see Eckert et al., 1997).  
 
Melanocytes. The highly dendritic melanocytes are the melanin-producing cells of the 
skin. They originate as non-pigmented precursors (melanoblasts) from Schwann cell 
precursors and the neural crest (Adameyko et al., 2009) and migrate after the closure of 
the neural tube to their final destinations where they undergo maturation. Melanocytes 
are located in the stria vascularis of the cochlea, the uval tract (cilliary, choroids, iris), 
the meninges, the epidermis and hair follicles (reviewed in Goding, 2007; Tolleson, 
2005). The bulge region of hair follicles serves as a niche for the skin melanocyte stem 
cell population and their progenitors that provide pigment to the growing hair 
(Nishimura et al., 2002). During aging, the loss of these cells accounts for hair graying 
(Nishimura et al., 2005). The highest number of melanocytes is found intrafollicular at 
the dermal-epidermal junction where they form together with approx. 36 keratinocytes 
the so called epidermal melanin units (Quevedo, 1972).  
 
1.6.2 The role of the AhR in normal skin functions 
In the skin, the expression and inducibility of the AhR and CYP1A1 greatly increase 
from the lower towards the upper layers. Even though the AhR pathway is present in all 
skin cells (dermal fibroblasts (Gradin et al., 1999), Langerhans cells (Jux et al., 2009), 
melanocytes (Villano et al., 2006), keratinocytes (reviewed in Swanson, 2004), its 
activation seems limited in fibroblasts and Langerhans cells. In keratinocytes, AhR 
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expression correlates very well with the differentiation status of the cells (Wanner et al., 
1995; Wanner et al., 1996). Proliferating keratinocytes show low nuclear AhR levels 
and are greatly unresponsive to ligand activation, whereas differentiated cells have high 
cytoplasmic receptor levels (Berghard et al., 1990; Ikuta et al., 2004a). In keratinocytes, 
the AhR is activated in response to ultraviolet radiation B (UVB) (280-320nm), 
resulting in the up-regulation of CYP1A1 expression and the activation of c-scr and 
epidermal growth factor receptor (EGFR) signaling (Fritsche et al., 2007). By sensing 
UVB, the AhR seems to contribute to the UV stress response system which orchestrates 
adaptive changes. Apart from functioning as a cytoplasmic sensor for UVB, the AhR 
has also been implicated to detect and mediate cellular changes in response to ozone 
(Afaq et al., 2009). Moreover, in epidermal cells the AhR appears to modulate the 
expression of genes such as slug and metalloproteinases fundamental for cell motility 
during skin development and renewal (Ikuta and Kawajiri, 2006; Villano et al., 2006). 
These observations point towards a role of the AhR in maintaining epidermal 
homeostasis. De-regulation of AhR-controlled processes in the skin by xenobiotics may 
therefore result in a variety of skin lesions.  
 
 
1.7 XENOBIOTIC-INDUCED SKIN LESIONS 
Environmental and occupational exposure to xenobiotics may cause the development of 
skin cancer, contact dermatitis, hyperpigmentation and chloracne (reviewed in 
Yamamoto and Tokura, 2003). Especially chloracne, the formation of acne-like 
eruptions, hyperkeratosis and epidermal thickening, is a hallmark of systemic exposure 
to dioxin in humans (Geusau et al., 2000; Schecter et al., 2006). The observed 
symptoms point towards a disruption of AhR-regulated keratinocyte proliferation and 
differentiation. Indeed, keratinocytes treated with TCDD showed increased terminal 
differentiation. As a consequence of increased corneocyte formation, the stratum 
corneum is abnormally thick in TCDD-exposed organisms (Greenlee et al., 1985; 
Loertscher et al., 2002; Loertscher et al., 2001a; Loertscher et al., 2001b; Sutter et al., 
2009).  
 
1.8 MELANOGENESIS AND XENOBIOTIC-INDUCED 
HYPERPIGMENTATION 
Often the development of chloracne is accompanied by an increase in pigmentation. 
The production of pigment (melanin), a process called melanogenesis, is essential for 
the protection of the skin against UV. Melanin is exclusively produced in melanocytes 
in specialized organelles, called melanosomes, which are passed to surrounding 
keratinocytes.  
 
1.8.1 The process of melanin formation 
The formation and distribution of melanin is a highly regulated process that requires (i) 
the biogenesis of melanosomes, (ii) the expression of melanogenic proteins and their 
correct trafficking into melanosomes and (iii) the transport and transfer of 
melanosomes to keratinocytes.  
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1.8.1.1 Biogenesis of melanosomes 
Melanin production is restricted to melanosomes, which are membrane-bound, 
lysosomal-like organelles that derive from the endosomal pathway (for review see 
Raposo and Marks, 2007). Melanosomes undergo a maturation process and based on 
their morphological appearance and the expression of melanogenic proteins they can be 
classified into four stages (for review see Marks and Seabra, 2001; Wasmeier et al., 
2008). Stage I premelanosomes are filled with irregular arranged filaments, but do not 
contain melanin. Even though all melanogenic proteins are present in premelanosomes, 
they are catalytically inactive due to the protolytic and acidic milieu (Kushimoto et al., 
2001). The proteolytic cleavage of the structural melanosomal membrane protein 
Pmel17 releases filaments that form the characteristically striated appearance of stage II 
melanosomes. In stage III melanosomes, melanin starts to accumulate on these 
filaments. Finally, fully maturated stage IV melanosomes are completely filled with 
melanin. The proper biogenesis of melanosomes is a prerequisite for the successful 
production of melanin  
 
1.8.1.2 Biosynthesis of melanin  
Melanocytes produce two types of melanin in their melanosomes, the black-brownish 
eumelanin and the yellow-reddish pheomelanin. Based on the type of melanin produced 
and its photoprotective properties, different skin types can be assigned (Cripps, 1981). 
In general, the constitutive skin color depends on (i) the number, size and distribution 
of melanosomes (Alaluf et al., 2002; Szabo et al., 1969; Thong et al., 2003), (ii) the 
total melanin content (Alaluf et al., 2002) and (iii) the ratio of eu- to pheomelanin 
(Wakamatsu et al., 2006). Even though melanosome numbers differ between different 
skin types, the number of melanocytes is rather equal at the same donor site (Tadokoro 
et al., 2005). In light-pigmented skin melanosomes appear grouped, whereas 
melanosomes in dark skin are more dispersed. The lower skin cancer incidence rates in 
dark-pigmented individuals are probably due to better photoprotection by eumelanin-
filled, dispersed melanosomes and higher DNA repair rates (Landi et al., 2002). 
Melanin polymers are formed by a complex biochemical pathway, called the Raper-
Mason pathway (Land et al., 2004). Polymer formation is initiated by hydroxylation of 
L-tyrosine to 3,4-dihydroxyphenylalanine (L-Dopa) and its oxidation to L-
dopaquinone. From this point on the chemical composition of the produced melanin is 
determined by the availability of melanogenic proteins and substrates. In the presence 
of thiol-containing compounds (del Marmol et al., 1996; Smit et al., 1997), L-
dopaquinone converts spontaneously to 3 or 5-cysteinyldopa or glutahionyldopa which 
is further converted to pheomelanin polymers. In the absence of thiol-containing 
compounds, eumelanogenesis occurs and L-dopaquinone is spontaneously 
decarboxylated to 5,6-dihydroxyindole (DHI) or converted by tyrosinase-related 
protein 2 to 5,6-dihydroxyindole-2-carboxylic acid (DHICA). DHI and DHICA are 
then further polymerized to the black eumelanin polymers (Figure 8).  
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Figure 8. Representation of the Raper-Mason pathway, the biochemical pathway of melanin 
synthesis. TYR, tyrosinase; TYRP1, tyrosinase-related protein 1; TYRP2, tyrosinase-related protein 2; L-
Dopa, 3,4-dihydroxyphenylalanine; 5,6-DHI, 5,6-dihydroxyindole; DHICA, 5,6-dihydroxyindole-2-
carboxylic acid; 5,6-IQ, 5,6-indolequinone;  5,6-IQCA, 5,6-indolequinone-2-carboxylic acid.  
 
Eu- and pheomelanin differ not only in their chemical composition, but also in their 
photoprotective properties. Whereas eumelanin is highly photoprotective and 
effectively in scattering and absorbing photons and UV-produced ROS (Ortonne, 
2002), pheomelanin is photolabile and shows reduced absorptive capacities (Chedekel 
et al., 1978). Besides its role in photoprotection, melanin is also involved in the 
chelation of xenobiotics. 
 
1.8.1.3 Melanogenic proteins 
Melanin formation is catalyzed by a family of melanosomal transmembrane type I 
glycoproteins called tyrosinase (TYR), tyrosinase-related protein 1 (TYRP1) and 2 
(TYRP2). The expression of these proteins and protein kinase C-β (PKC-β), a kinase 
involved in the posttranslational regulation of tyrosinase, is under the control of the 
microphthalmia-associated transcription factor (MITF) (Park et al., 2006; 
Steingrimsson et al., 2004). All three proteins share a common structural organization 
and a high amino acid sequence homology and contain (i) a C-terminal transmembrane 
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motif, (ii) two putative metal binding sites in the catalytic center, (iii) an EGF motif 
allowing interactions with the other melanogenic proteins and (iv) an N-terminal signal 
sequence for correct sorting and trafficking into melanosomes. Proper processing 
through the endoplasmic reticulum and Golgi and correct targeting of these proteins by 
specific adaptor proteins towards the melanosomal pathway is fundamental for melanin 
production (Setaluri, 2000; Wang and Hebert, 2006). Dislocation of tyrosinase by 
mutated adaptor protein 3, for example, accounts for the partial albinism observed in 
patients with the Hermansky-Pudlak syndrome.  
 
Tyrosinase (TYR). Tyrosinase (monophenol monooxygenase; EC 1.14.18.1) is the key 
and rate-limiting enzyme of the melanogenic pathway. This enzyme catalyzes (i) the 
first step in the melanin biosynthesis, the hydroxylation of L-tyrosine to L-dopa, (ii) the 
oxidation of L-dopa to L-dopaquinone and (iii) the oxidation of DHI thus removing 
DHI which acts inhibitory on the oxidation of L-tyrosine (Lerner et al., 1949). L-dopa 
acts both as a co-factor and a substrate for tyrosinase (Pomerantz and Warner, 1967) 
and is supplied by the phenylalanine hydroxylase (PAH, EC 1.14.16.1) and 
melanosomal tyrosine hydroxylase isoform I (THI, EC 1.14.16.2) (reviewed in 
Schallreuter, 2007).  
Tyrosinase activity correlates well with the amount of melanin produced and the 
constitutive skin color (Iozumi et al., 1993; Iwata et al., 1990). In the skin of light-
pigmented individuals, tyrosinase activity is lower due to the acidic milieu of 
melanosomes, whereas its activity is optimal at neutral pH in the lumen of 
melanosomes of dark-pigmented skin (Fuller et al., 2001).  
In contrast to its activity, tyrosinase mRNA and protein levels do not always match 
the melanin content (Iozumi et al., 1993; Naeyaert et al., 1991). Alterations in 
tyrosinase activity have been observed upon modulation of the PKC-β signaling 
pathway indicating that posttranslational modifications seems to be involved in the 
control of this enzyme. Inhibition of PKC-β reduces basal melanin production in vitro 
and in vivo (Park et al., 2004a; Park et al., 1993) and decreases UV-induced 
melanogenesis in vivo (Park et al., 2004a). Upon stimulation, PKC-β is targeted by the 
receptor for activated C-kinase (RACK) to the melanosomes (Park et al., 2004b) where 
it phosphorylates serine 505 and 509 of the cytoplasmic domain of tyrosinase (Park et 
al., 1999). This phosphorylation enhances the catalytic activity of tyrosinase and 
concomitantly favors the formation of the melanogenic multi-enzyme complex (Wu 
and Park, 2003), consisting of tyrosinase together with the tyrosinase-related proteins 1 
and 2.  
The catalytic activity of tyrosinase is essential for the melanogenic pathway and 
silencing of this gene completely abolishes melanin production (An et al., 2009). In 
humans, mutations in the tyrosinase gene are linked to the type I oculocutaneous 
albinism (Tripathi et al., 1992).  
 
Tyrosinase-related protein 1 (TYRP1). The exact catalytic activity of the tyrosinase-
related protein 1 (gp75; EC 1.14.18) has not been fully elucidated. TYRP1 functions as 
a DHICA oxidase in murine melanocytes (Jackson, 1988; Jimenez-Cervantes et al., 
1994; Kobayashi et al., 1994), but has no DHICA oxidase activity in human 
melanocytes (Boissy et al., 1998). In fact, TYRP1 may take part in the biogenesis of 
melanosomes, because melanosomes lacking TYRP1 appear deformed and are 
abnormally melanized (Setaluri, 2003). Furthermore, TYRP1 seems to support 
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tyrosinase stability by forming a complex together with tyrosinase and TYRP2 
(Kobayashi et al., 1998b; Orlow et al., 1994). Mutations in the TYRP1 gene result in a 
light brown skin color in otherwise dark-pigmented individuals, a pathological 
condition called oculocutaneous albinism 3 (reviewed in Sarangarajan and Boissy, 
2001). Thus, functional TYRP1 is required for proper eumelanogenesis.  
 
Tyrosinase-related protein 2 (TYRP2). Tyrosinase-related protein 2 (dopachrome 
tautomerase; EC 5.3.3.12) catalyzes the conversion of dopachrome to DHICA in the 
later steps of eumelanogenesis (Bouchard et al., 1994). Mice homozygote for the slaty 
mutation, a single base pair mutation in the TYRP2 gene, show reduced TYRP2 
activity and gray instead of black coat color (Jackson et al., 1992), demonstrating the 
importance of TYRP2 for the eumelanogenic pathway. In humans, however, no 
pigmentary disorders have been linked to mutations in TYRP2.   
 
1.8.1.4 Transport and transfer of melanosomes to keratinocytes 
Once melanosomes are maturated and filled with melanin, they are transported to the 
dendritic tip and passed onto surrounding keratinocytes by mechanisms that may 
include (i) the fusion of membranes of both cells, (ii) exocytosis and endocytosis, (iii) 
phagocytosis of melanocyte filopodia or (iv) direct inoculation (Seiberg, 2001).   
In keratinocytes, melanosomes are arranged in clusters, individually or, in  response 
to UV irradiation, as supranuclear caps to shield against UV-induced DNA damage 
(Kobayashi et al., 1998a).  
 
1.8.2 Stimulation of melanogenesis by ultraviolet radiation 
UV radiation (200-400nm), the major physiological stimulus for melanogenesis, evokes 
epidermal thickening and increased melanin production, a response known as the 
tanning response. The tanning response can be divided into (i) intermediate pigment 
darkening resulting in the photooxidation of existing melanin immediately after UV, in 
particular UVA, exposure and (ii) delayed tanning that occurs over days to weeks by de 
novo melanin synthesis and melanocyte proliferation. 
UV stimulates melanogenesis by both directly acting on melanocytes and by 
affecting keratinocytes (Figure 9). Human melanocytes undergo cell cycle arrest and 
upregulate the formation of melanin in response to UVB radiation (Abdel-Malek et al., 
1994). The main chromophore for UVB in these cells is DNA. UV-induced DNA 
damage i.e. the formation of cyclobutane pyrimidine and thymine dimers, and DNA 
repair mechanisms have been shown to initiate melanogenesis (Eller et al., 1996; Eller 
et al., 1994) while at the same time inducing p53. T-oligos, sequences that resemble the 
uncapped telomers, can also induced p53 and enhance melanin formation (Arad et al., 
2006). Besides its important role in DNA repair and cell cycle arrest, p53 is able to 
transcriptionally upregulate tyrosinase mRNA (Khlgatian et al., 2002). Apart from 
DNA, UVB is also able to damage melanocyte membranes leading to the release of 
diacylglycerol which stimulates tyrosinase activity via the activation of PKC-β 
(Carsberg et al., 1995; Gordon and Gilchrest, 1989). As the result of the up-regulation 
of tyrosinase mRNA levels and activity, the intracellular melanin content increases and 
irradiated cells enhance their melanosome and dendrite numbers (Friedmann and 
Gilchrest, 1987; Ramirez-Bosca et al., 1992). 
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Figure 9.  Schematic overview over UV-induced melanogenesis. Upon UV radiation, melanogenesis is 
stimulated (i) directly in melanocytes by DNA and membrane damage, (ii) autocrine signaling and (iii) 
paracrine signaling via factors released from stimulated keratinocytes. CPD, cyclobutane pyrimidine 
dimers; 6-4 PP, thymine dimers; SCF, stem cell factor; ET-1, endothelin-1; PG, prostaglandins; NO, 
nitric oxide; α-MSH, α-melanocyte stimulating hormone; ACTH, adenocorticotrophic hormone; MCR, 
melanocortin receptor; DAG, diacylglycerol; CREB, cAMP response element (CRE)-binding protein; 
MITF, microphthalmia-associated transcription factor; TYR, tyrosinase.   
 
Factors secreted from keratinocytes in response to UV irradiation facilitate further the 
induction of the melanogenic pathway, but stimulate also melanocyte proliferation. 
POMC-derived α-melanocyte stimulating hormone (α-MSH), produced both in 
keratinocytes and melanocytes, plays an important role in the induction of melanogenic 
gene expression and DNA repair mechanisms (Bohm et al., 2005) as well as in the 
stimulation of melanocyte proliferation (Abdel-Malek et al., 1995; Im et al., 1998). α-
MSH acts via the melanocortin receptor 1 (MCR-1), which is also upregulated in 
response to UV. MCR-1 activation upregulates cAMP production and subsequently 
stimulates MITF expression through cAMP response-element binding protein (CREB). 
Besides tyrosinase-related proteins and PKC-β, MITF controls also the transcription of 
various other genes of the melanogenic pathway, e.g. the melanosomal structure protein 
pmel17 (Du et al., 2003) and the melanosome transport protein RAB27 (Chiaverini et 
al., 2008). In addition to α-MSH, several other factors including endothelin-1 (ET-1), 
granulocyte-macrophage colony stimulating factor (GM-CSF), nitric oxide (NO), 
prostaglandins (PGE2, PGF2α), stem cell factor (SCF) and adenocorticotrophic hormone 
(ATCH) are released from surrounding keratinocytes or, in case of NO, ET-1 and α-
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MSH, by the melanocyte itself (reviewed in Hirobe, 2005). These factors act as 
melanogenic or mitogenic stimuli in an autocrine or paracrine manner on the 
melanocyte population. 
 
 
1.8.3 Xenobiotic-induced hyperpigmentation 
Increased skin pigmentation is not only observed in response to UV radiation, but also 
as a consequence of exposure to xenobiotics. In the early 1970´s, two incidences of 
contamination of cooking rice oil in Taiwan (“Yu-Cheng”) (Hsu et al., 1985; Lu and 
Wu, 1985) and Japan (“Yusho”) (Kikuchi, 1984; Urabe and Asahi, 1985) led to acne-
like eruptions, comedome formation as well as hyperpigmentation of the nails, mucosa 
and skin in exposed individuals. Even babies born by exposed mothers showed 
hyperpigmentation, a phenomenon called the fetal PCB syndrome (Yamashita and 
Hayashi, 1985). Similar symptoms can also be observed in excessive smokers who 
usually show hyperkeratosis and increased gingival pigmentation (Axell and Hedin, 
1982; Haresaku et al., 2007). Detailed histopathological analyses have revealed 
elevated melanin deposition in the hyperpigmented tissues (Hashiguchi et al., 1987; 
Pastor et al., 2002), thereby strengthening the evidence for an induction of the 
melanogenic pathway by these xenobiotics.  
 
Taken together, these reports clearly indicate that environmental contaminants, 
particularly PCBs, PAHs and dioxins, are able to interfere with the melanogenic 
pathway leading to the development of hyperpigmentation in exposed individuals. 
Given that these compounds are potent AhR activators, these data point towards a role 
of the AhR in melanogenesis. 
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2 COMMENTS ON METHODOLOGY 
 
2.1 CELL LINES 
The human hepatoma cell line HepG2 and the HepG2-derived cell line HepG2-XRE-
Luc were used to elucidate the regulation of AhR signaling by ligands and UVB (Paper 
I, II & III). HepG2-XRE-Luc cells are stably transfected with a pTX.DIR luciferase 
reporter under the control of two XREs of the rat CYP1A1 gene (Peters et al., 2006). 
The human breast cancer cell line MCF7 was used to study the effects of AhR 
ligand treatment on estrogen receptor signaling (Paper II). Since both fetal bovine 
serum (FBS) and phenol red show estrogenic properties (Berthois et al., 1986; Darbre 
et al., 1983), these cells were treated in phenol red-free medium containing 5% 
charcoal-treated FBS.  
For studies on the role of AhR signaling in melanogenesis, the intermediately 
pigmented human melanoma cell line FM55 was used (Paper IV).  
Supplementary experiments (Paper III & IV) were performed on the human 
keratinocyte cell line HaCaT (Boukamp et al., 1988) and HaCaT AhR knockout cells 
carrying AhR silencing shRNA (Fritsche et al., 2007).  
 
 
2.2 PRIMARY CELLS (MELANOCYTES) 
Normal human melanocytes were used to investigate the role of the AhR in 
melanogenesis (Paper IV). Primary cells were isolated from human foreskin collected 
from anonymous donors under the age of 10 years undergoing circumcisions. Cells 
derived from tissue samples of young persons are preferred for the establishment of 
cultures, since these cells generally have higher proliferation rates and longer lifespans 
compared to melanocytes collected from adult tissue (Eisinger and Marko, 1982; 
Gilchrest et al., 1984). Following circumcision, foreskin tissue samples were stored at 
4°C in growth medium and processed within 24 hours. Tissue samples were cleaned 
from excessive fat and shortly sterilized in antibiotics. For the separation of epidermis 
and dermis, tissue samples were incubated in dispase II solution (2mg/ml) at 4°C 
overnight. Dispase digestion separates dermis from epidermis along the basal 
membrane (Kitano and Okada, 1983), thereby favoring the isolation of a higher number 
of viable cells and reducing the risk for contamination with dermal fibroblasts (McLeod 
and Mason, 1995). After dispase treatment and removal of the dermis, epidermal sheets 
were trypsinized at 37°C for 40 minutes and single cell suspensions were collected by 
filtration through 40µm cell strainers. Cultures were purified by selective 
trypsinization. Short (~2 min) trypsin treatment at room temperature favors melanocyte 
detachment, whereas keratinocytes and fibroblasts detach after longer times (~5-7 min).  
Pure melanocyte cultures were propagated in commercially available melanocyte 
M2 growth medium (PromoCell) and kept subconfluent to avoid growth inhibition. In 
contrast to other cells including murine melanocytes, human melanocytes require the 
presence of two mitogens for proliferation in culture stimulating the MAPK and 
cAMP/PKA pathway (reviewed in Halaban, 2000). In early studies, melanocytes could 
only be cultured in the presence of phorbol 12-myristate 13-acetate (PMA) and cholera 
toxin (CT) (Eisinger and Marko, 1982) or bovine pituitary extracts (BPE) (Wilkins et 
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al., 1985). Both PMA and CT exert also anti-proliferating effects on keratinocytes and 
fibroblasts (Eisinger and Marko, 1982). The replacement of these components and BPE 
by physiological factors such as ET-1, basic fibroblast growth factor (bFGF) and α-
MSH (Swope et al., 1995) as well as the reduction of the serum content in the medium 
(Abdel-Naser, 2003) allow now melanocyte culture under more physiological 
conditions.  
To provide physiological growth conditions, the antibiotic-, serum- and PMA-free 
M2 growth medium was selected for this study. Melanocytes grown in this medium 
show an increased pheomelanin/eumelanin ratio, which suggests that M2 growth 
medium favors pheomelanogenesis (Duval et al., 2002).  
 
 
2.3 AhR AGONISTS AND ANTAGONISTS 
The following AhR agonists (Figure 10) and antagonists were used in these studies.  
 
Indolocarbazoles. The two indolocarbazoles, 6-formylindolo[3,2-b]carbazole (FICZ) 
and indolo[3,2-b]carbazole (ICZ), were chosen as examples of physiological ligands. 
FICZ has been identified as a photoproduct formed from the amino acid tryptophan 
when irradiated with UV (Rannug et al., 1987; Rannug et al., 1995) or visible light 
(Diani-Moore et al., 2006; Oberg et al., 2005) and its intracellular formation has been 
shown in UV-irradiated HaCaT cells (Fritsche et al., 2007). ICZ, the second 
indolocarbazole studied, is formed in the acidic environment of the stomach and by the 
intestinal flora from the secondary plant metabolite I3C (Bjeldanes et al., 1991), which 
is mainly present in vegetables of the Brassica genus e.g. Brussels sprouts, cabbage and 
cauliflower. Both indolocarbazoles are excellent AhR activators with binding affinities 
in the pM-nM range (Gillner et al., 1993; Gillner et al., 1985; Kleman et al., 1994; 
Rannug et al., 1987) and are rapidly metabolized (Bergander et al., 2004; Chen et al., 
1995). 
 
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). The prototypical AhR ligand TCDD 
activates the AhR at low nM concentrations. This environmental pollutant is 
metabolically inert and resistant to degradation (for review see Poland and Knutson, 
1982).  
Figure 10. Structures of AhR agonists used in this study.  
 
α-naphthoflavone (α-NF) and 3´-methoxy-4´-nitroflavone (MNF). These two 
flavones exhibit both antagonistic and agonistic properties. At nM-µM concentrations 
α-NF has been shown to inhibit TCDD-induced CYP1A1 gene expression and activity 
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(Blank et al., 1987; Merchant et al., 1990), whereas at higher µM concentrations and in 
the absence of TCDD, α-NF can stimulate AhR activation (Wilhelmsson et al., 1994).   
Similar to α-NF, MNF has been shown to compete with TCDD for binding sites 
thereby hindering nuclear translocation, DNA-binding, CYP1A1 induction and down-
regulation of activated receptor (Henry et al., 1999; Lu et al., 1995). Although MNF 
was first classified as a “pure AhR antagonist”, it was later identified as an agonist 
inducing CYP1A1 expression (Zhou and Gasiewicz, 2003). Due to both their agonistic 
and antagonistic properties, these compounds are also termed partial antagonists 
(Wilhelmsson et al., 1994; Zhou and Gasiewicz, 2003). 
 
 
2.4 ULTRAVIOLET LIGHT TREATMENT 
In the studies on AhR activation by UVB light (Paper III), a Philips TL20W/12RS lamp 
was used as an ultraviolet light source. The six UV tubes of this lamp emit ultraviolet 
light in the range of 280-320nm with an emission peak at 310nm. To obtain an UVB 
dose of 10mJ/cm2 cells were irradiated for 18sec at a distance of 40cm. Since phenol 
red and serum components can act as photosensitizers during irradiation, cells were 
irradiated in Mg2+/Ca2+-PBS in dishes with the lid removed. After irradiation, the PBS 
was immediately replaced by fresh cell culture medium. Sham-irradiated cells were 
handled similarly, but shielded with aluminum foil against irradiation.  
 
 
2.5 TRANSFECTION AND PLASMID CONSTRUCTS 
Plasmids were introduced into cells by transient transfections using Fugene-6 as 
transfection reagent (Paper II & III). The pTX.DIR construct contains a herpes simplex 
virus thymidine kinase (TK) promoter and luciferase reporter gene under the control of 
two XREs of the rat CYP1A1 gene (Berghard et al., 1993). The 2xERE-TK-Luc 
plasmid contains the TK promoter and the luciferase reporter gene under the control of 
two estrogen response elements (ERE) (Pettersson et al., 1997). The pCMX-GFP-AhR 
expression vector codes for a fusion protein of the murine AhR (amino acids: 1-805) 
fused to green fluorescent protein (GFP) (Kazlauskas et al., 2000). The pCMX-GFP-
AhR-A375I plasmid was constructed by subcloning pIRES-DRA375I into pCMX-GFP-
AhR. GFP-AhR-A375I contains a mutation at position 375 of the LBD substituting 
alanine by isoleucine. The pFA-AhR encodes a Gal4-AhR fusion protein in which the 
first 37 amino acids of the rat AhR are replaced by the Gal4 DBD. In the Gal4 
transactivation assay, the luciferase reporter gene (pFR-Luc) was under the control of 
the upstream activation sequence (UAS) to which Gal4 can bind (Backlund and 
Ingelman-Sundberg, 2004).  
 
 
2.6 USE OF INHIBITORS 
NFκB inhibitors SN50 and Bay 11-7085. In paper III, SN50 and Bay 11-7085 were 
used as inhibitors for the NFκB pathway. SN50 is a cell-permeable inhibitor peptide 
containing the NLS of the NFκB subunit p50 coupled to the hydrophobic region of the 
signal sequence of the Kaposi fibroblast growth factor to assure import into the cell 
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(Lin et al., 1995). Bay 11-7085 blocks the release of NFκB from IκBα by inhibiting 
IκBα phosphorylation and subsequently degradation (Pierce et al., 1997). 
 
PKC inhibitor Bisindolylmaleimide GF 109203X. In paper IV, the competitive 
inhibitor bisindolylmaleimide (Bis) was used. Bis inhibits PKC activity by preventing 
ATP binding to its catalytic site (Toullec et al., 1991). 
 
 
2.7 MELANOGENIC ASSAY  
Tyrosinase activity. For tyrosinase activity measurements (Paper IV), tyrosinase 
enzyme was obtained from supernatants of melanocyte lysates after centrifugation. 
Enzyme activity was measured spectrophotometrically at 492nm at 37°C for one hour 
as the formation of dopachrome in a reaction mix consisting of supernatant, L-Dopa 
(2mg/ml) and 50mM phosphate buffer at neutral pH. Neutral pH is required for optimal 
tyrosinase activity and L-dopachrome stability. Tyrosinase activity was calculated over 
the first 20 min (excluding the lag-phase) and normalized to protein concentrations. 
This assay may underestimate tyrosinase activity, because (i) only ½ of L-dopa is 
converted into L-dopochrome by tyrosinase, while the other ½  is reduced back to L-
dopa and (ii) L-dopachrome is concomitantly catalyzed by TYRP2 into DHICA 
(Nordlund et al., 2006). 
 
Melanin. To determine the melanin content of melanocytes (Paper IV), cells were 
harvested, centrifuged and pellets were solubilized in 1M NaOH for 1h at 60°C. 
Melanin was measured spectrophotometrically at 450nM.  
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3 AIMS OF THE PRESENT STUDY 
 
The overall aim of the present study was to elucidate the molecular mechanisms 
regulating AhR function and signaling upon activation by different stimuli including 
xenobiotics, potential physiological ligands and UVB. A further aim was to investigate 
the functional consequences of AhR activation by these different types of activators on 
normal physiological cell signaling.  
 
The specific aims of this study were: 
• To further characterize pathways for the formation and metabolic degradation 
of the suggested physiological AhR ligand FICZ as well as to identify the 
presence of FICZ metabolites in human material.  
• To gain insights into the regulation of the transcription factor and ubiquitin 
ligase function of the AhR (i) under physiological, xenobiotic-free conditions 
and (ii) in the presence of xenobiotics i.e. AhR activation and signaling upon 
indolocarbazole (FICZ and ICZ) vs TCDD treatment. 
Moreover, to investigate the functional consequences of differences in the 
regulation of AhR signaling under these two conditions.  
• To analyze the activation and regulation of AhR signaling upon UVB 
irradiation using the AhR-target gene CYP1A1 as an example 
• To elucidate AhR-mediated mechanisms underlying xenobiotic-induced 
hyperpigmentation and to define a novel role of the AhR in modulating human 
melanogenesis in the skin.    
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4 RESULTS AND DISCUSSION 
 
4.1 PROPERTIES OF 6-FORMYLINDOLO[3,2-b]CARBAZOLE (FICZ) – A 
SUGGESTED PHYSIOLOGICAL AhR LIGAND (PAPER I & II) 
AhR signaling and its regulation have mainly been studied upon activation by TCDD. 
This man-made and non-metabolizable compound has been intensively used as a 
prototypical ligand for the AhR and most of our understanding of AhR signaling is 
based on studies using TCDD or structurally similar xenobiotics as stimuli. Because 
these compounds are not endogenously produced or present in cells, xenobiotic-
induced AhR signaling may rather reflect the de-regulation of normal signaling than 
signaling under physiological conditions. In order to learn more about the role of the 
AhR in normal cellular functions, many attempts have been made to identify the 
endogenous ligands of this receptor. We used the tryptophan-derived photoproduct 6-
formylindolo[3,2-b]carbazole (FICZ) as an example of a physiological ligand and 
characterized its properties (Paper I). Later on, we investigated AhR activation and 
function under xenobiotic-free conditions by using FICZ and indolo[3,2-b]carbazole 
(ICZ) as ligands (Paper II). 
 
4.1.1 Characterization of FICZ 
4.1.1.1 FICZ - a bona fide ligand for the AhR 
Competitive binding studies in the late 1980´s showed that photoproducts of the amino 
acid tryptophan, but not tryptophan itself, were able to bind and activate the AhR 
(Helferich and Denison, 1991; Rannug et al., 1987). One of this photoproducts was 
identified as 6-formylindolo[3,2-b]carbazole, shortly termed FICZ (Rannug et al., 
1995). FICZ is a high affinity ligand and powerful AhR activator (Rannug et al., 1987; 
Wei et al., 2000) and by performing AhR-ELISA (Paper I) and dose-response curves at 
3 hours in HepG2-XRE-Luc cells (Paper II) we confirmed its potency. In HepG2-XRE-
Luc cells, FICZ activated the XRE-luciferase gene reporter with an EC50 value (EC50 
FICZ: 1.5(±0.61)·10-10M) that was 19.3 fold lower than the EC50 value for TCDD (EC50 
TCDD: 2.9(±0.86)·10-9M) indicating that FICZ is more powerful in activating the AhR 
than TCDD, the prototypical high affinity ligand. 
 
4.1.1.2 The light-dependent formation of FICZ and its metabolic fate 
Tryptophan seems to serve as a common precursor for many naturally-occurring AhR 
ligands including indolocarbazoles, indigoids, tryptanthrins, malassezin, trypthamine, 
indoleacetic acid and kynurenic acid. Many of these compounds are derived from 
tryptophan by enzymatic activity in both microorganisms and fungi as well as plants 
and higher organisms (reviewed in Denison and Nagy, 2003). In contrast to the 
enzymatic formation of these compounds, FICZ was formed upon irradiation of 
tryptophan with visible light and ultraviolet radiation, as also indicated in previous 
studies (Diani-Moore et al., 2006; Oberg et al., 2005). Because tryptophan is one of the 
amino acids that is able to absorb light in the range of UVB, UVB was very effectively 
in producing FICZ, whereas only low amounts of FICZ could be detected after UVA 
(320-400nm) irradiation of tryptophan solutions. Light and UVA-dependent FICZ 
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formation was enhanced by the photosensitizer riboflavine. In a study on keratinocytes, 
AhR activation was mainly observed after UVB irradiation and nearly no responses 
were obtained upon UVA irradiation (Fritsche et al., 2007). As shown here, FICZ can 
be effectively produced by irradiation of tryptophan. Whether FICZ can also be formed 
enzymatically like other tryptophan-derived AhR ligands has to be elucidated.  
FICZ is rapidly degraded in biological systems (Bergander et al., 2003; Bergander et 
al., 2004). A number of mono- or dihydroxylated metabolites, which were less efficient 
AhR activators, were produced when FICZ was metabolically degraded. The 
hydroxylation of FICZ was mainly catalyzed by CYP1A1, CYP1A2 and CYP1B1 
enzymes and FICZ was shown to be an extraordinary good substrate for these enzymes, 
especially for CYP1A1. The significance of the catalytic activity of CYP1A1 in FICZ 
metabolism was proven in the murine hepatoma cell line (Hepa-1 c37), containing non-
functional CYP1A1 enzyme. Hepa-1 c37 cells showed almost no FICZ metabolism, 
confirming that metabolism of FICZ occurs mainly through the CYP1A1 enzyme (Wei 
et al., 2000). To a lesser extent, FICZ was also converted by aldehyde oxidases to the 
indolo[3,2-b]carbazole-6-carboxylic acid (CICZ) which can be further hydroxylated by 
CYP1 enzymes. The hydroxylated metabolites of FICZ were very good substrates for 
sulfotransferases that catalyze the conjugation of sulfo-groups to form water-soluble 
and excretable sulfuric acid esters. In fact, sulfoconjugated metabolites of FICZ were 
identified in human urine samples by using LC/MS/MS (Paper I). The identification of 
FICZ-derived sulfoconjugates in biological samples suggests the presence of FICZ or 
its metabolites in biological systems and underlines the physiological relevance of this 
compound and its metabolites. 
 
4.1.2 AhR activation by FICZ 
FICZ is a high affinity AhR ligand, inducing a transient CYP1A1 expression at pM to 
nM concentrations (Wei et al., 1998). A rapid and transient increase in AhR activation, 
measured as the induction of luciferase reporter activity, was also observed in HepG2-
XRE-Luc cells treated with low nM concentrations of FICZ. Time-course experiments 
revealed a maximal induction at around 3 hours, after which levels decreased. Control 
levels were reached at around 12 hours (Paper I and II). This transient induction 
pattern, which is also observed after ICZ treatment, can be abrogated by stimulation 
with higher concentrations (µM-mM) (Wei, unpublished data; Chen et al., 1995). 
Endogenous gene expression of CYP1A1 and the AhR repressor, both AhR-target 
genes, showed a similar transient induction pattern in response to low concentrations of 
FICZ, peaking consistently with the reporter gene activity at around 3 hours before 
declining to basal levels (Paper II). These transient induction patterns of AhR activation 
and target gene expression correlated well with intracellular FICZ levels. Intracellular 
FICZ level declined rapidly over the first hours and were below detection limit after 3 
hours (Paper I). With the disappearance of ligand, also AhR activation tapered off.    
 
4.1.3 Autoregulatory loop between AhR signaling and CYP1A1 – FICZ 
induces its own metabolism 
AhR signaling and CYP1A1 seems to be linked to each other by an autoregulatory loop 
since high constitutive CYP1A1 mRNA levels have been observed in the absence of 
exogenous ligands in cells with impaired CYP1A1 enzyme activity (Chang and Puga, 
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1998; RayChaudhuri et al., 1990; Wei et al., 2000). Like many other naturally-
occurring compounds which are both AhR ligands and substrates for CYP1 
metabolizing enzymes (Chen et al., 1995; Schaldach et al., 1999; Sinal and Bend, 
1997), FICZ induces its own metabolism through the transcriptional up-regulation of 
AhR-controlled CYP1 genes. When CYP1A1 enzyme activity was impaired by α-NF 
treatment and FICZ metabolism was slowed down, luciferase reporter activity was not 
longer transient, but showed a rather sustained response to FICZ treatment (Paper I). 
Similar observations were also obtained from Hepa-1 c37 cells, deficient in functional 
CYP1A1. In these cells, FICZ treatment evokes a prolonged up-regulation of CYP1A1 
mRNA levels, an induction pattern similar to the one observed after stimulation with 
the non-metabolizable ligand TCDD (Wei et al., 2000). Moreover, CYP1A1 inhibition 
using chemical inhibitors resulted in cell cycle arrest in rat hepatoma cells, a response 
rather expected upon TCDD treatment (Levine-Fridman et al., 2004). It therefore seems 
that the autoregulation of ligand availability is essential for normal cell signaling and 
the maintenance of homeostatic functions. 
 
 
4.2 COMPARSION OF AhR SIGNALING UNDER PHYSIOLOGICAL AND 
NON-PHYSIOLOGICAL CONDITIONS (PAPER I & II) 
In order to understand the regulatory mechanisms controlling AhR signaling under 
physiological, xenobiotic-free conditions, we investigated AhR activity and function 
following activation by indolocarbazoles and compared it to the activation by TCDD. 
The indolocarbazoles FICZ and ICZ are naturally-occurring (Bjeldanes et al., 1991; 
Rannug et al., 1987) and rapidly metabolized through CYPs 450 (Paper I; Chen et al., 
1995), thereby fulfilling two properties that seems to be important for physiological 
ligands. TCDD, in contrast, is exclusively produced by anthropogenic activities and is 
due to its physiochemical properties resistant to biological degradation (Poland and 
Knutson, 1982).  
 
4.2.1 The regulation of the transcription factor and ubiquitin ligase 
function of the AhR by indolocarbazoles and TCDD  
In study II, we analyzed the transcription factor and ubiquitin ligase function of the 
AhR in HepG2 cells in response to indolocarbazoles and TCDD treatment. 
Indolocarbazole treatment evoked a transient induction of luciferase reporter gene 
activity and target gene expression, which was in contrast to the sustained 
transactivation of TCDD-activated AhR. These two classes of ligands may not only 
exert temporal different responses in gene expression, but may also induce different 
AhR target gene profiles as shown by Laub and colleagues (Laub et al., 2010). 
Differences between indolocarbazole and TCDD treatments were also observed with 
regard to the intracellular distribution and DNA-binding capacities of the activated 
receptor. Localization studies using a GFP-tagged mouse AhR, transiently transfected 
into HepG2 cells, revealed a rapid translocation of activated receptor from the 
cytoplasm into the nucleus upon FICZ, ICZ and TCDD activation. Yet, only TCDD-
activated AhR was still enhanced in the nuclear compartment after 6 hours, whereas 
indolocarbazole-activated receptor showed an equal distribution between cytoplasm 
and nucleus as also observed in vehicle treated cells. Studies using a mutant mAhR that 
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bears an alanine to isoleucine substitution at amino acid 375 in the LBD and shows 
impaired ligand recognition (Murray et al., 2005), confirmed that the observed 
differences were due to ligand activation of the receptor. Consistently with the 
subcellular compartmentalization data and the target gene expression, DNA-bound 
receptor was isolated from the CYP1A1 promoter of TCDD-treated cells after 16 hours. 
Upon indolocarbazole treatment, the AhR was only transiently recruited to XREs and 
was clearly not detectable after 16 hours. Interestingly, in comparison to TCDD, 
recruitment of the indolocarbazole-activated receptor was more rapidly (within 10 
minutes), a trend that was also observed in target gene expression and substrate 
degradation. Taken together, profound differences in the regulation of the 
transcriptional activation properties of the AhR by these two types of ligands exist.  
Even the ubiquitin ligase function of the receptor was distinctly regulated by 
indolocarbazoles and TCDD. AhR and ERα levels were down-regulated in response to 
both classes of ligands, suggesting that the ligase function is activated upon ligand 
binding independently on a specific type of ligand. Total AhR levels were rapidly and 
transient decreased via the 26S proteasomal pathway in response to indolocarbazole 
treatment, but remained persistent depleted upon TCDD exposure. Recovery of 
indolocarbazole-activated receptor was blocked by cycloheximide (CHX) co-treatment, 
indicating that new synthesis of receptor is necessary to restore basal levels. Whether 
ERα levels are restored after indolocarbazole treatment could not be assessed by 
immunoblotting, because the protein synthesis inhibitor CHX was required in all 
experiments due to the fast turnover of ERα (Reid et al., 2003). However, because 
MCF7 cells pre-treated with indolocarbazoles remained estrogen-responsive, a transient 
down-regulation of the ERα can be assumed.  
ERα regulates the growth of hormone-responsive breast cancer cells (Brunner et al., 
1989). An increasingly attractive strategy in breast cancer treatment, but also prostate 
cancer treatment, is the depletion of  steroid receptor levels in tumor cells (Rodriguez-
Gonzalez et al., 2008). Selective ER downregulators (SERDs), e.g. the ERα ligand ICI-
182780, have been used to promote the degradation of activated receptor. An 
alternative approach to induce ERα degradation may be via selective, non-toxic AhR 
ligands, which may also be effective in cases where ERα became resistant to hormone 
therapy. Recently, I3C, a precursor of ICZ, has been shown to induce ERα degradation 
via the AhR E3 ligase function thereby disrupting GATA3/ER crosstalk and 
subsequently ERα expression in breast cancer cells (Marconett et al., 2010). Moreover, 
in APCmin/+ mice, a mouse model for colon carcinogenesis, I3C has been shown to 
reduced the incidences of small intestine tumors by promoting AhR-mediated β-catenin 
degradation (Kawajiri et al., 2009). Thus, by inducing the ubiquitin ligase function of 
the receptor, non-toxic, physiological ligands may have important therapeutic 
implications for cancer prevention.  
 
4.2.2 Dynamic regulation of the AhR pathway is required for receptor 
responsiveness and physiological signaling 
The two functions of the AhR, the transcription factor and ubiquitin ligase function, 
were dynamically regulated upon activation by physiological ligands of the 
indolocarbazole type. Due to their fast metabolism (Paper I and Chen et al., 1995), 
these ligands activated AhR signaling in a transient manner and AhR activity could be 
rapidly reset to basal levels following the metabolic clearance of ligand and the 
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degradation of ligand-activated receptor. Rapid metabolism of activating ligands by 
ligand-induced CYPs and other drug-metabolizing enzymes has also been suggested as 
an underlying mechanism to obtain normal nuclear receptor signaling (reviewed by 
Nebert, 1991). Even degradation of activated receptor via the proteasomal pathway is a 
common mechanism for the regulation of nuclear receptors to limit receptor activity 
and retain ligand responsiveness (Wijayaratne and McDonnell, 2001). In case of the 
AhR, receptor levels are not only reduced in response to ligands, but also after 
stimulation by UVB (Paper III). By using an experimental design, in which cells were 
pre-treated with ligands for 5 hours, before new ligand stimulation after 14 hours of 
rest, we analyzed ligand responsiveness. Cells remained only ligand-responsive when 
pre-treated with indolocarbazoles, suggesting that a transient activation of this pathway 
and a rapid restoration of constitutive levels are important for normal cellular signaling. 
Transient receptor activation and degradation are also observed after treatment of cells 
and experimental animals with ITE (Henry et al., 2006). Animals treated with single or 
repeated doses of these metabolizable, naturally-occurring compounds, i.e. ICZ, FICZ 
and ITE, show no signs of toxicity (Henry et al., 2006; Mukai and Tischkau, 2007; 
Pohjanvirta et al., 2002) indicating that these ligands will not disturb physiological 
signaling.  
 
4.2.3 Dysregulation of dynamic AhR signaling - a mode of action of 
toxicity 
In contrast to indolocarbazole treatment, TCDD treatment resulted in prolonged AhR 
activation and persistent depletion of AhR and ER levels. As a functional consequence, 
cells became refractory to new ligand stimulation. Thus, TCDD rendered cells into a 
state in which normal dynamic cell signaling was interrupted. Disturbed signaling and 
impaired ligand responsiveness can also be observed in cells and mice in which AhR 
activity is artificially prolonged through the introduction of a constitutive active AhR, 
lacking parts of its LBD (Andersson et al., 2002; McGuire et al., 2001). AhR-CA mice 
show signs of TCDD toxicity (Brunnberg et al., 2006) suggesting that continuous AhR 
activation is unfavorable. Many regulatory mechanisms including the AhR repressor, 
metabolic clearance of ligands and ligand-induced receptor degradation seems to have 
evolved to prevent continuous AhR activation and the pleiotropic toxic effects linked to 
it (reviewed in Mitchell and Elferink, 2009). Disturbance of these processes and 
subsequently dysregulation of dynamic cell signaling may therefore be part of the mode 
of action of dioxins and other metabolically inert, synthetic compounds and account for 
their widely observed toxicity.  
 
 
4.3 STIMULATION OF THE AhR PATHWAY BY UVB USING THE 
EXAMPLE OF THE AhR TARGET GENE CYP1A1 (PAPER III) 
AhR activation has not only be observed after ligand treatment, but also after 
stimulation with UVB radiation (Fritsche et al., 2007). In  zebra fish (Behrendt et al., 
2010), murine (Goerz et al., 1996; Goerz et al., 1983) and human skin (Katiyar et al., 
2000) as well as in keratinocytes (Fritsche et al., 2007; Gonzalez et al., 2001; Villard et 
al., 2002; Wei et al., 1999) AhR target gene expression, in particular CYP1A1, 
CYP1A2 and CYP1B1, is induced following UVB irradiation. UV radiation affects 
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many signal transduction pathways (reviewed in Bender et al., 1997) and in paper III 
we analyzed its impact on AhR activation and CYP1A1 gene regulation. Due to the 
availability of the sensitive XRE-luciferase reporter in HepG2-XRE-Luc cells, we 
performed this study in human hepatoma cells (HepG2) instead of keratinocytes, which 
are clearly the physiological more relevant cell type. Most of the studies in paper III 
were performed with the reporter gene system and not on endogenous CYP1A1 gene 
expression. Because the half-lives of both luciferase and CYP1A1 mRNA and protein 
are quite similar (t1/2 mRNA~ 2-2.4 hours; t1/2 protein ~ 3 hours) (Lekas et al., 2000; 
Marderosian et al., 2006; Thompson et al., 1991; Werlinder et al., 2001), the reporter 
gene assay was used as an appropriate surrogate for gene expression analyses. The 
UVB doses used in most of the experiments ranged between 10-20mJ/cm2. These doses 
are significantly lower than the minimal erythema dose (MED) in humans and can 
therefore be considered as physiologically relevant.   
 
4.3.1 AhR activation by UVB irradiation 
HepG2-XRE-Luc cells responded to UVB irradiation with a slow, belated increase in 
luciferase reporter activity that could be blocked by treatment with the partial AhR 
antagonist MNF. Studies performed on HaCaT AhR KO cells, showing extremely low 
AhR protein levels, and Hepa-1 c12 cells lacking the AhR, confirmed the AhR as the 
mediator of UVB responses (Fritsche et al., 2007; Wei et al., 1999). In concordance 
with the reporter studies, endogenous CYP1A1 gene expression was also up-regulated 
by UVB at late time points. However, the temporal induction pattern observed after 
UVB irradiation was distinct from the induction by FICZ. As described earlier (Paper I 
and II), FICZ treatment at low nM concentrations resulted in a rapid and transient 
induction peaking at around 3-6 hours. On the contrary, UVB-induced reporter gene 
activity and CYP1A1 expression occurred first after 9 hours and was suppressed below 
control levels, i.e. levels obtained in sham-irradiated cells receiving new medium at 
treatment start, at earlier time points. It has been proposed that the inducing effects of 
UVB on AhR signaling are mediated by FICZ (Rannug et al., 1987), of which 
intracellular formation was shown in UVB-irradiated HaCaT cells (Fritsche et al., 
2007). However, the differences observed in kinetics in this study rather suggest the 
involvement of additional signaling molecules and factors.  
 
4.3.2 Interactions between the AhR and nuclear factor κB in the 
regulation of UVB-induced CYP1A1 gene expression 
As described above, UVB irradiation initially suppressed reporter gene activity and 
CYP1A1 gene expression in a dose-dependent manner. Suppression of CYP1A1 
expression has been noted after H2O2 treatment. This suppression is mediated by the 
nuclear factor I (NFI/CTF) (Barker et al., 1994; Morel and Barouki, 1998; Morel et al., 
2000), which undergoes redox cycling of cysteine residues in its TAD in response to 
oxidant treatment (Morel and Barouki, 2000). In TCDD-induced cells, suppression of 
CYP1A1 expression has also been observed after co-treatment with TNF-α, IL-1 β and 
LPS (Ke et al., 2001; Tian et al., 1999). These proinflammatory cytokines and 
microbial endotoxins have been shown to suppress AhR activity and CYP1A1 
expression through activation of the NFκB pathway (reviewed in Tian et al., 2002). 
Because NFκB can be activated through UVB-generated ROS (reviewed by Cooper 
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and Bowden, 2007), we investigated whether crosstalk between the two transcription 
factors underlies the modulation of UVB-induced CYP1A1 gene expression. Upon 
irradiation, the NFκB subunit p65 underwent nuclear translocation, but was mainly 
cytoplasmic at later time points when CYP1A1 expression was not longer suppressed. 
Two different NFκB inhibitors, the inhibitory peptide SN50 and the IκBα 
phosphorylation inhibitor Bay 11-7085 (Lin et al., 1995; Pierce et al., 1997), abolished 
the initial suppression suggesting that NFκB and AhR mutually regulate their activities 
in response to UVB. Despite their inability to bind to the AhR, as tested in the Gal4-
AhR fusion protein assay, both inhibitors themselves increased luciferase reporter gene 
activity. Whether this is due to an involvement of NFκB in the modulation of 
constitutive levels remains to be elucidated.   
p65, which is able to directly interact with the AhR (Tian et al., 1999), suppresses 
CYP1A1 gene expression through competition for SCR-1 and p300/CBP and blockage 
of histone acetylation (Ke et al., 2001). Which mechanism is involved in mediating the 
inhibitory effects of NFκB activation on AhR signaling following UVB irradiation 
remains unknown. The use of the XRE-luciferase reporter construct, which does not 
resemble the chromatin architecture of endogenous genes, allows no conclusions to be 
drawn about the inhibitory mechanisms of NFκB.   
 
4.3.3 AhR signaling as part of the UV stress response 
UVB irradiation restricted not only the expression of the CYP1A1 gene at early time 
points via the activation of NFκB, but decreased also the catalytic activity of the 
CYP1A1 enzyme. Upon UVB irradiation, CYP1A1 enzyme activity was damped as 
measured by the clearance of intracellular FICZ levels (see also Paper I). The reduction 
of CYP1A1 expression and activity may be a protective precaution of cells to limit 
ROS-generation by high CYP1A1 activity  (Barouki and Morel, 2001). Moreover, AhR 
signaling became refractory to repeated UVB irradiation and oxidant treatment, but 
remained responsive to ligand treatment. In contrast to the observed refractoriness in 
TCDD-pre-treated cells, reduced receptor levels seemed not clearly account for the 
receptor unresponsiveness after UVB and oxidant treatment. In response to oxidant 
exposure, proteins can undergo redox cycling of their cysteine residues. This may 
impair their ability to interact with DNA and other proteins and reduce their 
transactivation properties. Whether such changes affect upstream regulators of the AhR 
e.g. kinases or account for the inability of the AhR itself to respond to repeated UVB or 
oxidant treatment has to be investigated. 
The observed restriction of AhR signaling and CYP1A1 enzyme activity following 
UVB irradiation may be part of protective mechanisms of cells against environmental 
stressors. Stressors such as UV, oxidative stress and heat shock have also been shown 
to regulate the activity of many E3 ubiquitin ligases (reviewed by Ohtake et al., 2009). 
For instance, the CUL3 ubiquitin ligase complex is inactivated upon oxidative stress 
resulting in the stabilization of the transcription factor NRF2 involved in antioxidant 
responses (for review see Nguyen et al., 2009), whereas the CUL4A ligase is activated 
by UV targeting the xeroderma pigmentosum group C protein (XPC) to degradation 
thereby allowing nucleotide excision repair (reviewed by Jackson and Xiong, 2009). 
The down-regulation of AhR levels upon UVB irradiation may suggest that the AhR is 
part of a stress-responsive ubiquitin ligase complex that can be regulated by UVB and 
oxidative stress. However, it remains to be elucidated how this complex affects other 
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substrate proteins and contribute to the stress response system. Cellular responses to 
UV or oxidants are not only observed in skin cells. Even other cells e.g. hepatocytes, 
lymphocytes and HepG2 possess a functional antioxidant defense and UV stress 
response system and the AhR may be part of it.  
 
 
4.4 A NOVEL FUNCTION OF THE AhR IN THE SKIN (PAPER IV) 
As implicated in Paper III and reviewed in Ranug and Fritsche (Rannug and Fritsche, 
2006), AhR signaling can be stimulated by UVB and may be part of the UV stress 
response. Like many other cells, skin cells undergo adaptive changes to protect 
themselves against the deleterious effects of UVB radiation and UV-induced ROS 
production (Herrlich et al., 2008; Muthusamy and Piva, 2009). These changes include 
cell cycle arrest, DNA repair and, in the case of melanocytes, an enhanced formation of 
photon-absorbing melanin. An increase in pigmentation, a pathological condition called 
hyperpigmentation, can also be observed in humans after exposure to xenobiotics such 
as PAHs, PCBs and dioxins, compounds well-known to be AhR ligands (Axell and 
Hedin, 1982; Haresaku et al., 2007; Hsu et al., 1985; Lu and Wu, 1985; Urabe and 
Asahi, 1985; Yamashita and Hayashi, 1985). Even in other organisms than humans, 
enhanced melanogenesis has been reported after exposure to AhR ligands of xenobiotic 
origin (Iwata et al., 1981; Kleeman et al., 1988; Zodrow and Tanguay, 2003). These 
results and the data on AhR activation by UVB, the major physiological stimulus for 
the production of melanin, suggest a role of the AhR in melanogenesis.  
 
4.4.1 AhR signaling in melanocytes 
In order to study the role of the AhR in melanogenesis, we first characterized the AhR 
pathway in human melanocytes, the pigment-producing cells of the skin. Human 
primary melanocytes expressed low basal levels of AhR and ARNT mRNA compared 
to their cancerous counterparts in which AhR overexpression can clearly be linked to 
their invasive potential (Villano et al., 2006). Treatment of these cells in culture with 
TCDD and FICZ resulted in an up-regulation of AhR target genes e.g. CYP1A1, 
CYP1B1, the AhR repressor and the AhR itself. In agreement with the observations in 
Paper II, FICZ treatment provoked a transient induction, whereas expression levels 
were still up-regulated after 3 days by TCDD treatment. Even in melanocytes, ligand-
induced AhR degradation was detected confirming that the AhR pathway is fully 
functional in these cells. AhR protein levels varied in melanocytes from different 
donors, but could not clearly be coupled to the pigmentation status of the cells. 
 
4.4.2 The AhR mediates xenobiotic-induced hyperpigmentation 
The production of melanin is a very complex process that requires organelle biogenesis, 
gene expression, protein sorting and organelle transfer. However, the key and rate-
limiting step in the biochemical formation of melanin polymers is the oxidation of L-
tyrosine to L-dopa, a reaction that is solely catalyzed by the melanosomal tyrosinase 
enzyme. Tyrosinase enzyme activity, as measured by a spectrophotometrical 
absorbance-based enzyme assay, was up-regulated in an AhR-dependent manner in 
melanocytes upon TCDD treatment (10nM). The sustained up-regulation of tyrosinase 
activity was followed by an increase in intracellular melanin. Neither enhanced 
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tyrosinase activity nor melanin content could be attributed to the stimulation of 
melanocyte proliferation. Our observations are supported by histopathological analyses 
of hyperpigmented human skin which showed normal numbers of melanocytes, but 
elevated melanin accumulation (Hashiguchi et al., 1987; Pastor et al., 2002). 
The biosynthesis of melanin polymers is mainly determined by the activity of the 
tyrosinase enzyme, which can be posttranslational modified by phosphorylation. 
Phosphorylation of serine 505 and 509 by PKC-β enhances the catalytic activity of 
tyrosinase (Park et al., 1999) and promotes interactions with tyrosinase-related protein 
1 and 2 in the melanogenic complex, which further stabilizes tyrosinase (Wu and Park, 
2003). Co-treatment of melanocytes with the PKC-β inhibitor bisindolylmaleimide I 
(50nM) had no effect on TCDD-induced tyrosinase activity, excluding altered PKC-β 
signaling as the underlying mechanisms for the observed induction of tyrosinase 
activity, even though TCDD has been shown to interfere with this pathway in other 
cells. Interestingly, several potential XREs were identified in the 5´-flanking region of 
melanogenic genes. Three, respectively two XREs with the core nucleotide sequence of 
GCGTG exist in the promoter region of tyrosinase and tyrosinase-related protein 2 and 
expression of both melanogenic genes was up-regulated upon TCDD-treatment. Co-
treatment with MNF abolished the TCDD-induced tyrosinase gene expression, but had 
only a marginal effect on TYRP2 mRNA levels indicating a complex transcriptional 
regulation of this gene. Both melanogenic genes can therefore be considered as novel 
transcriptional targets for the AhR. Several other genes TYRP1, MCR1 and MITF, 
which are also involved in the regulation of melanogenesis, were tested upon ligand 
treatment, but none of them was induced at the tested time points.   
Taken together, this study revealed the molecular mechanisms underlying 
xenobiotic-induced hyperpigmentation. As we show here, xenobiotic exposure induces 
melanogenesis in human melanocytes via direct activation of the transcription factor 
function of the AhR and the modulation of melanogenic genes.  
 
4.4.3 A possible role of the AhR in UVB-induced melanogenesis 
We showed that xenobiotic-induced hyperpigmentation, as studied after TCDD 
exposure, is mediated through the AhR signaling pathway. However, an up-regulation 
of tyrosinase enzyme activity was also noted after FICZ treatment. As expected, 
tyrosinase tyrosinase activity was early and transiently induced in FICZ-treated cells 
and higher concentrations (up to 100nM) were required for a successful induction 
probably due to the rapid metabolic degradation of FICZ. Thus, it seems that tyrosinase 
regulation is also under the influence of AhR signaling activated by physiological 
ligands. The major physiological stimuli of melanogenesis is UVB radiation (reviewed 
in Kadekaro et al., 2003). Because the AhR can be activated by UVB (Fritsche et al., 
2007; Paper III), it is tempting to speculate that this receptor is also involved in the 
regulation of UVB-induced melanogenesis. Under the growth conditions (melanocyte 
growth medium M2) used in this study, melanocytes were extremely susceptible to 
UVB-induced apoptosis and showed decreased tyrosinase activities even at very low 
doses of irradiation. Melanocytes grown in M2 have high pheomelanin to eumelanin 
ratios (Duval et al., 2002) and may therefore be highly sensitive to UVB irradiation. 
Down-regulation of tyrosinase activity, growth cycle arrest (Im et al., 1998) and UVB-
induced apoptosis (Bohm et al., 2005) have been observed in melanocyte cultures 
grown in the absence of α-MSH suggesting that the observed cytotoxic effects of UVB 
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on our cultures may be an effect of the medium composition. Therefore it was not 
possible, under the experimental conditions used here, to elucidate whether UVB-
activated AhR mediates the stimulation of melanogenesis in irradiated human 
melanocytes. However, studies on AhR -/- mice revealed a reduced tanning response 
when compared to WT mice. These mice failed to enhance melanogenesis in response 
to UVB irradiation and showed impaired melanocyte proliferation and differentiation 
(B. Jux, personal communication). Whether AhR signaling mediates tanning in human 
melanocytes through similar mechanisms remains to be elucidated. 
In conclusion, these data suggest that the AhR does not only mediate xenobiotic-
induced hyperpigmentation, but also contribute to UVB-induced melanogenesis. 
 
4.4.4 The AhR, a novel factor involved in the regulation of human 
melanogenesis 
Many different factors and signal transduction pathways have been implicated in the 
regulation of melanogenesis (reviewed in Park et al., 2009). In this study, we identified 
the AhR as a novel regulator of human melanogenesis, a role that was greatly unknown 
to date. By regulating both adaptive responses e.g. the production of protective melanin 
and skin cell proliferation and differentiation, it seems that this receptor has important 
functions in maintaining skin homeostasis under normal conditions and in response to 
environmental stressors such as damaging UVB irradiation.  
In this study we investigated the direct effects of AhR activation on the melanogenic 
pathway in melanocyte monocultures. However, melanocytes are greatly stimulated to 
proliferate and produce melanin by paracrine factors secreted from surrounding cells 
including dermal fibroblasts, Langerhans cells and keratinocytes (Archambault et al., 
1995; Hirobe, 2005), which also express a functional AhR pathway. Especially 
keratinocytes, which form together with melanocytes functional epidermal melanin 
units, secret a number of different mitogenic and melanogenic factors. No differences 
in tanning were observed between conditional knock-out K5Cre+ mice, deficient in 
AhR in keratinocytes, and WT mice, suggesting that keratinocyte-derived factors 
involved in the regulation of murine melanogenesis may not necessarily be under the 
control of the AhR (B. Jux, personal communication). Experiments using co-culture 
systems or organotypical cultures of human skin cells may clarify whether AhR 
signaling in keratinocytes, in cooperation with its observed directs effects on 
melanogenic genes in melanocytes, contribute to the regulation of human 
melanogenesis. 
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5 CONCLUDING REMARKS AND FUTURE 
PERSPECTIVES 
 
As an approach to study AhR signaling in a more physiological context, two naturally-
occurring substances of the indolocarbazole type, FICZ and ICZ, were used in this 
study. Both compounds elicited very transient responses in terms of activation of the 
transcription factor and ubiquitin ligase function of the AhR allowing thereby the 
receptor to keep its ligand responsiveness. Rapid resetting of signal transduction 
pathways into non-induced, basal states is clearly required for viable cells to respond to 
new stimulation. An important prerequisite for these transient activation patterns is the 
rapid degradation of activated receptor and the rapid metabolic clearance of activating 
ligands. As shown with FICZ, these ligands are both AhR activators and targets for 
AhR-controlled CYP1 metabolizing enzymes. Thus, these ligands induce their own 
metabolic breakdown. The autoregulatory circuit between CYP1A1 activity and AhR 
signaling is therefore an important mechanism to restrict the activating potential of 
ligands. Disturbance of this regulatory loop, for instance by impairment of CYP1A1 
activity as observed after UVB irradiation or chemical inhibitor treatment, resulted in 
prolonged, TCDD-like responses. Continuous activation of the AhR, as observed in 
TCDD-treated cells, abolished dynamic cell signaling of both the AhR and other signal 
transduction pathways. It seems therefore that the disruption of dynamic regulation of 
AhR signaling may be the underlying mode of action for the toxicity of most non-
metabolizable xenobiotics including TCDD and structurally similar compounds.  
Besides xenobiotic exposure, normal cell signaling can also be disrupted upon UVB 
radiation. Cells try to compensate for the damaging effects of this physiological 
stimulus by initiating adaptive responses such as cell cycle arrest and DNA repair. As 
many other signaling pathways, the AhR is also activated upon UVB irradiation. AhR 
activity and CYP1A1 expression were restricted following irradiation by another UVB-
activated transcription factors, NFκB. The modulation of AhR signaling and CYP1A1 
expression may therefore be part of the UV stress response, protecting cells against the 
generation of more oxidative stress by elevated CYP1A1 levels and activity.  
Especially skin cells are frequently exposed to UVB irradiation and chemical 
factors, including xenobiotics, due to their position as the outermost barrier of the body. 
Like in other tissues, AhR signaling seems to be also important for the maintenance of 
the homeostasis in the skin. The production of protective pigment is induced in 
melanocytes in response to both UVB and xenobiotic exposure. As identified here, 
AhR signaling mediated the induction of the melanogenic pathway through the 
transcriptional control of genes encoding enzymes involved in the biochemical 
formation of melanin. The regulation of melanogenesis is clearly a novel function of 
the AhR in the skin.    
 
Normal cell signaling depends on the functioning of hundreds of signal transduction 
pathways, including the AhR signaling pathway. Numerous complex molecular 
mechanisms have evolved to control AhR activity and function as well as crosstalk 
with other pathways thereby ensuring proper signaling. As shown here, profound 
differences in AhR regulation exist between non-physiological and physiological 
ligands. Studies on AhR activation by xenobiotics may allow us indirectly to draw 
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conclusions about its involvement in physiological processes, but so far we have only 
got a glimpse of these. Thus, more has to be learned about the function and regulation 
of AhR signaling in a xenobiotic-free context. The use of naturally-occurring 
compounds as ligands will be extremely helpful to mimic the physiological situation 
under experimental conditions. In the end, this will help us to fully understand the 
physiological role of the AhR and to identify the physiological stimuli controlling this 
pathway.  
 
 
 
   43 
6 ACKNOWLEDGEMENTS 
 
Many people within science and outside science have contributed in one or the other 
way to this thesis. This chapter is devoted to all of you. 
 
I would like to express my sincere gratitude to my supervisor Agneta Rannug for 
excepting me as a PhD student in your lab and introducing me into the world of AhR 
signaling. Under all these years it has been very interesting, stimulating and sometimes 
challenging. 
 
I would like to thank Maria Backlund and Sandra Ceccatelli for being my co-
supervisors under these years. Maria, thank you for the many interesting discussions 
we had. 
 
I would like to thank all my collaborators for fruitful collaborations on the different 
projects. At Stockholms Universitet: Ulf Rannug and Emma Wincent for sharing your 
knowledge on FICZ metabolism. At CMB, KI: Lorenz Poellinger for giving the AhR 
ligand project many interesting ideas, Katarina Gradin for helping me with practical 
obstacles and for your critical eye when creating figures and Xiaowei Zheng for 
patiently helping me with the confocal microscope. At the Institut für 
Umweltmedizinische Forschung: Charlotte Esser, Bettina Jux, Ellen Fritsche, Julia 
Tigges and Jean Krutmann for a pleasant stay in Düsseldorf and interesting discussions 
about the AhR and melanocytes. Thanks to Amir Sharif for providing the tissue 
samples and Anastasia Simi for getting me started on the immunocytochemistry.  
 
I would like to thank my past and present colleagues at IMM and KI for nice coffee 
table conversations and chats: Lena, Margareta S, Margareta W, Gunnar, Birger, Per, 
Stephanie, Kristin, Afshin, Hong, Emma, Matias, Judith, Ann-Mari, Mathias, Anna-
Karin M, Bengt, Johan, Jill, Anna-Karin A, Brigitta, Anders, Birgit, Marie, Sara G, 
Miyuki, Sara B, Carolina, Maria H, Lubna, Fedor, Sara P, Paula, Lina L, Michaela 
and Markus. A special thanks to Gunnar Johanson for creating such a nice working 
atmosphere in your unit. Even though we could not share so much science, I really 
appreciate all the study visits and social activities we had. Thank you for getting me on 
an island horse, teaching me skating and for the yearly fantastic julbord. Thank you 
Stephanie, Anna-Karin, Kristin, Matias and Sara, past and present PhD fellows, for 
your strong support and encouragement. Matias, thank you for practical tips when 
preparing this thesis. You are my log KOW guru! A special thank to Kristin for helping 
me getting settled when I came to Stockholm and, even more important, for supplying 
me continuously with Kex chocklad. How would I have survived without a piece of 
Kex chocklad around 5pm ☺? 
 
I would also like to thank some people who introduced me into the wide world of 
science: Erik von Elert, former at the University of Konstanz. In your lab I started one 
afternoon during my undergraduate studies by spilling a little bit of a hardly-prepared 
solution. Despite this “accident”, I continued over the years in your lab. Thank you for 
your confidence and for early giving me a lot of  responsibility. Ann McElroy, SUNY-
 44 
NY, for introducing me to the field of toxicology and Walter Wahli, Beatrice 
Desvergne and Laurent Gelman, Lausanne, for getting me interested in intracellular 
receptors. 
 
I would like to thank all my friends, wherever you are, for reminding me about a life 
outside AhR signaling ☺: Michaela, Markus, Sandra, Nathalie, Susanne, Bernd, 
furthermore Mia, Emelie, Carina, Anna-Barbara, Anna and Caroline for hard, but fair 
badminton matches, Maria and Sara P for nice food experiences, Johan for your 
sacrificing walk back to Kvikkjokk, Songyan for a nice stay in CT, Torsten for the 
many interesting discussions about life in general and science in particular and for the 
many travel experiences we shared. Thanks to all IFAH table-tennis kids for giving me 
here and then a perspective on life. A special thanks to Susanne, for always keeping in 
touch – for simply being a true friend !!! 
 
I would like to give a very warm thanks to the Johansson-familj Maria, Johan, 
Elisabeth, Klara and Ebba for becoming my “second family” in Sweden - tack för att 
ni alltid ställer upp !!! Thanks to Stefan and Mimi for your warm welcome in LA and 
Stig and Ros-Mari for showing me Norrland.  
 
Especially, I would like to thank Mama, Papa, Oma Uschi, Oma Thea and the rest of 
my family in Germany for all support and caring under these years. Mama and Papa, 
thank you so much for your endless support, for always accepting my decisions (even 
though I often chose a life far away from Ronnenberg) and for always believing in me, 
my plans and my dreams. Ohne Euch wäre vieles nicht möglich gewesen. Danke, dass 
ihr immer für mich da seid !!! 
 
Last, but not least: Staffan, without your tremendous support I would not be standing 
here…tack för att du finns hos mig !!! 
 
 
   45 
7 REFERENCES 
 
Abbott, B.D., Birnbaum, L.S., and Perdew, G.H. (1995). Developmental Expression of Two 
Members of a New Class of Transcription Factors: I. Expression of Aryl Hydrocarbon Receptor 
in the C57BL/6N Mouse Embryo. Dev Dyn 204, 133-143. 
Abdel-Malek, Z., Swope, V., Smalara, D., Babcock, G., Dawes, S., and Nordlund, J. (1994). 
Analysis of the UV-Induced Melanogenesis and Growth Arrest of Human Melanocytes. 
Pigment Cell Res 7, 326-332. 
Abdel-Malek, Z., Swope, V.B., Suzuki, I., Akcali, C., Harriger, M.D., Boyce, S.T., Urabe, K., 
and Hearing, V.J. (1995). Mitogenic and Melanogenic Stimulation of Normal Human 
Melanocytes by Melanotropic Peptides. Proc Natl Acad Sci U S A 92, 1789-1793. 
Abdel-Naser, M.B. (2003). Mitogen Requirements of Normal Epidermal Human Melanocytes 
in a Serum and Tumor Promoter Free Medium. Eur J Dermatol 13, 29-33. 
Adachi, J., Mori, Y., Matsui, S., Takigami, H., Fujino, J., Kitagawa, H., Miller, C.A., III, Kato, 
T., Saeki, K., and Matsuda, T. (2001). Indirubin and Indigo Are Potent Aryl Hydrocarbon 
Receptor Ligands Present in Human Urine. J Biol Chem 276, 31475-31478. 
Adameyko, I., Lallemend, F., Aquino, J.B., Pereira, J.A., Topilko, P., Muller, T., Fritz, N., 
Beljajeva, A., Mochii, M., Liste, I., et al. (2009). Schwann Cell Precursors from Nerve 
Innervation Are a Cellular Origin of Melanocytes in Skin. Cell 139, 366-379. 
Afaq, F., Zaid, M.A., Pelle, E., Khan, N., Syed, D.N., Matsui, M.S., Maes, D., and Mukhtar, H. 
(2009). Aryl Hydrocarbon Receptor Is an Ozone Sensor in Human Skin. J Invest Dermatol 129, 
2396-2403. 
Alaluf, S., Atkins, D., Barrett, K., Blount, M., Carter, N., and Heath, A. (2002). Ethnic 
Variation in Melanin Content and Composition in Photoexposed and Photoprotected Human 
Skin. Pigment Cell Res 15, 112-118. 
An, S.M., Koh, J.S., and Boo, Y.C. (2009). Inhibition of Melanogenesis by Tyrosinase siRNA 
in Human Melanocytes. BMB Rep 42, 178-183. 
Andersson, P., McGuire, J., Rubio, C., Gradin, K., Whitelaw, M.L., Pettersson, S., Hanberg, A., 
and Poellinger, L. (2002). A Constitutively Active Dioxin/Aryl Hydrocarbon Receptor Induces 
Stomach Tumors. Proc Natl Acad Sci U S A 99, 9990-9995. 
Antonsson, C., Whitelaw, M.L., McGuire, J., Gustafsson, J.A., and Poellinger, L. (1995). 
Distinct Roles of the Molecular Chaperone Hsp90 in Modulating Dioxin Receptor Function Via 
the Basic Helix-Loop-Helix and PAS Domains. Mol Cell Biol 15, 756-765. 
Arad, S., Konnikov, N., Goukassian, D.A., and Gilchrest, B.A. (2006). T-Oligos Augment UV-
Induced Protective Responses in Human Skin. FASEB J 20, 1895-1897. 
Archambault, M., Yaar, M., and Gilchrest, B.A. (1995). Keratinocytes and Fibroblasts in a 
Human Skin Equivalent Model Enhance Melanocyte Survival and Melanin Synthesis after 
Ultraviolet Irradiation. J Invest Dermatol 104, 859-867. 
Axell, T., and Hedin, C.A. (1982). Epidemiologic Study of Excessive Oral Melanin 
Pigmentation with Special Reference to the Influence of Tobacco Habits. Scand J Dent Res 90, 
434-442. 
 46 
Baba, T., Mimura, J., Gradin, K., Kuroiwa, A., Watanabe, T., Matsuda, Y., Inazawa, J., 
Sogawa, K., and Fujii-Kuriyama, Y. (2001). Structure and Expression of the Ah Receptor 
Repressor Gene. J Biol Chem 276, 33101-33110. 
Baba, T., Mimura, J., Nakamura, N., Harada, N., Yamamoto, M., Morohashi, K.-i., and Fujii-
Kuriyama, Y. (2005). Intrinsic Function of the Aryl Hydrocarbon (Dioxin) Receptor as a Key 
Factor in Female Reproduction. Mol Cell Biol 25, 10040-10051. 
Backlund, M., and Ingelman-Sundberg, M. (2004). Different Structural Requirements of the 
Ligand Binding Domain of the Aryl Hydrocarbon Receptor for High- and Low-Affinity Ligand 
Binding and Receptor Activation. Mol Pharmacol 65, 416-425. 
Backlund, M., and Ingelman-Sundberg, M. (2005). Regulation of Aryl Hydrocarbon Receptor 
Signal Transduction by Protein Tyrosine Kinases. Cell Signal 17, 39-48. 
Bacsi, S.G., Reisz-Porszasz, S., and Hankinson, O. (1995). Orientation of the Heterodimeric 
Aryl Hydrocarbon (Dioxin) Receptor Complex on Its Asymmetric DNA Recognition Sequence. 
Mol Pharmacol 47, 432-438. 
Barhoover, M.A., Hall, J.M., Greenlee, W.F., and Thomas, R.S. (2010). Aryl Hydrocarbon 
Receptor Regulates Cell Cycle Progression in Human Breast Cancer Cells Via a Functional 
Interaction with Cyclin-Dependent Kinase 4. Mol Pharmacol 77, 195-201. 
Barker, C.W., Fagan, J.B., and Pasco, D.S. (1994). Down-Regulation of P4501A1 and 
P4501A2 mRNA Expression in Isolated Hepatocytes by Oxidative Stress. J Biol Chem 269, 
3985-3990. 
Barouki, R., and Morel, Y. (2001). Repression of Cytochrome P450 1A1 Gene Expression by 
Oxidative Stress: Mechanisms and Biological Implications. Biochem Pharmacol 61, 511-516. 
Behrendt, L., Jönsson, M.E., Goldstone, J.V., and Stegeman, J.J. (2010). Induction of 
Cytochrome P450 1 Genes and Stress Response Genes in Developing Zebrafish Exposed to 
Ultraviolet Radiation. Aquatic Toxicology In Press, Corrected Proof. 
Beischlag, T.V., Luis Morales, J., Hollingshead, B.D., and Perdew, G.H. (2008). The Aryl 
Hydrocarbon Receptor Complex and the Control of Gene Expression. Crit Rev Eukaryot Gene 
Expr 18, 207-250. 
Beischlag, T.V., and Perdew, G.H. (2005). ERα-AhR-Arnt Protein-Protein Interactions Mediate 
Estradiol-Dependent Transrepression of Dioxin-Inducible Gene Transcription. J Biol Chem 
280, 21607-21611. 
Bell, D.R., and Poland, A. (2000). Binding of Aryl Hydrocarbon Receptor (AhR) to AhR-
Interacting Protein. The Role of Hsp90. J Biol Chem 275, 36407-36414. 
Bender, K., Blattner, C., Knebel, A., Iordanov, M., Herrlich, P., and Rahmsdorf, H.J. (1997). 
UV-Induced Signal Transduction. J Photochem Photobiol B 37, 1-17. 
Berg, P., and Pongratz, I. (2001). Differential Usage of Nuclear Export Sequences Regulates 
Intracellular Localization of the Dioxin (Aryl Hydrocarbon) Receptor. J Biol Chem 276, 43231-
43238. 
Bergander, L., Wahlstrom, N., Alsberg, T., Bergman, J., Rannug, A., and Rannug, U. (2003). 
Characterization of in Vitro Metabolites of the Aryl Hydrocarbon Receptor Ligand 6-
Formylindolo[3,2-b]carbazole by Liquid Chromatography-Mass Spectrometry and NMR. Drug 
Metab Dispos 31, 233-241. 
Bergander, L., Wincent, E., Rannug, A., Foroozesh, M., Alworth, W., and Rannug, U. (2004). 
Metabolic Fate of the Ah Receptor Ligand 6-Formylindolo[3,2-b]carbazole. Chem Biol Inter 
149, 151-164. 
   47 
Berghard, A., Gradin, K., Pongratz, I., Whitelaw, M., and Poellinger, L. (1993). Cross-
Coupling of Signal Transduction Pathways: The Dioxin Receptor Mediates Induction of 
Cytochrome P-4501A1 Expression Via a Protein Kinase C-Dependent Mechanism. Mol Cell 
Biol 13, 677-689. 
Berghard, A., Gradin, K., and Toftgard, R. (1990). Serum and Extracellular Calcium Modulate 
Induction of Cytochrome P-4501A1 in Human Keratinocytes. J Biol Chem 265, 21086-21090. 
Bernshausen, T., Jux, B., Esser, C., Abel, J., and E., F. (2006). Tissue Distribution and Function 
of the Aryl Hydrocarbon Receptor Repressor (AhRR) in C57BL/6 and Aryl Hydrocarbon 
Receptor Deficient Mice. Arch Toxicol 80, 206-211. 
Berthois, Y., Katzenellenbogen, J.A., and Katzenellenbogen, B.S. (1986). Phenol Red in Tissue 
Culture Media Is a Weak Estrogen: Implications Concerning the Study of Estrogen-Responsive 
Cells in Culture. Proc Natl Acad Sci U S A 83, 2496-2500. 
Bjeldanes, L.F., Kim, J.Y., Grose, K.R., Bartholomew, J.C., and Bradfield, C.A. (1991). 
Aromatic Hydrocarbon Responsiveness-Receptor Agonists Generated from Indole-3-Carbinol 
in Vitro and in Vivo: Comparisons with 2,3,7,8-Tetrachlorodibenzo-p-dioxin. Proc Natl Acad 
Sci U S A 88, 9543-9547. 
Blank, J.A., Tucker, A.N., Sweatlock, J., Gasiewicz, T.A., and Luster, M.I. (1987). Alpha-
Naphthoflavone Antagonism of 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Induced Murine 
Lymphocyte Ethoxyresorufin-O-Deethylase Activity and Immunosuppression. Mol Pharmacol 
32, 169-172. 
Bohm, M., Wolff, I., Scholzen, T.E., Robinson, S.J., Healy, E., Luger, T.A., Schwarz, T., and 
Schwarz, A. (2005). Alpha-Melanocyte-Stimulating Hormone Protects from Ultraviolet 
Radiation-Induced Apoptosis and DNA Damage. J Biol Chem 280, 5795-5802. 
Boissy, R.E., Sakai, C., Zhao, H., Kobayashi, T., and Hearing, V.J. (1998). Human Tyrosinase 
Related Protein-1 (Trp-1) Does Not Function as a DHICA Oxidase Activity in Contrast to 
Murine Trp-1. Exp Dermatol 7, 198-204. 
Bouchard, B., Del Marmol, V., Jackson, I.J., Cherif, D., and Dubertret, L. (1994). Molecular 
Characterization of a Human Tyrosinase-Related-Protein-2 cDNA. Patterns of Expression in 
Melanocytic Cells. Eur J Biochem 219, 127-134. 
Boukamp, P., Petrussevska, R., Breitkreutz, D., Hornung, J., Markham, A., and Fusenig, N. 
(1988). Normal Keratinization in a Spontaneously Immortalized Aneuploid Human 
Keratinocyte Cell Line. J Cell Biol 106, 761-771. 
Brunnberg, S., Andersson, P., Lindstam, M., Paulson, I., Poellinger, L., and Hanberg, A. 
(2006). The Constitutively Active Ah Receptor (CA-AhR) Mouse as a Potential Model for 
Dioxin Exposure--Effects in Vital Organs. Toxicology 224, 191-201. 
Brunner, N., Bronzert, D., Vindelov, L.L., Rygaard, K., Spang-Thomsen, M., and Lippman, 
M.E. (1989). Effect on Growth and Cell Cycle Kinetics of Estradiol and Tamoxifen on MCF-7 
Human Breast Cancer Cells Grown in Vitro and in Nude Mice. Cancer Res 49, 1515-1520. 
Bunger, M.K., Moran, S.M., Glover, E., Thomae, T.L., Lahvis, G.P., Lin, B.C., and Bradfield, 
C.A. (2003). Resistance to 2,3,7,8-Tetrachlorodibenzo-p-dioxin Toxicity and Abnormal Liver 
Development in Mice Carrying a Mutation in the Nuclear Localization Sequence of the Aryl 
Hydrocarbon Receptor. J Biol Chem 278, 17767-17774. 
Butler, R.A., Kelley, M.L., Powell, W.H., Hahn, M.E., and Van Beneden, R.J. (2001). An Aryl 
Hydrocarbon Receptor (Ahr) Homologue from the Soft-Shell Clam, Mya Arenaria: Evidence 
That Invertebrate Ahr Homologues Lack 2,3,7,8-Tetrachlorodibenzo-p-dioxin and [Beta]-
Naphthoflavone Binding. Gene 278, 223-234. 
 48 
Carlson, D., and Perdew, G. (2002). A Dynamic Role for the Ah Receptor in Cell Signaling ? J 
Biochem Mol Tox 16, 317-325. 
Carrier, F., Owens, R.A., Nebert, D.W., and Puga, A. (1992). Dioxin-Dependent Activation of 
Murine CYP1A1 Gene Transcription Requires Protein Kinase C-Dependent Phosphorylation. 
Mol Cell Biol 12, 1856-1863. 
Carsberg, C.J., Ohanian, J., and Friedmann, P.S. (1995). Ultraviolet Radiation Stimulates a 
Biphasic Pattern of 1,2-Diacylglycerol Formation in Cultured Human Melanocytes and 
Keratinocytes by Activation of Phospholipases C and D. Biochem J 305 ( Pt 2), 471-477. 
Carver, L.A., and Bradfield, C.A. (1997). Ligand-Dependent Interaction of the Aryl 
Hydrocarbon Receptor with a Novel Immunophilin Homolog in Vivo. J Biol Chem 272, 11452-
11456. 
Carver, L.A., LaPres, J.J., Jain, S., Dunham, E.E., and Bradfield, C.A. (1998). Characterization 
of the Ah Receptor-Associated Protein, Ara9. J Biol Chem 273, 33580-33587. 
Chang, C.Y., and Puga, A. (1998). Constitutive Activation of the Aromatic Hydrocarbon 
Receptor. Mol Cell Biol 18, 525-535. 
Chapman-Smith, A., Lutwyche, J.K., and Whitelaw, M.L. (2004). Contribution of the 
Per/Arnt/Sim (PAS) Domains to DNA Binding by the Basic Helix-Loop-Helix PAS 
Transcriptional Regulators. J Biol Chem 279, 5353-5362. 
Chedekel, M.R., Smith, S.K., Post, P.W., Pokora, A., and Vessell, D.L. (1978). 
Photodestruction of Pheomelanin: Role of Oxygen. Proc Natl Acad Sci U S A 75, 5395-5399. 
Chen, H.-S., Singh, S.S., and Perdew, G.H. (1997). The Ah Receptor Is a Sensitive Target of 
Geldanamycin-Induced Protein Turnover. Arch Biochem Biophys 348, 190-198. 
Chen, H.S., and Perdew, G.H. (1994). Subunit Composition of the Heteromeric Cytosolic Aryl 
Hydrocarbon Receptor Complex. J Biol Chem 269, 27554-27558. 
Chen, S., Operana, T., Bonzo, J., Nguyen, N., and Tukey, R.H. (2005). Erk Kinase Inhibition 
Stabilizes the Aryl Hydrocarbon Receptor: Implications for Transcriptional Activation and 
Protein Degradation. J Biol Chem 280, 4350-4359. 
Chen, Y.-H., Riby, J., Srivastava, P., Bartholomew, J., Denison, M., and Bjeldanes, L. (1995). 
Regulation of CYP1A1 by Indolo[3,2-b]carbazole in Murine Hepatoma Cells. J Biol Chem 
270, 22548-22555. 
Chen, Y.H., and Tukey, R.H. (1996). Protein Kinase C Modulates Regulation of the CYP1A1 
Gene by the Aryl Hydrocarbon Receptor. J Biol Chem 271, 26261-26266. 
Chiaro, C.R., Patel, R.D., Marcus, C.B., and Perdew, G.H. (2007). Evidence for an Aryl 
Hydrocarbon Receptor-Mediated Cytochrome P450 Autoregulatory Pathway. Mol Pharmacol 
72, 1369-1379. 
Chiaverini, C., Beuret, L., Flori, E., Busca, R., Abbe, P., Bille, K., Bahadoran, P., Ortonne, J.-
P., Bertolotto, C., and Ballotti, R. (2008). Microphthalmia-Associated Transcription Factor 
Regulates Rab27A Gene Expression and Controls Melanosome Transport. J Biol Chem 283, 
12635-12642. 
Cho, Y.C., Zheng, W., and Jefcoate, C.R. (2004). Disruption of Cell-Cell Contact Maximally 
but Transiently Activates AhR-Mediated Transcription in 10T1/2 Fibroblasts. Toxicol Appl 
Pharmacol 199, 220-238. 
   49 
Cooper, S.J., and Bowden, G.T. (2007). Ultraviolet B Regulation of Transcription Factor 
Families: Roles of Nuclear Factor-Kappa B (NF-KappaB) and Activator Protein-1 (AP-1) in 
UVB-Induced Skin Carcinogenesis. Curr Cancer Drug Targets 7, 325-334. 
Crews, S.T., and Fan, C.-M. (1999). Remembrance of Things PAS: Regulation of Development 
by bHLH-PAS Proteins. Curr Opin Genet Dev 9, 580-587. 
Cripps, D.J. (1981). Natural and Artificial Photoprotection. J Investig Dermatol 77, 154-157. 
Dale, Y.R., and Eltom, S.E. (2006). Calpain Mediates the Dioxin-Induced Activation and 
Down-Regulation of the Aryl Hydrocarbon Receptor. Mol Pharmacol 70, 1481-1487. 
Darbre, P., Yates, J., Curtis, S., and King, R.J. (1983). Effect of Estradiol on Human Breast 
Cancer Cells in Culture. Cancer Res 43, 349-354. 
Davarinos, N.A., and Pollenz, R.S. (1999). Aryl Hydrocarbon Receptor Imported into the 
Nucleus Following Ligand Binding Is Rapidly Degraded Via the Cytosplasmic Proteasome 
Following Nuclear Export. J Biol Chem 274, 28708-28715. 
del Marmol, V., Ito, S., Bouchard, B., Libert, A., Wakamatsu, K., Ghanem, G., and Solano, F. 
(1996). Cysteine Deprivation Promotes Eumelanogenesis in Human Melanoma Cells. J Invest 
Dermatol 107, 698-702. 
Denison, M.S., and Nagy, S.R. (2003). Activation of the Aryl Hydrocarbon Receptor by 
Structurally Diverse Exogenous and Endogenous Chemicals. Annu Rev Pharmacol Toxicol 43, 
309-334. 
Denison, M.S., Pandini, A., Nagy, S.R., Baldwin, E.P., and Bonati, L. (2002). Ligand Binding 
and Activation of the Ah Receptor. Chem Biol Interact 141, 3-24. 
Diani-Moore, S., Labitzke, E., Brown, R., Garvin, A., Wong, L., and Rifkind, A.B. (2006). 
Sunlight Generates Multiple Tryptophan Photoproducts Eliciting High Efficacy CYP1A 
Induction in Chick Hepatocytes and in Vivo. Toxicol Sci 90, 96-110. 
DiNatale, B.C., Murray, I.A., Schroeder, J.C., Flaveny, C.A., Lahoti, T.S., Laurenzana, E.M., 
Omiecinski, C.J., and Perdew, G.H. (2010). Kynurenic Acid Is a Potent Endogenous Ah 
Receptor Ligand That Synergistically Induces Interleukin 6 in the Presence of Inflammatory 
Signaling. Toxicol Sci in press. 
Dolwick, K.M., Schmidt, J.V., Carver, L.A., Swanson, H.I., and Bradfield, C.A. (1993a). 
Cloning and Expression of a Human Ah Receptor cDNA. Mol Pharmacol 44, 911-917. 
Dolwick, K.M., Swanson, H.I., and Bradfield, C.A. (1993b). In Vitro Analysis of Ah Receptor 
Domains Involved in Ligand-Activated DNA Recognition. Proc Natl Acad Sci U S A 90, 8566-
8570. 
Dong, L., Ma, Q., and Whitlock, J.P., Jr. (1996). DNA Binding by the Heterodimeric Ah 
Receptor. J Biol Chem 271, 7942-7948. 
Du, J., Miller, A.J., Widlund, H.R., Horstmann, M.A., Ramaswamy, S., and Fisher, D.E. 
(2003). Mlana/Mart1 and Silv/Pmel17/Gp100 Are Transcriptionally Regulated by MITF in 
Melanocytes and Melanoma. Am J Pathol 163, 333-343. 
Duncan, D.M., Burgess, E.A., and Duncan, I. (1998). Control of Distal Antennal Identity and 
Tarsal Development in Drosophila by Spineless-Aristapedia, a Homolog of the Mammalian 
Dioxin Receptor. Genes Dev 12, 1290-1303. 
Duval, C., Smit, N.P.M., Kolb, R.M., Regnier, M., Pavel, S., and Schmidt, R. (2002). 
Keratinocytes Control the Pheo/Eumelanin Ratio in Cultured Normal Melanocytes. Pigment 
Cell Res 15, 440-446. 
 50 
Eckert, R.L., Crish, J.F., and Robinson, N.A. (1997). The Epidermal Keratinocyte as a Model 
for the Study of Gene Regulation and Cell Differentiation. Physiol Rev 77, 397-424. 
Eisinger, M., and Marko, O. (1982). Selective Proliferation of Normal Human Melanocytes in 
Vitro in the Presence of Phorbol Ester and Cholera Toxin. Proc Natl Acad Sci U S A 79, 2018-
2022. 
Elferink, C.J., Ge, N.-L., and Levine, A. (2001). Maximal Aryl Hydrocarbon Receptor Activity 
Depends on an Interaction with the Retinoblastoma Protein. Mol Pharmacol 59, 664-673. 
Elizondo, G., Fernandez-Salguero, P., Sheikh, M.S., Kim, G.-Y., Fornace, A.J., Lee, K.S., and 
Gonzalez, F.J. (2000). Altered Cell Cycle Control at the G2/M Phases in Aryl Hydrocarbon 
Receptor-Null Embryo Fibroblast. Mol Pharmacol 57, 1056-1063. 
Eller, M.S., Ostrom, K., and Gilchrest, B.A. (1996). DNA Damage Enhances Melanogenesis. 
Proc Natl Acad Sci U S A 93, 1087-1092. 
Eller, M.S., Yaar, M., and Gilchrest, B.A. (1994). DNA Damage and Melanogenesis. Nature 
372, 413-414. 
Ema, M., Ohe, N., Suzuki, M., Mimura, J., Sogawa, K., Ikawa, S., and Fujii-Kuriyama, Y. 
(1994). Dioxin Binding Activities of Polymorphic Forms of Mouse and Human 
Arylhydrocarbon Receptors. J Biol Chem 269, 27337-27343. 
Emmons, R., Duncan, D., Estes, P., Kiefel, P., Mosher, J., Sonnenfeld, M., Ward, M., Duncan, 
I., and Crews, S. (1999). The Spineless-Aristapedia and Tango bHLH-PAS Proteins Interact to 
Control Antennal and Tarsal Development in Drosophila. Development 126, 3937-3945. 
Enan, E., Dunlap, D.Y., and Matsumura, F. (1998). Use of C-Src and C-Fos Knockout Mice for 
the Studies on the Role of C-Src Kinase Signaling in the Expression of Toxicity of TCDD. J 
Biochem Mol Toxicol 12, 263-274. 
Enan, E., and Matsumura, F. (1996). Identification of C-Src as the Integral Component of the 
Cytosolic Ah Receptor Complex, Transducing the Signal of 2,3,7,8-Tetrachlorodibenzo-p-
dioxin (TCDD) through the Protein Phosphorylation Pathway. Biochem Pharmacol 52, 1599-
1612. 
Esser, C., Rannug, A., and Stockinger, B. (2009). The Aryl Hydrocarbon Receptor in 
Immunity. Trends in Immunology 30, 447-454. 
Evans, B.R., Karchner, S.I., Allan, L.L., Pollenz, R.S., Tanguay, R.L., Jenny, M.J., Sherr, D.H., 
and Hahn, M.E. (2008). Repression of Aryl Hydrocarbon Receptor (Ahr) Signaling by AhR 
Repressor: Role of DNA Binding and Competition for AhR Nuclear Translocator. Mol 
Pharmacol 73, 387-398. 
Fernandez-Salguero, P., Pineau, T., Hilbert, D., McPhail, T., Lee, S., Kimura, S., Nebert, D., 
Rudikoff, S., Ward, J., and Gonzalez, F. (1995). Immune System Impairment and Hepatic 
Fibrosis in Mice Lacking the Dioxin-Binding Ah Receptor. Science 268, 722-726. 
Fernandez-Salguero, P.M., Hilbert, D.M., Rudikoff, S., Ward, J.M., and Gonzalez, F.J. (1996). 
Aryl-Hydrocarbon Receptor-Deficient Mice Are Resistant to 2,3,7,8-Tetrachlorodibenzo-p-
dioxin-Induced Toxicity. Toxicol Appl Pharmacol 140, 173-179. 
Fernandez-Salguero, P.M., Ward, J.M., Sundberg, J.P., and Gonzalez, F.J. (1997). Lesions of 
Aryl-Hyrdocarbon Receptor-Deficient Mice. Vet Pathol 34, 605-614. 
Flaveny, C., Perdew, G.H., and Miller, C.A., 3rd (2009). The Aryl-Hydrocarbon Receptor Does 
Not Require the p23 Co-Chaperone for Ligand Binding and Target Gene Expression in Vivo. 
Toxicol Lett 189, 57-62. 
   51 
Friedmann, P.S., and Gilchrest, B.A. (1987). Ultraviolet Radiation Directly Induces Pigment 
Production by Cultured Human Melanocytes. J Cell Physiol 133, 88-94. 
Fritsche, E., Schafer, C., Calles, C., Bernsmann, T., Bernshausen, T., Wurm, M., Hubenthal, U., 
Cline, J.E., Hajimiragha, H., Schroeder, P., et al. (2007). Lightening up the UV Response by 
Identification of the Arylhydrocarbon Receptor as a Cytoplasmatic Target for Ultraviolet B 
Radiation. Proc Natl Acad Sci U S A 104, 8851-8856. 
Fujii-Kuriyama, Y., and Kawajiri, K. (2010). Molecular Mechanisms of the Physiological 
Functions of the Aryl Hydrocarbon (Dioxin) Receptor, a Multifunctional Regulator That Senses 
and Responds to Environmental Stimuli. Proc Jpn Acad Ser B Phys Biol Sci 86, 40-53. 
Fujii-Kuriyama, Y., and Mimura, J. (2005). Molecular Mechanisms of AhR Functions in the 
Regulation of Cytochrome P450 Genes. Biochem Biophys Res Commun 338, 311-317. 
Fukunaga, B.N., and Hankinson, O. (1996). Identification of a Novel Domain in the Aryl 
Hydrocarbon Receptor Required for DNA Binding. J Biol Chem 271, 3743-3749. 
Fuller, B.B., Spaulding, D.T., and Smith, D.R. (2001). Regulation of the Catalytic Activity of 
Preexisting Tyrosinase in Black and Caucasian Human Melanocyte Cell Cultures. Exp Cell Res 
262, 197-208. 
Furness, S.G., Lees, M.J., and Whitelaw, M.L. (2007). The Dioxin (Aryl Hydrocarbon) 
Receptor as a Model for Adaptive Responses of bHLH/PAS Transcription Factors. FEBS Lett 
581, 3616-3625. 
Ge, N.-L., and Elferink, C.J. (1998). A Direct Interaction between the Aryl Hydrocarbon 
Receptor and Retinoblastoma Protein. J Biol Chem 273, 22708-22713. 
Geusau, A., Jurecka, W., Nahavandi, H., Schmidt, J.B., Stingl, G., and Tschachler, E. (2000). 
Punctate Keratoderma-Like Lesions on the Palms and Soles in a Patient with Chloracne: A 
New Clinical Manifestation of Dioxin Intoxication? Br J Dermatol 143, 1067-1071. 
Giannone, J.V., Li, W., Probst, M., and Okey, A.B. (1998). Prolonged Depletion of Ah 
Receptor without Alteration of Receptor mRNA Levels after Treatment of Cells in Culture with 
2,3,7,8-Tetrachlorodibenzo-p-dioxin,. Biochem Pharmacol 55, 489-497. 
Gilchrest, B.A., Vrabel, M.A., Flynn, E., and Szabo, G. (1984). Selective Cultivation of Human 
Melanocytes from Newborn and Adult Epidermis. J Invest Dermatol 83, 370-376. 
Gillner, M., Bergman, J., Cambillau, C., Alexandersson, M., Fernstrom, B., and Gustafsson, J. 
(1993). Interactions of Indolo[3,2-b]carbazoles and Related Polycyclic Aromatic Hydrocarbons 
with Specific Binding Sites for 2,3,7,8-Tetrachlorodibenzo-p-dioxin in Rat Liver. Mol 
Pharmacol 44, 336-345. 
Gillner, M., Bergman, J., Cambillau, C., Fernstrom, B., and Gustafsson, J. (1985). Interactions 
of Indoles with Specific Binding Sites for 2,3,7,8-Tetrachlorodibenzo-p-dioxin in Rat Liver. 
Mol Pharmacol 28, 357-363. 
Goding, C.R. (2007). Melanocytes: The New Black. Int J Biochem Cell Biol 39, 275-279. 
Goerz, G., Barnstorf, W., Winnekendonk, G., Bolsen, K., Fritsch, C., and Tsambaos, D. (1996). 
Influence of Uva and Uvb Irradiation on Hepatic and Cutaneous P450 Isoenzymes. Arch 
Dermatol Res 289, 46-51. 
Goerz, G., Merk, H., Bolsen, K., Tsambaos, D., and Berger, H. (1983). Influence of Chronic 
UV-Light Exposure on Hepatic and Cutaneous Monooxygenases. Experientia 39, 385-386. 
 52 
Gomez-Duran, A., Carvajal-Gonzalez, J.M., Mulero-Navarro, S., Santiago-Josefat, B., Puga, 
A., and Fernandez-Salguero, P.M. (2009). Fitting a Xenobiotic Receptor into Cell Homeostasis: 
How the Dioxin Receptor Interacts with TGFbeta Signaling. Biochem Pharmacol 77, 700-712. 
Gonzalez, M.-C., Marteau, C., Franchi, J., and Migliore-Samour, D. (2001). Cytochrome P450 
4A11 Expression in Human Keratinocytes: Effects of Ultraviolet Irradiation. Br J Dermatol 
145, 749-757. 
Gordon, P.R., and Gilchrest, B.A. (1989). Human Melanogenesis Is Stimulated by 
Diacylglycerol. J Invest Dermatol 93, 700-702. 
Goryo, K., Suzuki, A., Carpio, C.A.D., Siizaki, K., Kuriyama, E., Mikami, Y., Kinoshita, K., 
Yasumoto, K.-i., Rannug, A., Miyamoto, A., et al. (2007). Identification of Amino Acid 
Residues in the Ah Receptor Involved in Ligand Binding. Biochem Biophys Res Commun 354, 
396-402. 
Gottlicher, M., Cikryt, P., and Wiebel, F.J. (1990). Inhibiton of Growth by 2,3,7,8-
Terachlorodibezo-p-Dioxin in 5L Rat Hepatoma Cells Is Associated with the Presence of Ah 
Receptor. Carcinogenesis 11, 2205-2210. 
Gradin, K., Toftgard, R., Poellinger, L., and Berghard, A. (1999). Repression of Dioxin Signal 
Transduction in Fibroblasts. Identification of a Putative Repressor Associated with Arnt. J Biol 
Chem 274, 13511-13518. 
Greenlee, W.F., Dold, K.M., and Osborne, R. (1985). Actions of 2,3,7,8-Tetrachlorodibenzo-p-
dioxin (TCDD) on Human Epidermal Keratinocytes. In Vitro Cell Dev Biol 291, 509-512. 
Gu, Y.-Z., Hogenesch, J.B., and Bradfield, C.A. (2000). The PAS Superfamily: Sensors of 
Environmental and Developmental Signals. Annu Rev Pharmacol Toxicol 40, 519-561. 
Guengerich, P.F., Martin, M.V., McCormick, W.A., Nguyen, L.P., Glover, E., and Bradfield, 
C.A. (2004). Aryl Hydrocarbon Receptor Response to Indigoids in Vitro and in Vivo. Arch 
Biochem Biophys 423, 309-316. 
Haarmann-Stemmann, T., Bothe, H., and Abel, J. (2009). Growth Factors, Cytokines and Their 
Receptors as Downstream Targets of Arylhydrocarbon Receptor (AhR) Signaling Pathways. 
Biochem Pharmacol 77, 508-520. 
Haarmann-Stemmann, T., Bothe, H., Kohli, A., Sydlik, U., Abel, J., and Fritsche, E. (2007). 
Analysis of the Transcriptional Regulation and Molecular Function of the Aryl Hydrocarbon 
Receptor Repressor in Human Cell Lines. Drug Metab Dispos 35, 2262-2269. 
Hahn, M.E. (2002). Aryl Hydrocarbon Receptors: Diversity and Evolution. Chem Biol Inter 
141, 131-160. 
Hahn, M.E., Allan, L.L., and Sherr, D.H. (2009). Regulation of Constitutive and Inducible Ahr 
Signaling: Complex Interactions Involving the AhR Repressor. Biochem Pharmacol 77, 485-
497. 
Halaban, R. (2000). The Regulation of Normal Melanocyte Proliferation. Pigment Cell Res 13, 
4-14. 
Hankinson, O. (2005). Role of Coactivators in Transcriptional Activation by the Aryl 
Hydrocarbon Receptor. Arch Biochem Biophys 433, 379-386. 
Haresaku, S., Hanioka, T., Tsutsui, A., and Watanabe, T. (2007). Association of Lip 
Pigmentation with Smoking and Gingival Melanin Pigmentation. Oral Dis 13, 71-76. 
   53 
Harper, P.A., Riddick, D.S., and Okey, A.B. (2006). Regulating the Regulator: Factors That 
Control Levels and Activity of the Aryl Hydrocarbon Receptor. Biochem Pharmcol 72, 267-
279. 
Hashiguchi, I., Akamine, A., Miyatake, S., Hara, Y., Maeda, K., Toriya, Y., Aono, M., 
Fukuyama, H., and Okumura, H. (1987). [Histological Study on the Gingiva of the Patient with 
Yusho and of PCB-Poisoned Monkeys]. Fukuoka Igaku Zasshi 78, 259-265. 
Heath-Pagliuso, S., Rogers, W.J., Tullis, K., Seidel, S.D., Cenijn, P.H., Brouwer, A., and 
Denison, M.S. (1998). Activation of the Ah Receptor by Tryptophan and Tryptophan 
Metabolites. Biochemistry 37, 11508-11515. 
Heid, S.E., Pollenz, R.S., and Swanson, H.I. (2000). Role of Heat Shock Protein 90 
Dissociation in Mediating Agonist-Induced Activation of the Aryl Hydrocarbon Receptor. Mol 
Pharmacol 57, 82-92. 
Helferich, W., and Denison, M. (1991). Ultraviolet Photoproducts of Tryptophan Can Act as 
Dioxin Agonists. Mol Pharmacol 40, 674-678. 
Henklova, P., Vrzal, R., Ulrichova, J., and Dvorak, Z. (2008). Role of Mitogen-Activated 
Protein Kinases in Aryl Hydrocarbon Receptor Signaling. Chem Biol Interact 172, 93-104. 
Henry, E.C., Bemis, J.C., Henry, O., Kende, A.S., and Gasiewicz, T.A. (2006). A Potential 
Endogenous Ligand for the Aryl Hydrocarbon Receptor Has Potent Agonist Activity in Vitro 
and in Vivo. Arch Biochem Biophys 450, 67-77. 
Henry, E.C., and Gasiewicz, T.A. (2008). Molecular Determinants of Species-Specific Agonist 
and Antagonist Activity of a Substituted Flavone Towards the Aryl Hydrocarbon Receptor. 
Arch Biochem Biophys 472, 77-88. 
Henry, E.C., Kende, A.S., Rucci, G., Totleben, M.J., Willey, J.J., Dertinger, S.D., Pollenz, R.S., 
Jones, J.P., and Gasiewicz, T.A. (1999). Flavone Antagonists Bind Competitively with 2,3,7,8-
Tetrachlorodibenzo-p-dioxin (TCDD) to the Aryl Hydrocarbon Receptor but Inhibit Nuclear 
Uptake and Transformation. Mol Pharmacol 55, 716-725. 
Herrlich, P., Karin, M., and Weiss, C. (2008). Supreme Enlightenment: Damage Recognition 
and Signaling in the Mammalian UV Response. Mol Cell 29, 279-290. 
Hirobe, T. (2005). Role of Keratinocyte-Derived Factors Involved in Regulating the 
Proliferation and Differentiation of Mammalian Epidermal Melanocytes. Pigment Cell Res 18, 
2-12. 
Hsu, S.T., Ma, C.I., Hsu, S.K., Wu, S.S., Hsu, N.H., Yeh, C.C., and Wu, S.B. (1985). 
Discovery and Epidemiology of PCB Poisoning in Taiwan: A Four-Year Followup. Environ 
Health Perspect 59, 5-10. 
Huang, X., Powell-Coffman, J.A., and Jin, Y. (2004). The Ahr-1 Aryl Hydrocarbon Receptor 
and Its Co-Factor the Aha-1 Aryl Hydrocarbon Receptor Nuclear Translocator Specify 
Gabaergic Neuron Cell Fate in C. Elegans. Development 131, 819-828. 
Ikuta, T., Eguchi, H., Tachibana, T., Yoneda, Y., and Kawajiri, K. (1998). Nuclear Localization 
and Export Signals of the Human Aryl Hydrocarbon Receptor. J Biol Chem 273, 2895-2904. 
Ikuta, T., and Kawajiri, K. (2006). Zinc Finger Transcription Factor Slug Is a Novel Target 
Gene of Aryl Hydrocarbon Receptor. Exp Cell Res 312, 3585-3594. 
Ikuta, T., Kobayashi, Y., and Kawajiri, K. (2004a). Cell Density Regulates Intracellular 
Localization of Aryl Hydrocarbon Receptor. J Biol Chem 279, 19209-19216. 
 54 
Ikuta, T., Kobayashi, Y., and Kawajiri, K. (2004b). Phosphorylation of Nuclear Localization 
Signal Inhibits the Ligand-Dependent Nuclear Import of Aryl Hydrocarbon Receptor. Biochem 
Biophys Res Commun 317, 545-550. 
Ikuta, T., Tachibana, T., Watanabe, J., Yoshida, M., Yoneda, Y., and Kawajiri, K. (2000). 
Nucleocytoplasmic Shuttling of the Aryl Hydrocarbon Receptor. J Biochem 127, 503-509. 
Im, S., Moro, O., Peng, F., Medrano, E.E., Cornelius, J., Babcock, G., Nordlund, J.J., and 
Abdel-Malek, Z.A. (1998). Activation of the Cyclic AMP Pathway by Alpha-Melanotropin 
Mediates the Response of Human Melanocytes to Ultraviolet B Radiation. Cancer Res 58, 47-
54. 
Iozumi, K., Hoganson, G.E., Pennella, R., Everett, M.A., and Fuller, B.B. (1993). Role of 
Tyrosinase as the Determinant of Pigmentation in Cultured Human Melanocytes. J Invest 
Dermatol 100, 806-811. 
Iwata, K., Inui, N., and Takeuchi, T. (1981). Induction of Active Melanocytes in Mouse Skin 
by Carcinogens: A New Method for Detection of Skin Carcinogens. Carcinogenesis 2, 589-591. 
Iwata, M., Corn, T., Iwata, S., Everett, M.A., and Fuller, B.B. (1990). The Relationship 
between Tyrosinase Activity and Skin Color in Human Foreskins. J Invest Dermatol 95, 9-15. 
Jackson, I.J. (1988). A cDNA Encoding Tyrosinase-Related Protein Maps to the Brown Locus 
in Mouse. Proc Natl Acad Sci U S A 85, 4392-4396. 
Jackson, I.J., Chambers, D.M., Tsukamoto, K., Copeland, N.G., Gilbert, D.J., Jenkins, N.A., 
and Hearing, V.J. (1992). A Second Tyrosinase-Related Protein, Trp-2, Maps to and Is Mutated 
at the Mouse Slaty Locus. EMBO J 11, 527-535. 
Jackson, S., and Xiong, Y. (2009). Crl4s: The Cul4-Ring E3 Ubiquitin Ligases. Trends 
Biochem Sci 34, 562-570. 
Jain, S., Dolwick, K.M., Schmidt, J.V., and Bradfield, C.A. (1994). Potent Transactivation 
Domains of the Ah Receptor and the Ah Receptor Nuclear Translocator Map to Their Carboxyl 
Termini. J Biol Chem 269, 31518-31524. 
Jimenez-Cervantes, C., Solano, F., Kobayashi, T., Urabe, K., Hearing, V.J., Lozano, J.A., and 
Garcia-Borron, J.C. (1994). A New Enzymatic Function in the Melanogenic Pathway. The 5,6-
Dihydroxyindole-2-Carboxylic Acid Oxidase Activity of Tyrosinase-Related Protein-1 (Trp1). 
J Biol Chem 269, 17993-18000. 
Joiakim, A., Mathieu, P.A., Elliott, A.A., and Reiners, J.J., Jr. (2004). Superinduction of 
CYP1A1 in MCF10A Cultures by Cycloheximide, Anisomycin, and Puromycin: A Process 
Independent of Effects on Protein Translation and Unrelated to Suppression of Aryl 
Hydrocarbon Receptor Proteolysis by the Proteasome. Mol Pharmacol 66, 936-947. 
Jux, B., Kadow, S., and Esser, C. (2009). Langerhans Cell Maturation and Contact 
Hypersensitivity Are Impaired in Aryl Hydrocarbon Receptor-Null Mice. J Immunol 182, 
6709-6717. 
Kadekaro, A.L., Kavanagh, R.J., Wakamatsu, K., Ito, S., Pipitone, M.A., and Abdel-Malek, 
Z.A. (2003). Cutaneous Photobiology. The Melanocyte Vs. The Sun: Who Will Win the Final 
Round? Pigment Cell Res 16, 434-447. 
Kanno, Y., Miyama, Y., Takane, Y., Nakahama, T., and Inouye, Y. (2007). Identification of 
Intracellular Localization Signals and of Mechanisms Underlining the Nucleocytoplasmic 
Shuttling of Human Aryl Hydrocarbon Receptor Repressor. Biochem Biophys Res Commun 
364, 1026-1031. 
   55 
Karchner, S.I., Franks, D.G., Powell, W.H., and Hahn, M.E. (2002). Regulatory Interactions 
among Three Members of the Vertebrate Aryl Hydrocarbon Receptor Family: AhR Repressor, 
AhR1, and AhR2. J Biol Chem 277, 6949-6959. 
Kashuba, E.V., Gradin, K., Isaguliants, M., Szekely, L., Poellinger, L., Klein, G., and 
Kazlauskas, A. (2006). Regulation of Transactivation Function of the Aryl Hydrocarbon 
Receptor by the Epstein-Barr Virus-Encoded Ebna-3 Protein. J Biol Chem 281, 1215-1223. 
Katiyar, S.K., Matsui, M.S., and Mukhtar, H. (2000). Ultraviolet-B Exposure of Human Skin 
Induces Cytochromes P450 1A1 and 1B1. J Invest Dermatol 114, 328-333. 
Kawajiri, K., Kobayashi, Y., Ohtake, F., Ikuta, T., Matsushima, Y., Mimura, J., Pettersson, S., 
Pollenz, R.S., Sakaki, T., Hirokawa, T., et al. (2009). Aryl Hydrocarbon Receptor Suppresses 
Intestinal Carcinogenesis in Apcmin/+ Mice with Natural Ligands. Proc Natl Acad Sci U S A 
106, 13481-13486. 
Kazlauskas, A., Poellinger, L., and Pongratz, I. (1999). Evidence That the Co-Chaperone p23 
Regulates Ligand Responsiveness of the Dioxin (Aryl Hydrocarbon) Receptor. J Biol Chem 
274, 13519-13524. 
Kazlauskas, A., Poellinger, L., and Pongratz, I. (2000). The Immunophilin-Like Protein XAP2 
Regulates Ubiquitination and Subcellular Localization of the Dioxin Receptor. J Biol Chem 
275, 41317-41324. 
Ke, S., Rabson, A.B., Germino, J.F., Gallo, M.A., and Tian, Y. (2001). Mechanism of 
Suppression of Cytochrome P-450 1A1 Expression by Tumor Necrosis Factor-Alpha and 
Lipopolysaccharide. J Biol Chem 276, 39638-39644. 
Kewley, R.J., Whitelaw, M.L., and Chapman-Smith, A. (2004). The Mammalian Basic Helix-
Loop-Helix/PAS Family of Transcriptional Regulators. Int J Biochem Cell Biol 36, 189-204. 
Khlgatian, M.K., Hadshiew, I.M., Asawanonda, P., Yaar, M., Eller, M.S., Fujita, M., Norris, 
D.A., and Gilchrest, B.A. (2002). Tyrosinase Gene Expression Is Regulated by p53. J Invest 
Dermatol 118, 126-132. 
Kikuchi, M. (1984). Autopsy of Patients with Yusho. Am J Ind Med 5, 19-30. 
Kim, D.W., Gazourian, L., Quadri, S.A., Romieu-Mourez, R., Sherr, D.H., and Sonenshein, 
G.E. (2000). The RelA Nf-Kappab Subunit and the Aryl Hydrocarbon Receptor (AhR) 
Cooperate to Transactivate the C-Myc Promoter in Mammary Cells. Oncogene 19, 5498-5506. 
Kim, M.D., Jan, L.Y., and Jan, Y.N. (2006). The bHLH-PAS Protein Spineless Is Necessary for 
the Diversification of Dendrite Morphology of Drosophila Dendritic Arborization Neurons. 
Genes Dev 20, 2806-2819. 
Kimura, A., Naka, T., Nohara, K., Fujii-Kuriyama, Y., and Kishimoto, T. (2008). Aryl 
Hydrocarbon Receptor Regulates Stat1 Activation and Participates in the Development of Th17 
Cells. Proc Natl Acad Sci U S A 105, 9721-9726. 
Kitano, Y., and Okada, N. (1983). Separation of the Epidermal Sheet by Dispase. Br J Dermatol 
108, 555-560. 
Kleeman, J.M., Olson, J.R., and Peterson, R.E. (1988). Species Differences in 2,3,7,8-
Tetrachlorodibenzo-p-dioxin Toxicity and Biotransformation in Fish. Fundam Appl Toxicol 10, 
206-213. 
Kleman, M., Poellinger, L., and Gustafsson, J. (1994). Regulation of Human Dioxin Receptor 
Function by Indolocarbazoles, Receptor Ligands of Dietary Origin. J Biol Chem 269, 5137-
5144. 
 56 
Kobayashi, N., Nakagawa, A., Muramatsu, T., Yamashina, Y., Shirai, T., Hashimoto, M.W., 
Ishigaki, Y., Ohnishi, T., and Mori, T. (1998a). Supranuclear Melanin Caps Reduce Ultraviolet 
Induced DNA Photoproducts in Human Epidermis. J Invest Dermatol 110, 806-810. 
Kobayashi, T., Imokawa, G., Bennett, D.C., and Hearing, V.J. (1998b). Tyrosinase Stabilization 
by Tyrp1 (the Brown Locus Protein). J Biol Chem 273, 31801-31805. 
Kobayashi, T., Urabe, K., Winder, A., Jimenez-Cervantes, C., Imokawa, G., Brewington, T., 
Solano, F., Garcia-Borron, J.C., and Hearing, V.J. (1994). Tyrosinase Related Protein 1 (Trp1) 
Functions as a Dhica Oxidase in Melanin Biosynthesis. EMBO J 13, 5818-5825. 
Kolluri, S.K., Weiss, C., Koff, A., and Gottlicher, M. (1999). P27(Kip1) Induction and 
Inhibition of Proliferation by the Intracellular Ah Receptor in Developing Thymus and 
Hepatoma Cells. Genes Dev 13, 1742-1753. 
Kumar, M.B., Ramadoss, P., Reen, R.K., Vanden Heuvel, J.P., and Perdew, G.H. (2001). The 
Q-Rich Subdomain of the Human Ah Receptor Transactivation Domain Is Required for 
Dioxin-Mediated Transcriptional Activity. J Biol Chem 276, 42302-42310. 
Kushimoto, T., Basrur, V., Valencia, J., Matsunaga, J., Vieira, W.D., Ferrans, V.J., Muller, J., 
Appella, E., and Hearing, V.J. (2001). A Model for Melanosome Biogenesis Based on the 
Purification and Analysis of Early Melanosomes. Proc Natl Acad Sci U S A 98, 10698-10703. 
Land, E.J., Ramsden, C.A., and Riley, P.A. (2004). Quinone Chemistry and Melanogenesis. 
Methods in Enzymology 378, 88-109. 
Landi, M.T., Baccarelli, A., Tarone, R.E., Pesatori, A., Tucker, M.A., Hedayati, M., and 
Grossman, L. (2002). DNA Repair, Dysplastic Nevi, and Sunlight Sensitivity in the 
Development of Cutaneous Malignant Melanoma. J Natl Cancer Inst 94, 94-101. 
Laub, L.B., Jones, B.D., and Powell, W.H. (2010). Responsiveness of a Xenopus Laevis Cell 
Line to the Aryl Hydrocarbon Receptor Ligands 6-Formylindolo[3,2-b]carbazole (FICZ) and 
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD). Chem Biol Interact 183, 202-211. 
Lekas, P., Tin, K.L., Lee, C., and Prokipcak, R.D. (2000). The Human Cytochrome P450 1A1 
mRNA Is Rapidly Degraded in HEPG2 Cells. Arch Biochem Biophys 384, 311-318. 
Lerner, A.B., Fitzpatrick, T.B., Calkins, E., and Summerson, W.H. (1949). Mammalian 
Tyrosinase: Preparation and Properties. J Biol Chem 178, 185-195. 
Levine-Fridman, A., Chen, L., and Elferink, C.J. (2004). Cytochrome P4501A1 Promotes G1 
Phase Cell Cycle Progression by Controlling Aryl Hydrocarbon Receptor Activity. Mol 
Pharmacol 65, 461-469. 
Lin, Y.Z., Yao, S.Y., Veach, R.A., Torgerson, T.R., and Hawiger, J. (1995). Inhibition of 
Nuclear Translocation of Transcription Factor NF-Kappa B by a Synthetic Peptide Containing a 
Cell Membrane-Permeable Motif and Nuclear Localization Sequence. J Biol Chem 270, 14255-
14258. 
Lindebro, M.C., Poellinger, L., and Whitelaw, M.L. (1995). Protein-Protein Interaction Via 
PAS Domains: Role of the PAS Domain in Positive and Negative Regulation of the bHLH/PAS 
Dioxin Receptor-Arnt Transcription Factor Complex. EMBO J 14, 3528-3539. 
Loertscher, J.A., Lin, T.-M., Peterson, R.E., and Allen-Hoffmann, B.L. (2002). In Utero 
Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin Causes Accelerated Terminal Differentiation 
in Fetal Mouse Skin. Toxicol Sci 68, 465-472. 
Loertscher, J.A., Sadek, C.S., and Allen-Hoffmann, B.L. (2001a). Treatment of Normal Human 
Keratinocytes with 2,3,7,8-Tetrachlorodibenzo-p-dioxin Causes a Reduction in Cell Number, 
but No Increase in Apoptosis. Toxicol Appl Pharmacol 175, 114-120. 
   57 
Loertscher, J.A., Sattler, C.A., and Allen-Hoffmann, B.L. (2001b). 2,3,7,8-Tetrachlorodibenzo-
p-dioxin Alters the Differentiation Pattern of Human Keratinocytes in Organotypic Culture. 
Toxicol Appl Pharmacol 175, 121-129. 
Long, W.P., Pray-Grant, M., Tsai, J.C., and Perdew, G.H. (1998). Protein Kinase C Activity Is 
Required for Aryl Hydrocarbon Receptor Pathway-Mediated Signal Transduction. Mol 
Pharmacol 53, 691-700. 
Lu, Y.C., and Wu, Y.C. (1985). Clinical Findings and Immunological Abnormalities in Yu-
Cheng Patients. Environ Health Perspect 59, 17-29. 
Lu, Y.F., Santostefano, M., Cunningham, B.D.M., Threadgill, M.D., and Safe, S. (1995). 
Identification of 3'-Methoxy-4'-Nitroflavone as a Pure Aryl Hydrocarbon (Ah) Receptor 
Antagonist and Evidence for More Than One Form of the Nuclear Ah Receptor in MCF-7 
Human Breast Cancer Cells. Arch Biochem Biophys 316, 470-477. 
Ma, Q., and Baldwin, K.T. (2000). 2,3,7,8-Tetrachlorodibenzo-P-Dioxin-Induced Degradation 
of Aryl Hydrocarbon Receptor (AhR) by the Ubiquitin-Proteasome Pathway. Role of the 
Transcription Activaton and DNA Binding of AhR. J Biol Chem 275, 8432-8438. 
Ma, Q., Renzelli, A.J., Baldwin, K.T., and Antonini, J.M. (2000). Superinduction of CYP1A1 
Gene Expression. Regulation of 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Induced Degradation of 
Ah Receptor by Cycloheximide. J Biol Chem 275, 12676-12683. 
Ma, Q., and Whitlock, J., Jr (1996). The Aromatic Hydrocarbon Receptor Modulates the Hepa 
1c1c7 Cell Cycle and Differentiated State Independently of Dioxin. Mol Cell Biol 16, 2144-
2150. 
Ma, Q., and Whitlock, J.P., Jr. (1997). A Novel Cytoplasmic Protein That Interacts with the Ah 
Receptor, Contains Tetratricopeptide Repeat Motifs, and Augments the Transcriptional 
Response to 2,3,7,8-Tetrachlorodibenzo-p-dioxin. J Biol Chem 272, 8878-8884. 
Machemer, D.E.W., and Tukey, R.H. (2005). The Role of Protein Kinase C in Regulation of 
TCDD-Mediated CYP1A1 Gene Expression. Toxicol Sci 87, 27-37. 
Mahon, M.J., and Gasiewicz, T.A. (1995). Ah Receptor Phosphorylation: Localization of 
Phosphorylation Sites to the C-Terminal Half of the Protein. Arch Biochem Biophys 318, 166-
174. 
Marconett, C.N., Sundar, S.N., Poindexter, K.M., Stueve, T.R., Bjeldanes, L.F., and Firestone, 
G.L. (2010). Indole-3-Carbinol Triggers AhR-Dependent ER{Alpha} Protein Degradation in 
Breast Cancer Cells Disrupting an ER{Alpha}-Gata3 Transcriptional Cross-Regulatory Loop. 
Mol Biol Cell, E09-08-0689. 
Marderosian, M., Sharma, A., Funk, A.P., Vartanian, R., Masri, J., Jo, O.D., and Gera, J.F. 
(2006). Tristetraprolin Regulates Cyclin D1 and C-Myc mRNA Stability in Response to 
Rapamycin in an Akt-Dependent Manner Via p38 MAPK Signaling. Oncogene 25, 6277-6290. 
Marks, M.S., and Seabra, M.C. (2001). The Melanosome: Membrane Dynamics in Black and 
White. Nature Reviews: Molecular Cell Biology 2, 1-11. 
Marlowe, J.L., Knudsen, E.S., Schwemberger, S., and Puga, A. (2004). The Aryl Hydrocarbon 
Receptor Displaces p300 from E2F-Dependent Promoters and Represses S Phase-Specific 
Gene Expression. J Biol Chem 279, 29013-29022. 
McGuire, J., Okamoto, K., Whitelaw, M.L., Tanaka, H., and Poellinger, L. (2001). Definition 
of a Dioxin Receptor Mutant That Is a Constitutive Activator of Transcription: Delineation of 
Overlapping Repression and Ligand Binding Functions within the PAS Domain. J Biol Chem 
276, 41841-41849. 
 58 
McLeod, S.D., and Mason, R.S. (1995). Isolation of Enriched Human Melanocyte Cultures 
from Fetal, Newborn and Adult Skin. Methods in Cell Science 17, 187-193. 
McMillan, B.J., and Bradfield, C.A. (2007). The Aryl Hydrocarbon Receptor Is Activated by 
Modified Low-Density Lipoprotein. Proc Natl Acad Sci U S A 104, 1412-1417. 
Merchant, M., Arellano, L., and Safe, S. (1990). The Mechanism of Action of [Alpha]-
Naphthoflavone as an Inhibitor of 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Induced CYP1A1 Gene 
Expression. Arch Biochem Biophys 281, 84-89. 
Meyer, B.K., Pray-Grant, M.G., Vanden Heuvel, J.P., and Perdew, G.H. (1998). Hepatitis B 
Virus X-Associated Protein 2 Is a Subunit of the Unliganded Aryl Hydrocarbon Receptor Core 
Complex and Exhibits Transcriptional Enhancer Activity. Mol Cell Biol 18, 978-988. 
Mimura, J., Ema, M., Sogawa, K., and Fujii-Kuriyama, Y. (1999). Identification of a Novel 
Mechanism of Regulation of Ah (Dioxin) Receptor Function. Genes Dev 13, 20-25. 
Mimura, J., Yamashita, K., Nakamura, K., Morita, M., Takagi, T., Nakao, K., Ema, M., 
Sogawa, K., Yasuda, M., Katsuki, M., et al. (1997). Loss of Teratogenic Response to 2,3,7,8-
Tetrachlorodibenzo-p-dioxin (TCDD) in Mice Lacking the Ah (Dioxin) Receptor. Genes to 
Cells 2, 645-654. 
Minsavage, G.D., Park, S.K., and Gasiewicz, T.A. (2004). The Aryl Hydrocarbon Receptor 
(AhR) Tyrosine 9, a Residue That Is Essential for AhR DNA Binding Activity, Is Not a 
Phosphoresidue but Augments AhR Phosphorylation. J Biol Chem 279, 20582-20593. 
Mitchell, K.A., and Elferink, C.J. (2009). Timing Is Everything: Consequences of Transient and 
Sustained AhR Activity. Biochem Pharmacol 77, 947-956. 
Morel, Y., and Barouki, R. (1998). Down-Regulation of Cytochrome P450 1A1 Gene Promoter 
by Oxidative Stress. Critical Contribution of Nuclear Factor 1. J Biol Chem 273, 26969-26976. 
Morel, Y., and Barouki, R. (2000). The Repression of Nuclear Factor I/CCAAT Transcription 
Factor (NFI/CTF) Transactivating Domain by Oxidative Stress Is Mediated by a Critical 
Cysteine (Cys-427). Biochem J 348 Pt 1, 235-240. 
Morel, Y., Coumoul, X., Nalpas, A., and Barouki, R. (2000). Nuclear Factor I/CCAAT Box 
Transcription Factor Trans-Activating Domain Is a Negative Sensor of Cellular Stress. Mol 
Pharmacol 58, 1239-1246. 
Moriguchi, T., Motohashi, H., Hosoya, T., Nakajima, O., Takahashi, S., Ohsako, S., Aoki, Y., 
Nishimura, N., Tohyama, C., Fujii-Kuriyama, Y., et al. (2003). Distinct Response to Dioxin in 
an Arylhydrocarbon Receptor (AhR)-Humanized Mouse. Proc Natl Acad Sci U S A 100, 5652-
5657. 
Mukai, M., and Tischkau, S.A. (2007). Effects of Tryptophan Photoproducts in the Circadian 
Timing System: Searching for a Physiological Role for Aryl Hydrocarbon Receptor. Toxicol 
Sci 95, 172-181. 
Murray, I.A., Reen, R.K., Leathery, N., Ramadoss, P., Bonati, L., Gonzalez, F.J., Peters, J.M., 
and Perdew, G.H. (2005). Evidence That Ligand Binding Is a Key Determinant of Ah 
Receptor-Mediated Transcriptional Activity. Arch Biochem Biophys 442, 59-71. 
Muthusamy, V., and Piva, T.J. (2009). The UV Response of the Skin: A Review of the MAPK, 
NFκB and TNFα Signal Transduction Pathways. Arch Dermatol Res 302, 5-17. 
Naeyaert, J.M., Eller, M., Gordon, P.R., Park, H.Y., and Gilchrest, B.A. (1991). Pigment 
Content of Cultured Human Melanocytes Does Not Correlate with Tyrosinase Message Level. 
Br J Dermatol 125, 297-303. 
   59 
Nebert, D.W. (1991). Minireview: Proposed Role of Drug-Metabolizing Enzymes: Regulation 
of Steady State Levels of the Ligands That Effect Growth, Homeostasis, Differentiation, and 
Neuroendocrine Functions. Mol Endocrinol 5, 1203-1214. 
Nebert, D.W., Dalton, T.P., Okey, A.B., and Gonzalez, F.J. (2004). Role of Aryl Hydrocarbon 
Receptor-Mediated Induction of the Cyp1 Enzymes in Environmental Toxicity and Cancer. J 
Biol Chem 279, 23847-23850. 
Nguyen, L.P., and Bradfield, C.A. (2007). The Search for Endogenous Activators of the Aryl 
Hydrocarbon Receptor. Chem Res Toxicol 21, 102-116. 
Nguyen, T., Nioi, P., and Pickett, C.B. (2009). The Nrf2-Antioxidant Response Element 
Signaling Pathway and Its Activation by Oxidative Stress. J Biol Chem 284, 13291-13295. 
Nishimura, E.K., Granter, S.R., and Fisher, D.E. (2005). Mechanisms of Hair Graying: 
Incomplete Melanocyte Stem Cell Maintenance in the Niche. Science 307, 720-724. 
Nishimura, E.K., Jordan, S.A., Oshima, H., Yoshida, H., Osawa, M., Moriyama, M., Jackson, 
I.J., Barrandon, Y., Miyachi, Y., and Nishikawa, S. (2002). Dominant Role of the Niche in 
Melanocyte Stem-Cell Fate Determination. Nature 416, 854-860. 
Nordlund, J.N., Boissy, R.E., Hearing, V.J., King, R.A., Oetting, W.S., and Ortonne, J. (2006). 
The Pigmentary System: Physiology and Pathophysiology, 2nd Edition (Wiley-Blackwell), pp. 
261-281. 
Oberg, M., Bergander, L., Hakansson, H., Rannug, U., and Rannug, A. (2005). Identification of 
the Tryptophan Photoproduct 6-Formylindolo[3,2-b]carbazole, in Cell Culture Medium, as a 
Factor That Controls the Background Aryl Hydrocarbon Receptor Activity. Toxicol Sci 85, 
935-943. 
Oesch-Bartlomowicz, B., Huelster, A., Wiss, O., Antoniou-Lipfert, P., Dietrich, C., Arand, M., 
Weiss, C., Bockamp, E., and Oesch, F. (2005). Aryl Hydrocarbon Receptor Activation by 
cAMP Vs. Dioxin: Divergent Signaling Pathways. Proc Natl Acad Sci U S A 102, 9218-9223. 
Ohtake, F., Baba, A., Fujii-Kuriyama, Y., and Kato, S. (2008). Intrinsic AhR Function 
Underlies Cross-Talk of Dioxins with Sex Hormone Signalings. Biochem Biophys Res 
Commun 370, 541-546. 
Ohtake, F., Baba, A., Takada, I., Okada, M., Iwasaki, K., Miki, H., Takahashi, S., Kouzmenko, 
A., Nohara, K., Chiba, T., et al. (2007). Dioxin Receptor Is a Ligand-Dependent E3 Ubiquitin 
Ligase. Nature 446, 562-566. 
Ohtake, F., Fujii-Kuriyama, Y., and Kato, S. (2009). AhR Acts as an E3 Ubiquitin Ligase to 
Modulate Steroid Receptor Functions. Biochem Pharmacol 77, 474-484. 
Ohtake, F., Takeyama, K.-i., Matsumoto, T., Kitagawa, H., Yamamoto, Y., Nohara, K., 
Tohyama, C., Krust, A., Mimura, J., Chambon, P., et al. (2003). Modulation of Oestrogen 
Receptor Signalling by Association with the Activated Dioxin Receptor. Nature 423, 545-550. 
Orlow, S.J., Zhou, B.K., Chakraborty, A.K., Drucker, M., Pifko-Hirst, S., and Pawelek, J.M. 
(1994). High-Molecular-Weight Forms of Tyrosinase and the Tyrosinase-Related Proteins: 
Evidence for a Melanogenic Complex. J Invest Dermatol 103, 196-201. 
Ortonne, J.P. (2002). Photoprotective Properties of Skin Melanin. Br J Dermatol 146 Suppl 61, 
7-10. 
Oshima, M., Mimura, J., Sekine, H., Okawa, H., and Fujii-Kuriyama, Y. (2009). Sumo 
Modification Regulates the Transcriptional Repressor Function of Aryl Hydrocarbon Receptor 
Repressor. J Biol Chem 284, 11017-11026. 
 60 
Oshima, M., Mimura, J., Yamamoto, M., and Fujii-Kuriyama, Y. (2007). Molecular 
Mechanism of Transcriptional Repression of AhR Repressor Involving Ankra2, Hdac4, and 
Hdac5. Biochem Biophys Res Commun 364, 276-282. 
Pandini, A., Denison, M.S., Song, Y., Soshilov, A.A., and Bonati, L. (2007). Structural and 
Functional Characterization of the Aryl Hydrocarbon Receptor Ligand Binding Domain by 
Homology Modeling and Mutational Analysis. Biochemistry 46, 696-708. 
Pandini, A., Soshilov, A.A., Song, Y., Zhao, J., Bonati, L., and Denison, M.S. (2009). Detection 
of the TCDD Binding-Fingerprint within the Ah Receptor Ligand Binding Domain by 
Structurally Driven Mutagenesis and Functional Analysis. Biochemistry 48, 5972-5983. 
Park, H.-Y., Lee, J., Gonzalez, S., Middelkamp-Hup, M.A., Kapasi, S., Peterson, S., and 
Gilchrest, B.A. (2004a). Topical Application of a Protein Kinase C Inhibitor Reduces Skin and 
Hair Pigmentation. J Investig Dermatol 122, 159-166. 
Park, H.-Y., Perez, J.M., Laursen, R., Hara, M., and Gilchrest, B.A. (1999). Protein Kinase C-
Beta  Activates Tyrosinase by Phosphorylating Serine Residues in Its Cytoplasmic Domain. J 
Biol Chem 274, 16470-16478. 
Park, H.-Y., Wu, H., Killoran, C.E., and Gilchrest, B.A. (2004b). The Receptor for Activated 
C-Kinase-I (Rack-I) Anchors Activated PKC-{Beta} on Melanosomes. J Cell Sci 117, 3659-
3668. 
Park, H., Russakovsky, V., Ohno, S., and Gilchrest, B. (1993). The Beta Isoform of Protein 
Kinase C Stimulates Human Melanogenesis by Activating Tyrosinase in Pigment Cells. J Biol 
Chem 268, 11742-11749. 
Park, H.Y., Kosmadaki, M., Yaar, M., and Gilchrest, B.A. (2009). Cellular Mechanisms 
Regulating Human Melanogenesis. Cell Mol Life Sci 66, 1493-1506. 
Park, H.Y., Wu, C., Yonemoto, L., Murphy-Smith, M., Wu, H., Stachur, C.M., and Gilchrest, 
B.A. (2006). MITF Mediates cAMP-Induced Protein Kinase C-Beta Expression in Human 
Melanocytes. Biochem J 395, 571-578. 
Park, S., Henry, E.C., and Gasiewicz, T.A. (2000). Regulation of DNA Binding Activity of the 
Ligand-Activated Aryl Hydrocarbon Receptor by Tyrosine Phosphorylation. Arch Biochem 
Biophys 381, 302-312. 
Pastor, M.A., Carrasco, L., Izquierdo, M.J., Farina, M.C., Martin, L., Renedo, G., and Requena, 
L. (2002). Chloracne: Histopathologic Findings in One Case. J Cutan Pathol 29, 193-199. 
Perdew, G.H. (1988). Association of the Ah Receptor with the 90-kDa Heat Shock Protein. J 
Biol Chem 263, 13802-13805. 
Perdew, G.H., and Bradfield, C.A. (1996). Mapping the 90 kDa Heat Shock Protein Binding 
Region of the Ah Receptor. Biochem Mol Biol Int 39, 589-593. 
Peters, A.K., Nijmeijer, S., Gradin, K., Backlund, M., Bergman, A., Poellinger, L., Denison, 
M.S., and Van den Berg, M. (2006). Interactions of Polybrominated Diphenyl Ethers with the 
Aryl Hydrocarbon Receptor Pathway. Toxicol Sci 92, 133-142. 
Petrulis, J.R., Kusnadi, A., Ramadoss, P., Hollingshead, B., and Perdew, G.H. (2003). The 
Hsp90 Co-Chaperone XAP2 Alters Importin Beta Recognition of the Bipartite Nuclear 
Localization Signal of the Ah Receptor and Represses Transcriptional Activity. J Biol Chem 
278, 2677-2685. 
Petrulis, J.R., and Perdew, G.H. (2002). The Role of Chaperone Proteins in the Aryl 
Hydrocarbon Receptor Core Complex. Chem Biol Inter 141, 25-40. 
   61 
Pettersson, K., Grandien, K., Kuiper, G.G., and Gustafsson, J.A. (1997). Mouse Estrogen 
Receptor Beta Forms Estrogen Response Element-Binding Heterodimers with Estrogen 
Receptor Alpha. Mol Endocrinol 11, 1486-1496. 
Phelan, D., Winter, G.M., Rogers, W.J., Lam, J.C., and Denison, M.S. (1998). Activation of the 
Ah Receptor Signal Transduction Pathway by Bilirubin and Biliverdin. Arch Biochem Biophys 
357, 155-163. 
Pierce, J.W., Schoenleber, R., Jesmok, G., Best, J., Moore, S.A., Collins, T., and Gerritsen, 
M.E. (1997). Novel Inhibitors of Cytokine-Induced Ikappa Balpha Phosphorylation and 
Endothelial Cell Adhesion Molecule Expression Show Anti-Inflammatory Effects in Vivo. J 
Biol Chem 272, 21096-21103. 
Pohjanvirta, R., Korkalainen, M., McGuire, J., Simanainen, U., Juvonen, R., Tuomisto, J.T., 
Unkila, M., Viluksela, M., Bergman, J., Poellinger, L., et al. (2002). Comparison of Acute 
Toxicities of Indolo[3,2-b]carbazole (ICZ) and 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) in 
TCDD-Sensitive Rats. Food and Chemical Toxicology 40, 1023-1032. 
Pohjanvirta, R., and Tuomisto, J. (1994). Short-Term Toxicity of 2,3,7,8-Tetrachlorodibenzo-p-
dioxin in Laboratory Animals: Effects, Mechanisms, and Animal Models. Pharmacol Rev 46, 
483-549. 
Poland, A., and Knutson, J.C. (1982). 2,3,7,8-Tetrachlorodibenzo-p-dioxin and Related 
Halogenated Aromatic Hydrocarbons: Examination of the Mechanism of Toxicity. Annu Rev 
Pharmacol Toxicol 22, 517-554. 
Pollenz, R. (1996). The Aryl-Hydrocarbon Receptor, but Not the Aryl-Hydrocarbon Receptor 
Nuclear Translocator Protein, Is Rapidly Depleted in Hepatic and Nonhepatic Culture Cells 
Exposed to 2,3,7,8-Tetrachlorodibenzo-p-dioxin. Mol Pharmacol 49, 391-398. 
Pollenz, R.S. (2002). The Mechanism of Ah Receptor Protein Down-Regulation (Degradation) 
and Its Impact on Ah Receptor-Mediated Gene Regulation. Chem Biol Interact 141, 41-61. 
Pollenz, R.S. (2007). Specific Blockage of Ligand-Induced Degradation of the Ah Receptor by 
Proteasome but Not Calpain Inhibitors in Cell Culture Lines from Different Species. Biochem 
Pharmacol 74, 131-143. 
Pollenz, R.S., and Barbour, E.R. (2000). Analysis of the Complex Relationship between 
Nuclear Export and Aryl Hydrocarbon Receptor-Mediated Gene Regulation. Mol Cell Biol 20, 
6095-6104. 
Pollenz, R.S., and Buggy, C. (2006). Ligand-Dependent and -Independent Degradation of the 
Human Aryl Hydrocarbon Receptor (hAhR) in Cell Culture Models. Chem Biol Inter 164, 49-
59. 
Pollenz, R.S., Davarinos, N.A., and Shearer, T.P. (1999). Analysis of Aryl Hydrocarbon 
Receptor-Mediated Signaling During Physiological Hypoxia Reveals Lack of Competition for 
the Aryl Hydrocarbon Nuclear Translocator Transcription Factor. Mol Pharmacol 56, 1127-
1137. 
Pollenz, R.S., and Dougherty, E.J. (2005). Redefining the Role of the Endogenous XAP2 and 
C-Terminal Hsp70-Interacting Protein on the Endogenous Ah Receptors Expressed in Mouse 
and Rat Cell Lines. J Biol Chem 280, 33346-33356. 
Pollenz, R.S., Popat, J., and Dougherty, E.J. (2005). Role of the Carboxy-Terminal 
Transactivation Domain and Active Transcription in the Ligand-Induced and Ligand-
Independent Degradation of the Mouse Ahb-1 Receptor. Biochem Pharmcol 70, 1623-1633. 
Pollenz, R.S., Santostefano, M.J., Klett, E., Richardson, V.M., Necela, B., and Birnbaum, L.S. 
(1998). Female Sprague-Dawley Rats Exposed to a Single Oral Dose of 2,3,7,8-
 62 
Tetrachlorodibenzo-p-dioxin Exhibit Sustained Depletion of Aryl Hydrocarbon Receptor 
Protein in Liver, Spleen, Thymus, and Lung. Toxicol Sci 42, 117-128. 
Pollenz, R.S., Wilson, S.E., and Dougherty, E.J. (2006). Role of Endogenous XAP2 Protein on 
the Localization and Nucleocytoplasmic Shuttling of the Endogenous Mouse Ahb-1 Receptor 
in the Presence and Absence of Ligand. Mol Pharmacol 70, 1369-1379. 
Pomerantz, S.H., and Warner, M.C. (1967). 3,4-Dihydroxy-L-Phenylalanine as the Tyrosinase 
Cofactor. Occurrence in Melanoma and Binding Constant. J Biol Chem 242, 5308-5314. 
Pongratz, I., Mason, G.G., and Poellinger, L. (1992). Dual Roles of the 90-kDa Heat Shock 
Protein Hsp90 in Modulating Functional Activities of the Dioxin Receptor. Evidence That the 
Dioxin Receptor Functionally Belongs to a Subclass of Nuclear Receptors Which Require 
Hsp90 Both for Ligand Binding Activity and Repression of Intrinsic DNA Binding Activity. J 
Biol Chem 267, 13728-13734. 
Pongratz, I., Stromstedt, P.E., Mason, G.G., and Poellinger, L. (1991). Inhibition of the Specific 
DNA Binding Activity of the Dioxin Receptor by Phosphatase Treatment. J Biol Chem 266, 
16813-16817. 
Powell-Coffman, J.A., Bradfield, C.A., and Wood, W.B. (1998). Caenorhabditis Elegans 
Orthologs of the Aryl Hydrocarbon Receptor and Its Heterodimerization Partner the Aryl 
Hydrocarbon Receptor Nuclear Translocator. Proc Natl Acad Sci U S A 95, 2844-2849. 
Probst, M.R., Reisz-Porszasz, S., Agbunag, R.V., Ong, M.S., and Hankinson, O. (1993). Role 
of the Aryl Hydrocarbon Receptor Nuclear Translocator Protein in Aryl Hydrocarbon (Dioxin) 
Receptor Action. Mol Pharmacol 44, 511-518. 
Procopio, M., Lahm, A., Tramontano, A., Bonati, L., and Pitea, D. (2002). A Model for 
Recognition of Polychlorinated Dibenzo-p-Dioxins by the Aryl Hydrocarbon Receptor. FEBS 
269, 13-18. 
Puga, A., Barnes, S.J., Dalton, T.P., Chang, C.-y., Knudsen, E.S., and Maier, M.A. (2000). 
Aromatic Hydrocarbon Receptor Interaction with the Retinoblastoma Protein Potentiates 
Repression of E2F-Dependent Transcription and Cell Cycle Arrest. J Biol Chem 275, 2943-
2950. 
Qin, H., Zhai, Z., and Powell-Coffman, J.A. (2006). The Caenorhabditis Elegans Ahr-1 
Transcription Complex Controls Expression of Soluble Guanylate Cyclase Genes in the Urx 
Neurons and Regulates Aggregation Behavior. Dev Biol 298, 606-615. 
Quevedo, W.C. (1972). Epidermal-Melanin Units: Melanocyte-Keratinocyte Interactions. Am 
Zoologist 12, 35-41. 
Quintana, F.J., Basso, A.S., Iglesias, A.H., Korn, T., Farez, M.F., Bettelli, E., Caccamo, M., 
Oukka, M., and Weiner, H.L. (2008). Control of Treg and Th17 Cell Differentiation by the Aryl 
Hydrocarbon Receptor. Nature 453, 65-71. 
Ramadoss, P., Petrulis, J.R., Hollingshead, B.D., Kusnadi, A., and Perdew, G.H. (2004). 
Divergent Roles of Hepatitis B Virus X-Associated Protein 2 (XAP2) in Human Versus Mouse 
Ah Receptor Complexes. Biochemistry 43, 700-709. 
Ramirez-Bosca, A., Bernd, A., Werner, R., Dold, K., and Holzmann, H. (1992). Effect of the 
Dose of Ultraviolet Radiation on the Pigment Formation by Human Melanocytes in Vitro. Arch 
Dermatol Res 284, 358-362. 
Rannug, A., and Fritsche, E. (2006). The Aryl Hydrocarbon Receptor and Light. Biol Chem 
387, 1149-1157. 
   63 
Rannug, A., Rannug, U., Rosenkranz, H.S., Winqvist, L., Westerholm, R., Agurell, E., and 
Grafstrom, A.K. (1987). Certain Photooxidized Derivatives of Tryptophan Bind with Very 
High Affinity to the Ah Receptor and Are Likely to Be Endogenous Signal Substances. J Biol 
Chem 262, 15422-15427. 
Rannug, U., Rannug, A., Sjoberg, U., Li, H., Westerholm, R., and Bergman, J. (1995). 
Structure Elucidation of Two Tryptophan-Derived, High Affinity Ah Receptor Ligands. Chem 
Biol 2, 841-845. 
Raposo, G., and Marks, M.S. (2007). Melanosomes - Dark Organelles Enlighten Endosomal 
Membrane Transport. Nat Rev Mol Cell Biol 8, 786-797. 
RayChaudhuri, B., Nebert, D.W., and Puga, A. (1990). The Murine CYP1A1 Gene Negatively 
Regulates Its Own Transcription and That of Other Members of the Aromatic Hydrocarbon-
Responsive [Ah] Gene Battery. Mol Endocrinol 4, 1773-1781. 
Reick M, Robertson RW, Pasco DS, and JB, F. (1994). Down-Regulation of Nuclear Aryl 
Hydrocarbon Receptor DNA-Binding and Transactivation Functions: Requirement for a Labile 
or Inducible Factor. Molecular and cellular biology 14, 5653-5660. 
Reid, G., Hubner, M.R., Metivier, R., Brand, H., Denger, S., Manu, D., Beaudouin, J., 
Ellenberg, J., and Gannon, F. (2003). Cyclic, Proteasome-Mediated Turnover of Unliganded 
and Liganded ERalpha on Responsive Promoters Is an Integral Feature of Estrogen Signaling. 
Mol Cell 11, 695-707. 
Reyes, H., Reisz-Porszasz, S., and Hankinson, O. (1992). Identification of the Ah Receptor 
Nuclear Translocator Protein (Arnt) as a Component of the DNA Binding Form of the Ah 
Receptor. Science 256, 1193-1195. 
Richter, C.A., Tillitt, D.E., and Hannink, M. (2001). Regulation of Subcellular Localization of 
the Aryl Hydrocarbon Receptor (AhR). Arch Biochem Biophys 389, 207-217. 
Roberts, B.J., and Whitelaw, M.L. (1999). Degradation of the Basic Helix-Loop-Helix/Per-
Arnt-Sim Homology Domain Dioxin Receptor Via the Ubiquitin/Proteasome Pathway. J Biol 
Chem 274, 36351-36356. 
Rodriguez-Gonzalez, A., Cyrus, K., Salcius, M., Kim, K., Crews, C.M., Deshaies, R.J., and 
Sakamoto, K.M. (2008). Targeting Steroid Hormone Receptors for Ubiquitination and 
Degradation in Breast and Prostate Cancer. Oncogene 27, 7201-7211. 
Roman, B.L., Pollenz, R.S., and Peterson, R.E. (1998). Responsiveness of the Adult Male Rat 
Reproductive Tract to 2,3,7,8-Tetrachlorodibenzo-p-dioxin Exposure: Ah Receptor and Arnt 
Expression, CYP1A1 Induction, and Ah Receptor Down-Regulation. Toxicol Appl Pharmacol 
150, 228-239. 
Rowlands, J., McEwan, I., and Gustafsson, J. (1996). Trans-Activation by the Human Aryl 
Hydrocarbon Receptor and Aryl Hydrocarbon Receptor Nuclear Translocator Proteins: Direct 
Interactions with Basal Transcription Factors. Mol Pharmacol 50, 538-548. 
Sadek, C.M., and Allen-Hoffmann, B.L. (1994a). Cytochrome P4501A1 Is Rapidly Induced in 
Normal Human Keratinocytes in the Absence of Xenobiotics. J Biol Chem 269, 16067-16074. 
Sadek, C.M., and Allen-Hoffmann, B.L. (1994b). Suspension-Mediated Induction of Hepa 
1c1c7 CYP1A1 Expression Is Dependent on the Ah Receptor Signal Transduction Pathway. J 
Biol Chem 269, 31505-31509. 
Sarangarajan, R., and Boissy, R. (2001). Tyrp1 and Oculocutaneous Albinism Type 3. Pigment 
Cell Res 14, 437-444. 
 64 
Schaldach, C.M., Riby, J., and Bjeldanes, L.F. (1999). Lipoxin A4: A New Class of Ligand for 
the Ah Receptor. Biochemistry 38, 7594-7600. 
Schallreuter, K.U. (2007). Advances in Melanocyte Basic Science Research. Dermatologic 
Clinics, Pigmentary Disorders 25, 283-291. 
Schecter, A., Birnbaum, L., Ryan, J.J., and Constable, J.D. (2006). Dioxins: An Overview. 
Environ Res 101, 419-428. 
Schmidt, J.V., Su, G.H.-T., Reddy, J.K., Simon, M.C., and Bradfield, C.A. (1996). 
Characterization of a Murine AhR Null Allele: Involvement of the Ah Receptor in Hepatic 
Growth and Development. Proc Natl Acad Sci U S A 93, 6731-6736. 
Schwartz, A.L., and Ciechanover, A. (2009). Targeting Proteins for Destruction by the 
Ubiquitin System: Implications for Human Pathobiology. Annu Rev Pharmacol Toxicol 49, 73-
96. 
Seiberg, M. (2001). Keratinocyte-Melanocyte Interactions During Melanosome Transfer. 
Pigment Cell Res 14, 236-242. 
Seidel, S.D., Winters, G.M., Rogers, W.J., Ziccardi, M.H., Li, V., Keser, B., and Denison, M.S. 
(2001). Activation of the Ah Receptor Signaling Pathway by Prostaglandins. J Biochem Mol 
Toxicol 15, 187-196. 
Setaluri, V. (2000). Sorting and Targeting of Melanosomal Membrane Proteins: Signals, 
Pathways, and Mechanisms. Pigment Cell Res 13, 128-134. 
Setaluri, V. (2003). The Melanosome: Dark Pigment Granule Shines Bright Light on Vesicle 
Biogenesis and More. J Invest Dermatol 121, 650-660. 
Shetty, P.V., Bhagwat, B.Y., and Chan, W.K. (2003). p23 Enhances the Formation of the Aryl 
Hydrocarbon Receptor-DNA Complex. Biochem Pharmacol 65, 941-948. 
Shimizu, Y., Nakatsuru, Y., Ichinose, M., Takahashi, Y., Kume, H., Mimura, J., Fujii-
Kuriyama, Y., and Ishikawa, T. (2000). Benzo[a]Pyrene Carcinogenicity Is Lost in Mice 
Lacking the Aryl Hydrocarbon Receptor. Proc Natl Acad Sci U S A 97, 779-782. 
Shin, S., Wakabayashi, N., Misra, V., Biswal, S., Lee, G.H., Agoston, E.S., Yamamoto, M., and 
Kensler, T.W. (2007). Nrf2 Modulates Aryl Hydrocarbon Receptor Signaling: Influence on 
Adipogenesis. Mol Cell Biol 27, 7188-7197. 
Sinal, C.J., and Bend, J.R. (1997). Aryl Hydrocarbon Receptor-Dependent Induction of 
CYP1A1 by Bilirubin in Mouse Hepatoma Hepa 1c1c7 Cells. Mol Pharmacol 52, 590-599. 
Singh, K.P., Casado, F.L., Opanashuk, L.A., and Gasiewicz, T.A. (2009). The Aryl 
Hydrocarbon Receptor Has a Normal Function in the Regulation of Hematopoietic and Other 
Stem/Progenitor Cell Populations. Biochem Pharmacol 77, 577-587. 
Smit, N.P.M., Van der Meulen, H., Koerten, H.K., Kolb, R.M., Mommaas, A.M., Lentjes, 
E.G.F.M., and Pavel, S. (1997). Melanogenesis in Cultured Melanocytes Can Be Substantially 
Influenced by L-Tyrosine and L-Cysteine. J Invest Dermatol 109, 796-800. 
Song, J., Clagett-Dame, M., Peterson, R.E., Hahn, M.E., Westler, W.M., Sicinski, R.R., and 
DeLuca, H.F. (2002). A Ligand for the Aryl Hydrocarbon Receptor Isolated from Lung. Proc 
Natl Acad Sci U S A 99, 14694-14699. 
Song, Z., and Pollenz, R.S. (2002). Ligand-Dependent and Independent Modulation of Aryl 
Hydrocarbon Receptor Localization, Degradation, and Gene Regulation. Mol Pharmacol 62, 
806-816. 
   65 
Soshilov, A., and Denison, M.S. (2008). Role of the Per/Arnt/Sim Domains in Ligand-
Dependent Transformation of the Aryl Hydrocarbon Receptor. J Biol Chem 283, 32995-33005. 
Steingrimsson, E., Copeland, N.G., and Jenkins, N.A. (2004). Melanocytes and the 
Microphthalmia Transcription Factor Network. Annu Rev Genet 38, 365-411. 
Sun, W., Zhang, J., and Hankinson, O. (1997). A Mutation in the Aryl Hydrocarbon Receptor 
(AhR) in a Cultured Mammalian Cell Line Identifies a Novel Region of Ahr That Affects DNA 
Binding. J Biol Chem 272, 31845-31854. 
Sutter, C.H., Yin, H., Li, Y., Mammen, J.S., Bodreddigari, S., Stevens, G., Cole, J.A., and 
Sutter, T.R. (2009). EGF Receptor Signaling Blocks Aryl Hydrocarbon Receptor-Mediated 
Transcription and Cell Differentiation in Human Epidermal Keratinocytes. Proc Natl Acad Sci 
U S A 106, 4266-4271. 
Swanson, H.I. (2002). DNA Binding and Protein Interactions of the AhR/Arnt Heterodimer 
That Facilitate Gene Activation. Chem Biol Interact 141, 63-76. 
Swanson, H.I. (2004). Cytochrome P450 Expression in Human Keratinocytes: An Aryl 
Hydrocarbon Receptor Perspective. Chem Biol Inter 149, 69-79. 
Swanson, H.I., and Jun-hua, Y. (1996). Mapping the Protein/DNA Contact Sites of the Ah 
Receptor and Ah Receptor Nuclear Translocator. J Biol Chem 271, 31657-31665. 
Swedenborg, E., and Pongratz, I. (2010). AhR and Arnt Modulate ER Signaling. Toxicology 
268, 132-138. 
Swope, V.B., Medrano, E.E., Smalara, D., and Abdel-Malek, Z.A. (1995). Long-Term 
Proliferation of Human Melanocytes Is Supported by the Physiologic Mitogens [Alpha]-
Melanotropin, Endothelin-1, and Basic Fibroblast Growth Factor. Exp Cell Res 217, 453-459. 
Szabo, G., Gerald, A.B., Pathak, M.A., and Fitzpatrick, T.B. (1969). Racial Differences in the 
Fate of Melanosomes in Human Epidermis. Nature 222, 1081-1082. 
Tadokoro, T., Yamaguchi, Y., Batzer, J., Coelho, S.G., Zmudzka, B.Z., Miller, S.A., Wolber, 
R., Beer, J.Z., and Hearing, V.J. (2005). Mechanisms of Skin Tanning in Different 
Racial/Ethnic Groups in Response to Ultraviolet Radiation. J Invest Dermatol 124, 1326-1332. 
Tauchi, M., Hida, A., Negishi, T., Katsuoka, F., Noda, S., Mimura, J., Hosoya, T., Yanaka, A., 
Aburatani, H., Fujii-Kuriyama, Y., et al. (2005). Constitutive Expression of Aryl Hydrocarbon 
Receptor in Keratinocytes Causes Inflammatory Skin Lesions. Mol Cell Biol 25, 9360-9368. 
Taylor, B.L., and Zhulin, I.B. (1999). PAS Domains: Internal Sensors of Oxygen, Redox 
Potential, and Light. Microbiol Mol Biol Rev 63, 479-506. 
Thompson, J.F., Hayes, L.S., and Lloyd, D.B. (1991). Modulation of Firefly Luciferase 
Stability and Impact on Studies of Gene Regulation. Gene 103, 171-177. 
Thong, H.Y., Jee, S.H., Sun, C.C., and Boissy, R.E. (2003). The Patterns of Melanosome 
Distribution in Keratinocytes of Human Skin as One Determining Factor of Skin Colour. Br J 
Dermatol 149, 498-505. 
Tian, Y., Ke, S., Chen, M., and Sheng, T. (2003). Interactions between the Aryl Hydrocarbon 
Receptor and P-TEFB. J Biol Chem 278, 44041-44048. 
Tian, Y., Ke, S., Denison, M.S., Rabson, A.B., and Gallo, M.A. (1999). Ah Receptor and NF-
Kappa B Interactions, a Potential Mechanism for Dioxin Toxicity. J Biol Chem 274, 510-515. 
Tian, Y., Rabson, A.B., and Gallo, M.A. (2002). Ah Receptor and NF-[Kappa]B Interactions: 
Mechanisms and Physiological Implications. Chem Biol Inter 141, 97-115. 
 66 
Tohkin, M., Fukuhara, M., Elizondo, G., Tomita, S., and Gonzalez, F.J. (2000). Aryl 
Hydrocarbon Receptor Is Required for p300-Mediated Induction of DNA Synthesis by 
Adenovirus E1a. Mol Pharmacol 58, 845-851. 
Tolleson, W.H. (2005). Human Melanocyte Biology, Toxicology, and Pathology. J Environ Sci 
Health C Environ Carcinog Ecotoxicol Rev 23, 105-161. 
Tomita, S., Sinal, C.J., Yim, S.H., and Gonzalez, F.J. (2000). Conditional Disruption of the 
Aryl Hydrocarbon Receptor Nuclear Translocator (Arnt) Gene Leads to Loss of Target Gene 
Induction by the Aryl Hydrocarbon Receptor and Hypoxia-Inducible Factor 1{Alpha}. Mol 
Endocrinol 14, 1674-1681. 
Toullec, D., Pianetti, P., Coste, H., Bellevergue, P., Grand-Perret, T., Ajakane, M., Baudet, V., 
Boissin, P., Boursier, E., Loriolle, F., et al. (1991). The Bisindolylmaleimide GF 109203x Is a 
Potent and Selective Inhibitor of Protein Kinase C. J Biol Chem 266, 15771-15781. 
Tripathi, R.K., Hearing, V.J., Urabe, K., Aroca, P., and Spritz, R.A. (1992). Mutational 
Mapping of the Catalytic Activities of Human Tyrosinase. J Biol Chem 267, 23707-23712. 
Tsuchiya, Y., Nakajima, M., Itoh, S., Iwanari, M., and Yokoi, T. (2003). Expression of Aryl 
Hydrocarbon Receptor Repressor in Normal Human Tissues and Inducibility by Polycyclic 
Aromatic Hydrocarbons in Human Tumor-Derived Cell Lines. Toxicol Sci 72, 253-259. 
Urabe, H., and Asahi, M. (1985). Past and Current Dermatological Status of Yusho Patients. 
Environ Health Perspect 59, 11-15. 
Vaziri, C., and Faller, D.V. (1997). A Benzo[a]Pyrene-Induced Cell Cycle Checkpoint 
Resulting in p53-Independent G1 Arrest in 3T3 Fibroblasts. J Biol Chem 272, 2762-2769. 
Vaziri, C., Schneider, A., Sherr, D.H., and Faller, D.V. (1996). Expression of the Aryl 
Hydrocarbon Receptor Is Regulated by Serum and Mitogenic Growth Factors in Murine 3T3 
Fibroblasts. J Biol Chem 271, 25921-25927. 
Veldhoen, M., Hirota, K., Westendorf, A.M., Buer, J., Dumoutier, L., Renauld, J.C., and 
Stockinger, B. (2008). The Aryl Hydrocarbon Receptor Links Th17-Cell-Mediated 
Autoimmunity to Environmental Toxins. Nature 453, 106-109. 
Villano, C.M., Murphy, K.A., Akintobi, A., and White, L.A. (2006). 2,3,7,8-
Tetrachlorodibenzo-p-dioxin (TCDD) Induces Matrix Metalloproteinase (MMP) Expression 
and Invasion in A2058 Melanoma Cells. Toxicol Appl Pharmacol 210, 212-224. 
Villard, P.H., Sampol, E., Elkaim, J.L., Puyoou, F., Casanova, D., Seree, E., Durand, A., and 
Lacarelle, B. (2002). Increase of CYP1B1 Transcription in Human Keratinocytes and HaCat 
Cells after UV-B Exposure. Toxicol Appl Pharmacol 178, 137-143. 
Vogel, C.F.A., Sciullo, E., Li, W., Wong, P., Lazennec, G., and Matsumura, F. (2007). RelB, a 
New Partner of Aryl Hydrocarbon Receptor-Mediated Transcription. Mol Endocrinol 21, 2941-
2955. 
Wakamatsu, K., Kavanagh, R., Kadekaro, A.L., Terzieva, S., Sturm, R.A., Leachman, S., 
Abdel-Malek, Z., and Ito, S. (2006). Diversity of Pigmentation in Cultured Human Melanocytes 
Is Due to Differences in the Type as Well as Quantity of Melanin. Pigment Cell Res 19, 154-
162. 
Wang, N., and Hebert, D.N. (2006). Tyrosinase Maturation through the Mammalian Secretory 
Pathway: Bringing Color to Life. Pigment Cell Res 19, 3-18. 
Wanner, R., Brommer, S., Czarnetzki, B.M., and Rosenbach, T. (1995). The Differentiation-
Related Upregulation of Aryl Hydrocarbon Receptor Transcript Levels Is Suppressed by 
Retinoic Acid. Biochem Biophys Res Commun 209, 706-711. 
   67 
Wanner, R., Panteleyev, A., Henz, B.M., and T., R. (1996). Retinoic Acid Affects the 
Expression Rate of the Differenation-Related Genes Aryl-Hydrocarbon Receptor, Arnt and 
Keratin 4 in Proliferative Keratinocytes Only. Biochim Biophys Acta 1317, 105-111. 
Wasmeier, C., Hume, A.N., Bolasco, G., and Seabra, M.C. (2008). Melanosomes at a Glance. J 
Cell Sci 121, 3995-3999. 
Wei, Y.-D., Bergander, L., Rannug, U., and Rannug, A. (2000). Regulation of CYP1A1 
Transcription Via the Metabolism of the Tryptophan-Derived 6-Formylindolo[3,2-b]carbazole. 
Arch Biochem Biophys 383, 99-107. 
Wei, Y.-D., Helleberg, H., Rannug, U., and Rannug, A. (1998). Rapid and Transient Induction 
of CYP1A1 Gene Expression in Human Cells by the Tryptophan Photoproduct 6-
Formylindolo[3,2-b]carbazole. Chem Biol Interact 110, 39-55. 
Wei, Y.-D., Rannug, U., and Rannug, A. (1999). UV-Induced CYP1A1 Gene Expression in 
Human Cells Is Mediated by Tryptophan. Chem Biol Inter 118, 127-140. 
Werlinder, V., Backlund, M., Zhukov, A., and Ingelman-Sundberg, M. (2001). Transcriptional 
and Post-Translational Regulation of CYP1A1 by Primaquine. J Pharmacol Exp Ther 297, 206-
214. 
Wernet, M.F., Mazzoni, E.O., Celik, A., Duncan, D.M., Duncan, I., and Desplan, C. (2006). 
Stochastic Spineless Expression Creates the Retinal Mosaic for Colour Vision. Nature 440, 
174-180. 
White, S.S., and Birnbaum, L.S. (2009). An Overview of the Effects of Dioxins and Dioxin-
Like Compounds on Vertebrates, as Documented in Human and Ecological Epidemiology. J 
Environ Sci Health C Environ Carcinog Ecotoxicol Revs 27, 197 - 211. 
Whitelaw, M., Pongratz, I., Wilhelmsson, A., Gustafsson, J.A., and Poellinger, L. (1993a). 
Ligand-Dependent Recruitment of the Arnt Coregulator Determines DNA Recognition by the 
Dioxin Receptor. Mol Cell Biol 13, 2504-2514. 
Whitelaw, M.L., Gottlicher, M., Gustafsson, J.A., and Poellinger, L. (1993b). Definition of a 
Novel Ligand Binding Domain of a Nuclear bHLH Receptor: Co-Localization of Ligand and 
Hsp90 Binding Activities within the Regulable Inactivation Domain of the Dioxin Receptor. 
EMBO J 12, 4169-4179. 
Whitlock, J.P. (1999). Induction of Cytochrome P4501A1. Annu Rev Pharmacol Toxicol 39, 
103-125. 
Wijayaratne, A.L., and McDonnell, D.P. (2001). The Human Estrogen Receptor-Alpha Is a 
Ubiquitinated Protein Whose Stability Is Affected Differentially by Agonists, Antagonists, and 
Selective Estrogen Receptor Modulators. J Biol Chem 276, 35684-35692. 
Wilhelmsson, A., Whitelaw, M., Gustafsson, J., and Poellinger, L. (1994). Agonistic and 
Antagonistic Effects of Alpha-Naphthoflavone on Dioxin Receptor Function. Role of the Basic 
Region Helix-Loop-Helix Dioxin Receptor Partner Factor Arnt. J Biol Chem 269, 19028-
19033. 
Wilkins, L., Gilchrest, B.A., Szabo, G., Weinstein, R., and Maciag, T. (1985). The Stimulation 
of Normal Human Melanocyte Proliferation in Vitro by Melanocyte Growth Factor from 
Bovine Brain. J Cell Physiol 122, 350-361. 
Wormke, M., Stoner, M., Saville, B., and Safe, S. (2000). Crosstalk between Estrogen Receptor 
[Alpha] and the Aryl Hydrocarbon Receptor in Breast Cancer Cells Involves Unidirectional 
Activation of Proteasomes. FEBS Letters 478, 109-112. 
 68 
Wormke, M., Stoner, M., Saville, B., Walker, K., Abdelrahim, M., Burghardt, R., and Safe, S. 
(2003). The Aryl Hydrocarbon Receptor Mediates Degradation of Estrogen Receptor Alpha 
through Activation of Proteasomes. Mol Cell Biol 23, 1843-1855. 
Wu, H., and Park, H.-Y. (2003). Protein Kinase C-[Beta]-Mediated Complex Formation 
between Tyrosinase and Trp-1. Biochem Biophys Res Commun 311, 948-953. 
Yamamoto, O., and Tokura, Y. (2003). Photocontact Dermatitis and Chloracne: Two Major 
Occupational and Environmental Skin Diseases Induced by Different Actions of Halogenated 
Chemicals. J Dermatol Sci 32, 85-94. 
Yamashita, F., and Hayashi, M. (1985). Fetal PCB Syndrome: Clinical Features, Intrauterine 
Growth Retardation and Possible Alteration in Calcium Metabolism. Environ Health Perspect 
59, 41-45. 
Zhou, J., and Gasiewicz, T.A. (2003). 3'-Methoxy-4'-Nitroflavone, a Reported Aryl 
Hydrocarbon Receptor Antagonist, Enhances CYP1A1 Transcription by a Dioxin Responsive 
Element-Dependent Mechanism. Arch Biochem Biophys 416, 68-80. 
Zodrow, J.M., and Tanguay, R.L. (2003). 2,3,7,8-Tetrachlorodibenzo-p-dioxin Inhibits 
Zebrafish Caudal Fin Regeneration. Toxicol Sci 76, 151-161. 
 
 
 
